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Abstract 
 
Polyurethanes are an attractive class of material for bioprosthesis 
development due to the ability to manipulate their elasticity and strength. 
However, their use as long term biological implants is hampered by 
biodegradation. A novel polyurethane has been developed which 
incorporates nano-engineered polyhedral oligomeric silsesquioxane within 
poly(carbonate-urea) urethane to improve the biostability of the latter. 
Previous investigators have found this material to be cytocompatible and to 
have low thrombogenicity. 
The medium and long term clinical results of currently available 
prosthetic small calibre vascular bypass grafts are poor, due to neo-intimal 
hyperplasia associated with their non-compliant properties. 
The investigation reported here commences with the benchtop 
manufacture of compliant small calibre grafts using an original extrusion-
phase inversion technique. The reproducibility of the technique as well as the 
effect on the pore structure of different coagulation conditions is 
demonstrated. Fundamental mechanical characterisation of the grafts 
produced is then presented, by way of tensillometry to demonstrate the 
viscous and elastic properties of the material. These are made more relevant 
to the clinical setting with functional mechanical characterisation of the grafts, 
showing graft compliance in a biomimetic flow circuit along with viscoelastic 
hysteresis, along with burst pressure testing. An examination of burst 
pressure testing methodology is also shown, in the light of the various non-
standardised strategies reported in the graft-testing literature. Mechanical 
characterisation shows the short-term safety for use, but durability studies in 
the biological haemodynamic environment serve to assess longer term 
fatigability as well as confirming biostability. This has been reported using a 
stringent ovine carotid interposition model which remained patent over the full 
investigation period representing at least 45 million pulsatile cycles. Physico-
chemical analysis; integrity of the structure, microstructure and ultrastructure; 
preservation of mechanical properties and immunohistological analysis were 
used to examine the grafts after implantation to show their healing properties 
and biostability. 
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compliant outer sleeve is abutted results in a composite stress strain 
relationship which can approximate the „J-shaped‟ stress-strain curve of 
artery. 
Fig 8.5. The typical sigmoid curve generated from tensile testing of polymeric 
samples. Tangential points are included to demonstrate the incremental 
elastic modulus at different parts of the curve. 
Fig 8.6. The compliance profiles of thick and thin-walled 6% POSS conduits 
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Fig 8.7. Increasing the hard segment results in a reduction of compliance. 
Fig 8.8.  Chain-disruption of the hard segment results in a maintenance of 
compliance. 
Fig 8.9. Burst pressures and standard deviations for each graft type. 
Fig 8.10. A single viscoelastic loop measured during steady pulsatile flow 
through a 2% POSS thin conduit. 
Fig 8.11. Fifteen consecutive viscoelastic cycles during steady state pulsatile 
flow through a 2% POSS thin conduit. The area within each loop was 
similar, with the demonstrated variation being caused by lateral conduit 
wall movement due to the pulsatile flow. 
Fig 8.12. Elastic Distension Ratios for each graft type with standard deviation. 
Fig 8.13.  Longitudinal strain due to pressure within the grafts: 2% POSS thin 
Fig 8.14.  Longitudinal strain due to pressure within the grafts: 2% POSS fat. 
Fig 8.15. Longitudinal strain due to pressure within the grafts: 6% POSS thin 
Fig 8.16. Longitudinal strain due to pressure within the grafts: 6% POSS fat. 
Fig 8.17. Longitudinal strain due to pressure within the grafts: 2% POSS thin 
with increased hard segment. 
Fig 8.18. Longitudinal strain due to pressure within the grafts: 2% POSS thin 
with hard segment chain disruption. 
 
Chapter 9 
Fig 9.1. Summary of the different burst pressure measuring techniques. 
Fig 9.2. Burst pressures obtained via the different measuring techniques. Data 
are mean±SD of six experiments. 
Fig 9.3. Subjecting a graft with an interconnected porous structure to 
intraluminal pressure of 300mmHg leads to „sweating‟ of water through 
the wall. 
Fig 9.4. The aneurysmal point is a more accurate term than burst pressure, 
defined as the point at which further infusion at the same rate does not 
result in any increase in pressure (in this case 347mmHg). 
 
Chapter 10 
Fig 10.1. The mechanism of free radical stimulated oxidative crosslinking of 
adjacent polycarbonate soft segments. 
Fig 10.2. Free radical mediated crosslinking between polycarbonate soft 
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segment and the hard segment. 
Fig 10.3. After initial (oxidative) free radical damage, polycarbonate soft 
segment degradation is caused by a combination of oxidative and 
hydrolytic means.  
 Fig 10.4. Uniform smooth lining on the lumen seen on longitudinal 
cleavage of the graft. The prolene suture (blue) at the anastomotic line is 
visible. 
 Fig 10.5. Close up of the smooth, uniform lumen lining of the explanted 
graft. 
 Fig 10.6. The fibrous capsule surrounding the explanted graft. 
 Fig 10.7. Cross section of the explanted graft, showing the florid fibrous 
capsule. The section has been cut near the anastomotic line, showing 
the native artery and the suture line. 
 Fig 10.8. Outer Surface SEM of the explanted graft showing no evidence 
of pitting, fissuring, cracking or balding. Scale bar is 125μm 
Fig 10.9. Inner lumen SEM showing ultrascopic ridges covered with a lattice 
structure. Scale bar is 125μm 
Fig 10.10. Higher magnification SEM of the ultrascopic ridges of the lumen 
lining of the explanted graft showing cell-like structures on the surface 
with varying degrees of flattening. Scale bar is 10μm. 
Fig 10.11. H&E staining of the graft wall, showing the lumen (superior). 
Fig 10.12. CD31 antibody staining showing uptake throughout the slide 
including the graft wall. There is a concentration of uptake at the blood 
contact surface on the periphery of the fibrinocellular layer which 
developed within the graft lumen. There is a second increased uptake in 
cellular tubular organisations within the pores. 
Fig 10.13. The immediate graft wall luminal surface where the fibrinous layer is 
not present showing increased uptake of the anti-vWF immunostain. 
Fig 10.14. Small tubular cellular structures within the graft pores which 
immunostain heavily with anti-vWF. 
Fig 10.15. FTIR analysis of the pre and post-implantation grafts showing 
preservation of the Si-O peak at 1240 cm-1 and the -NHCO- bonds at 
1740 cm-1. 
Fig 10.16. The compliance of the post-implantation graft compared with the pre-
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implantation graft. The results are shown for the graft alone and with the 
fibrous capsule attached. 
Fig 10.17. TGA results for the pre-implantation and post-implantation grafts, 
showing the two distinct points of increasing weight loss as the 
temperature is increased – approximately 275 and 425°C. This is the 
same for both samples. 
Fig 10.18. DSC thermograms for pre and post-implantation grafts. There was no 
significant difference in Tg. The test was terminated at 250°C which was 
before the melting point (Tm) was reached. 
Fig 10.19. DMA result showing the storage modulus from the glassy phase, 
through the Tg into the rubbery plateau for the pre and post-implantation 
grafts. The increase in storage modulus after implantation is significant in 
the glassy phase. 
Fig 10.20. DMA result showing the loss modulus from the glassy phase, through 
the Tg into the rubbery plateau for the pre and post-implantation grafts. 
The increase in loss modulus after implantation is significant in the glassy 
phase. 
Fig 10.21. Tan δ against temperature for pre and post-implantation grafts, 
showing the maximum peak value, corresponding with Tg. 
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4mm ePTFE sourced from same graft. 
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Table 7.3. Results obtained from longitudinal tensile testing of dogbone 
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shaded samples were technically failed tests due to graft slippage (T2) 
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area (F1). 
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their proportion overall (without adding more POSS) and by interrupting 
their three dimensional structure. 
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Table 9.2. Methods used and results obtained for burst pressure testing of 
tubular conduits over the last ten years. A Medline search was 
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Table 10.1. Graft summary for each sheep, including duplex results pre and 
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Table 10.2. Burst pressure for the graft pre and post-implantation. The post-
implantation burst pressure was obtained with and without the fibrous 
capsule. 
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1 
Development of a synthetic small calibre vascular bypass graft 
 
1.1 Introduction 
 
The infrainguinal arterial bypass is one of the key vascular procedures1, 
with an estimated 12810 revascularisation procedures carried out in 1993 in the 
United Kingdom with a lower limb critical ischaemia prevalence of 1 in 2500. 
More recent actual (non-estimated) figures have not been available although 
there is a national database of index vascular procedures (Dendrite) which 
relies on voluntary data submission. Approximately 50% of the membership of 
the Vascular Society of Great Britain and Ireland (VSGBI) does not submit 
numbers to the database. The success of lower limb arterial bypass is limited if 
a prosthetic graft is used2 or the distal anastomosis crosses the knee joint  (Fig 
1.1). 
 Wherever possible, the patients own long saphenous vein is used3; 
however, this is not available or suitable in a significant proportion of cases4. 
Arm veins may be used with primary patency of 60%-85% at 3-5 years5, the 
difference with saphenous vein being attributable to previous venepuncture, 
phlebitis, oversized diameter, a propensity towards phlebitis and aneurysmal 
dilatation. Human umbilical vein grafts, which are commercially available have 
been shown to have a higher patency than prosthetic alternatives, but are prone 
to aneurysm formation in the long term and their use has not been widespread6.  
Cryopreserved allografts have one year patency rates of only 52%7 with the 
additional complications over autologous grafts of immunoreaction and proximal 
post-anastomotic stenosis. Good patency rates with the use of segments of the 
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deep venous system of the leg have been found8 with Schulman achieving 89% 
secondary patency at 3 years in selected patients9, but the surgery is difficult 
and prolonged due to the need for extensive dissection at both the proximal and 
distal anastomotic sites; also the fear of severe venous oedema as a result of 
venous outflow obstruction10 has meant that this approach has never been in 
favour with clinicians. The main prosthetic materials developed for bypass 
grafting are polyethylene terephthalate (Dacron) and polytetrafluoroethylene 
(PTFE). The former is a condensation polymer obtained from ethylene glycol 
and terephthalic acid. It is manufactured into a woven corrugated graft that is 
suitable for large vessel segment replacement where flow rates are high, such 
as diseased aorta replacement. In small vessel disease however, there is 
considerable reaction between Dacron and the native artery as well as with 
blood11 causing a rapid build up of fibrin at the blood/graft interface, so making it 
appear unsuitable for infrainguinal bypass. However, the early experience of 
high thrombogenicity of Dacron grafts resulting in poor results infrainguinally 
has not been reevaluated in the light of platelet inhibitory therapy and the 
development of coated Dacron grafts which remove the need for pre-clotting. 
Devine and McCollum12 have recently reported a multicentre randomized 
controlled trial with a minimum of five years follow-up where heparin-bonded 
Dacron showed a greater patency than PTFE for the first three years with a 
statistically insignificant difference thereafter. Expanded PTFE has achieved 
widespread use as a smaller diameter tubular graft for infrainguinal bypass. In 
above knee femoropopliteal revascularisation, individual groups have published 
data to suggest that the patency rates when using PTFE are not significantly 
different to that for saphenous vein13;14. However, these studies lack power and 
a meta-analysis of the collated data showed that at every point in time, the 
patency was greater when autologous saphenous vein was used3. 
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Fig 1.1 Distal bypass using PTFE has considerably worse patency than 
proximal bypass or autologous vein grafting13;15;16. 
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1.2 Historical Perspective 
 
1.2.1 The birth of vascular bypass surgery 
 
Modern vascular surgical practice has evolved as a result of the 
development of angiography. This in turn was made possible by the observation 
of the Roentgen ray (or X-ray) by Wilhelm Konrad Roentgen in 1895 for which 
he was awarded the Nobel Prize. It was around this time that Alexis Carrel 
(another Nobel laureate) started considering the repair of vascular structures 
and in particular, the use of venous conduits, vascular anastomosis and aseptic 
technique. Soon after, x-ray visualisation of cadaveric vessels was 
demonstrated by Haschek and Lindenthal. Brooks used iodine-based contrast 
media for lower-limb arteriography in 1923 and in 1929 Reynaldos Dos Santos 
performed translumbar aortography. His son, John Cid Dos Santos 
subsequently developed endarterectomy, which he called “disobliteration of the 
artery”. In 1948, autologous saphenous vein was used by Kunlin17 to 
successfully bypass a popliteal „swelling‟ and subsequently femoropopliteal 
bypass.  
Since that time, no conduit has managed to better or even match the 
patency rates of autologous vein segments for small vessel peripheral vascular 
bypass in the distal limbs. This is despite a considerable research effort aimed 
at developing alternatives. The drive for this research is due to two factors. 
Firstly, autologous vein is not available for bypass in approximately a third of 
patients. In addition, the long term patency rates of the available alternatives are 
poor, causing high re-intervention rates, morbidity and low quality of life. A very 
short period of clinical trials of allografts was terminated due to antigenicity 
problems encountered, leading to dilatation and aneurysm, even after 
attempted attenuation with ethylene oxide; radiation; cryopreservation; protein 
denaturing and dessication.  
Whilst angiography and anticoagulant technology was developing, 
attention was focusing more and more on synthetic materials as possible 
vascular replacement. Voorhees‟ critical observation that a loose silk thread in 
the canine right ventricle became coated with a glistening endothelial-like 
surface which did not attract a thrombus covering lead to him replacing a canine 
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aorta with vinyon-N in 1952, after experimenting with silk handkerchiefs and 
nylon. He determined that the glistening layer was mainly fibrin and realised that 
it was necessary to encourage fibroblast infiltration and reorganisation with a 
porous structure to achieve endothelialisation. Vinyon-N afforded these 
properties as well as enough stiffness to prevent buckling of the conduits on 
bending and tissue incorporation. In 1954 Voorhees undertook a  successful 
clinical trial with 17 femoropopliteal bypasses and a popliteal aneurysm 
bypass18. 
This success achieved with vinyon-N stimulated the clinical evaluation of 
grafts made from a number of textiles including Nylon and Orlon in 1955. 
However, all of these synthetic fabrics lost tensile strength over time after 
implantation. In 1957 DeBakey introduced Dacron, which due to its superior 
post-implantation fatigue testing quickly became the gold-standard synthetic 
graft for aortic aneurysm repair and remains so to this day. In 1965, Dacron 
grafts were modified by adding a velour component to the inner and outer 
surfaces to provide a filamentous texture which encouraged tissue attachment 
and simplified the pre-clotting process. External support was added to resist 
kinking of grafts as they crossed joints. 
However, the success of Dacron in large calibre high flow vessel 
replacement was not replicated when considering small diameter vessels with 
low flow rates. Here the relative vascular stasis combined with inherent 
thrombogenicity of the material caused early thrombotic occlusion and 
neointimal hyperplasia concentrated at the anastomotic sites contributed to 
long-term failure. Instead, the search shifted away from textile technology 
towards polymeric synthetics. 
 
1.2.2 Peripheral artery bypass 
 
The drive to find suitable alternatives to autologous vein for lower limb 
bypass was given fresh impetus by the commencement of the Korean war in 
1950. Vein grafting for arterial injury salvaged thousands of limbs19 but the 
traumatic extent left many more victims without available vein. This was in direct 
contrast with the apparent indifference and delay in building on Carrel‟s work on 
venous grafts, until Kunlin revisited it two world wars later. In 1959, 
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polytetrafluoroethylene (PTFE) grafts were introduced by Edwards (Teflon). 
Aortic grafts were difficult to make from PTFE but they were successfully used 
by Matsumoto in 1973 for small calibre arterial replacement20. Initial evaluation 
of clinical trials suggested PTFE to be as effective as vein for infrainguinal 
bypass21;22. However, medium term use demonstrated neointimal hyperplasia 
as a mechanism for graft occlusion23. In 1978, Kidson and Abbott made the 
direct association between occlusion and the lack of elasticity of PTFE and 
Dacron24. This association appeared stronger for distal bypass involving small 
calibre vessels (<6mm internal diameter). Controversy exists however as to 
whether or not graft inelasticity results in neointimal hyperplasia. Nevertheless, 
alternative graft materials to PTFE for small vessel bypass have been sought, 
concentrating on elastic materials, with a view to compliance matching between 
graft and artery. 
The classes of material investigated with limited success so far as potential 
synthetic small diameter vascular grafts include polypropylene, silicone rubber 
and polyurethanes.  
 
1.2.2.1 Polypropylene 
 
Polypropylene has the advantages of having low thrombogenicity, low 
inflammatory reaction and a highly crystalline, hence strong structure. However, 
this crystallinity means that it is non-compliant like PTFE. It is susceptible to 
slow oxidative degradation in vivo but as a small calibre vascular graft, has 
been shown to outperform PTFE in the medium term25. However long term 
biostability is suspect, with surface cracking and serious wall weaknesses 
developing over several years, making polypropylene ultimately unsuitable26. 
Therefore, this polymer has since been discounted from further investigation. 
 
1.2.2.2 Compliant materials for peripheral artery bypass 
 
Sottiurai has characterised intimal hyperplasia in detail and shown it to 
be multiple laminae of extracellular matrix (ECM) and cells – principally 
myofibroblasts deep to the lumen and mesenchymal type cells adjacent to the 
lumen27. He has also shown that physical stresses on smooth muscle cells 
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trigger their synthesis of ECM28. In vitro flow simulations and mathematical 
models have demonstrated that anastomotic geometry29 and inelastic grafts30 
contribute to abnormal stresses at the heel, toe and floor of the anastomotic 
region – precisely the points of intimal hyperplasia. Any approach to optimise 
anastomotic geometry and simulate the elastic nature of the native artery will 
therefore reduce intimal hyperplasia, which is the principle cause of medium 
term occlusion in small vessel bypass. This has been the driving force behind 
the development of compliant materials as vascular conduits. 
 
1.2.2.2.1 Silicone rubber 
 
The need for high elasticity would suggest silicone as a potential graft 
material, as it is largely inert31 with low leucocyte and complement activation32. 
Its medical use is well established including long term implantation33 and 
demonstrable in vitro biostability34. Silicone elasticity is not lost after 
implantation and tissue incorporation35. However, the hydrophobicity of pure 
polysiloxane makes it thrombogenic, with a high affinity for fibrinogen. Therefore 
graft technology exploiting the compliance characteristics of silicone have 
involved hydrophilic copolymer copolymerisation36 or organic group 
attachment37 to reduce thrombogenicity. 
Recently, however, the issue of long term biostability has been 
readdressed, mainly due to a number of reports of rupture and migration of 
silicone breast implant material38. Silicone bonds may hydrolyse and oxidise, 
with accumulation of silica and other breakdown products in the liver39. This 
long term uncertainty has meant a move away from the use of silicones in 
biomedical devices involving prolongued implantation. 
 
1.2.2.2.2 Polyurethane 
 
The nylons were discovered in 1935 and soon monopolised the synthetic 
textile market with multiple patents ensuring exclusivity for DuPont. The search 
for alternative fabrics lead to the discovery of polyurethanes in 1937 by Otto 
Bayer40. Initially, his product was viewed with scepticism but the concept of 
reacting diisocyanates with diols or diamines to form chains linked by urethane 
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bonds, soon attracted widespread interest due to the sheer range of physical 
characteristics possible. In particular they could be hard or soft; flexible or rigid. 
They were seen as superior to silicone for implantation purposes due to their 
considerable hardness. This translated to greater flex-fatigue resistance in the 
case of Lycra. Marketing Lycra under the tradename Biomer signalled an 
explosion in polyurethane development for medical device technology.  
The initial polyurethanes considered utilised polyester as the amorphous 
macroglycol matrix in which the crystalline urethane-linked hard segment 
floated. However the ester bonds were shown to undergo rapid hydrolysis and 
degradation in vivo, making them unsuited to use within the body, even for short 
periods. Polyether macroglycol was more promising allowing implantation for 
over a week, before any signs of surface fissuring. The ether bonds were 
susceptible to slow oxidative degradation. They were suited to temporary 
implantation and biomer was clinically tested as a material for temporary 
ventricular assist devices, showing mechanical integrity in the short term41. The 
biostability of polyurethanes is considered in detail in Chapter 10. 
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1.3 Current Standing 
 
Even now, there is no synthetic small calibre vascular prosthesis which 
has been clinically proven to improve on PTFE. The vascular surgical 
community is desperate for an improved graft due to the poor long term patency 
of PTFE grafts <6mm despite immaculate surgical technique, medical adjuncts 
and patient cooperation. For this reason, if autologous vessels are available, 
they are used whenever possible for small vessel replacement. However, 
suitable autologous vessels are not always available, and so PTFE is often 
necessary despite its poor performance. In the United States, vascular 
surgeons‟ performance is already assessed and compared by operative 
success rates for key procedures such as peripheral artery bypass. This is also 
being formally instituted in the United Kingdom via the VSGBI and informally via 
freedom of information requests from the national media. However as things 
currently stand, the success of distal bypass may have more to do with 
availability of good quality saphenous vein than surgical competence. 
 
1.3.1 Polycarbonate-based polyurethane 
 
For longstanding implantation without biodegradation, the polycarbonate 
macroglycol is currently considered to be much more stable than either 
polyester or polyether. The Chronoflex graft is made from polycarbonate 
macroglycol, eliminating ester and ether links42 and thus improving biostability. It 
is an elastic self sealing graft, making it potentially suitable for vascular access 
and small vessel bypass43. Compared with its contemporary polyurethanes, it 
has favourable haemocompatibility44, although its thrombogenicity can be 
lowered further by surface modification45-47 or endothelial cell seeding48. 
Unfortunately, even polycarbonate-based polyurethane shows biodegradation 
and aneurysmal changes after just 10 weeks implantation in a sheep model47. 
In fact, polycarbonate soft segments are susceptible to hydrolysis, as might be 
expected from their chemical structure. However, it is the enhanced hard 
segment interaction with polycarbonate which can render the overall structure 
resistant to degradation49. The challenge now is to optimise this interaction to 
yield a non-biodegradable graft.
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1.3.2 Poly(carbonate-urea) urethane incorporating polyhedral oligomeric 
silsesquioxane nanocomposite 
 
The initial aim in producing this nanocomposite polymer was to improve 
biostability further for long term biological implant functionality. However in vitro 
studies have shown it to have a very favourable blood compatibility profile as 
well50. This suggests the exciting prospect of a novel compliant synthetic 
vascular bypass prosthesis. The problems associated with graft thrombosis and 
neointimal hyperplasia are most prevalent in small calibre (<6mm) prostheses, 
leading to poor medium and long term results, so the development of these 
conduits from the nanocomposite would have the highest impact. 
 
1.4 The Importance of mechanical testing 
 
The major reasons for extensive testing of new materials at every stage 
of their development include: 
 
a. Safety. 
b. Proof of reliability. 
c. Quality control. 
d. Show adherence to accepted standards. 
e. Demonstrate improvement over established products. 
 
 
Historically, the development of potential synthetic small calibre bypass 
prostheses has been rushed with a number of fundamental mechanical flaws 
being uncovered only after clinical use has started. PTFE was initially 
introduced clinically with a reported burst pressure of 600mmHg51. However, 
after human implantation, a number of early reported aneurysms of the graft 
wall required further reinforcement and improvements in the sintering process 
used. 
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1.5 Thesis overview 
 
The above highlights the great importance of rigorous mechanical testing 
of potential grafts. To this end, a discussion of the mechanical properties which 
need to be considered when developing small calibre vascular prostheses 
follows. If mechanical properties relate to intimal hyperplasia and its role in 
medium and long term graft occlusion, thrombogenicity of synthetic materials 
cause immediate occlusion with thrombus. The blood compatibility of the 
polymer has been shown to be highly favourable previously50. This unique 
property could not be predicted at the conceptual stages for the nanocomposite, 
and the mechanism is not fully understood. Nevertheless, when considering low 
flow states, anti-thrombogenicity is hugely desired and manipulation of materials 
to this aim is a large field of research. An examination of graft surface 
thrombogenicity as well as the methods used to improve the blood:graft 
interface is reviewed. The opposite philosophy is to accept the inherent 
thrombogenicity of synthetic materials, and look to alternatives. This view has 
contributed to the determined trek towards the tissue engineered vascular graft. 
The rapid advances in this blood vessel replacement technology have been 
appraised, with emphasis on the clinical viability of the tissue-engineered 
approach. The original work presented commences with the description of a 
novel process for the manufacture of porous tubular conduits from the polymer 
solution. Mechanical characterisation of the resultant grafts was undertaken. 
The mechanical properties as relevant to the physiological and surgical 
environments were also elucidated. These two served to describe the 
viscoelastic nature of the grafts as well as assessing their mechanical safety for 
in vivo work. The grafts were exposed to haemodynamic flow within the 
biological environment in a long-term ovine model and the results are reported 
here. The aim in carrying out these testing procedures is to show their potential 
for further development as vascular bypass grafts for clinical use. Industry 
standard test methods have been used, and where test standards are 
controversial, these controversies have been delineated with justification for the 
methodology used. 
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2 
The mechanical properties of infrainguinal vascular bypass grafts: their 
role in influencing patency. 
 
2.1 Introduction 
 
Small diameter grafts (<6mm) are especially liable to occlusion and 
research into the causes of this failure and possible alternative materials with 
properties more akin to the original artery has been undertaken in recent times. 
Between 2 and 24months, Intimal Hyperplasia (IH) has been shown to be 
responsible for poor graft patency52. Vascular endothelial cell damage triggers 
the formation of  IH. The postulated reasons for IH are mechanical in origin; the 
difference in compliance between native vessel and graft; change in direction of 
flow at the anastomosis; luminal diameter difference at the anastomosis; vessel 
wall damage53 and suture technique54. Interposing an autologous vein cuff, and 
in so doing, making the compliance mismatch more gradual,  redistributes IH 
away from the most critical areas of the anastomosis, principally the heel, the 
toe and recipient artery floor55, leading to some improvement in patency but 
keeping the overall levels of IH unchanged. 
Fluid dynamics studies have revealed how endothelial damage may 
result from compliance mismatch. The cells are directly affected by altered 
stresses of blood flow through the anastomosis, known as wall shear stress 
(WSS). Even within the human arterial system, the shear stress varies between 
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different vessels56 with superficial femoral artery mean wall shear rates of 130.3 
sec-1 compared with a carotid value of 333.3 sec-1. In addition, in a large vessel 
such as the aorta, WSS and flow rate have been shown to vary according to 
different physiological conditions such as exercise. This is obviously not 
associated with IH. Experimental evidence suggests both high and low57 shear 
stress as causative factors for IH. One explanation for this would be that it is the 
resultant flow pattern changes rather than the shear stress itself that is the 
cause. These include divergent flow associated with low shear stress resulting 
in flow separation, rarefaction and increased oscillatory shear. On the other 
hand, there is convergent flow associated with high shear stress which is 
responsible for endothelial cell injury. 
The research into alternatives to ePTFE and Dacron has concentrated 
on new materials with viscoelasticity properties similar to native artery, 
principally polyurethane due to its compliance and favourable biocompatibility. 
This review aims to discuss the critically important roles mechanical properties 
such as viscoelasticity and haemodynamics play in maintaining patency of 
infrainguinal bypass grafts. 
 
2.2 Basic Mechanical Theoretical Considerations 
 
Poisseuille‟s law states that the head of pressure flowing in a tube (P) is 
directly proportional to the tube length (L), the rate of flow (Q) and the viscosity 
(η), and inversely proportional to the fourth power of the internal radius (ri) of 
that tube. 
 
           (1) 
          
Substituting the Ohms Law analogy which states that P=RQ 
(R=impedence) and the value of K, calculated experimentally: 
 
           (2) 
 
Therefore, when considering bypass conduits, the impedance to flow is 
drastically increased by reducing the graft calibre, thereby reducing flow rate 
and increasing the risk of vascular stasis and so promoting the thrombogenic 
 
P= KLQη/ri
4 
 
R=8ηL/πri
4 
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state. 
However these equations hold only for pure laminar flow in a rigid pipe – 
every particle is moving parallel to the axis of the tube with a constant velocity. 
Within one lamina, all particles will have the same velocity and moreover, 
laminae near the centre of the tube have greater velocity than more peripheral 
ones – this flow profile being parabolic. (See Fig 2.1). 
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Fig 2.1. The parabolic profile of laminar flow. A purely „Newtonian‟ fluid displays 
this flow pattern. However, blood is not a homogenous mixture of small 
particles, and so is not „Newtonian‟ in its behaviour. 
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These theoretical considerations do not hold true completely in the 
arterial system for numerous reasons. Firstly, the artery is not a rigid pipe. In 
fact it is a complexly compliant structure with intrinsic and extrinsic mechanisms 
to vary its compliance and shape, and in so doing, contributing to the pressure 
for flow itself. Next, blood flow only approaches laminar flow in the largest 
arteries. Even in these vessels, the rate of flow is not steady and it is only in 
diastole and early systole that laminar flow is observed. Turbulent flow due to 
branching vessels is also widespread. Being a suspension of particles of 
various size, blood is a non-Newtonian fluid. This makes its behaviour 
unpredictable, especially in small diameter vessels. 
Nevertheless the laminar model can be used to describe useful concepts 
in the investigation and description of the mechanical properties of blood 
vessels and flow. One such model is Wall Shear Stress (WSS). 
The resistance R in Poiseuille‟s Formula relates to the impedence to flow 
of a particle in one lamina caused by the friction of the adjacent lamina. In the 
same way, at the most peripheral lamina there is a force exerted by the particles 
flowing here on the wall of the vessel itself. This action against the wall is 
termed WSS. Therefore when considering the vessel wall; 
 
 
          (3) 
 
The tendency for deformation of the vessel wall due to pulsatile flow of 
blood within it is, within physiological limits, elastic. This is to say that if the 
blood force is removed, the vessel will return to its previous shape. However, 
the force does not cause an instantaneous deformation, like when a weight is 
placed on a spring. The shape change, in the presence of a constant force is a 
gradual one and the same is true when the force is removed. This property of 
delay is termed viscosity. The blood vessel demonstrates a combined 
viscoelastic tendency. 
Overall the mechanical behaviour of an artery is complex. The ideal graft 
for anastomosis would replicate this behaviour. In order to simplify the 
investigation and description of this behaviour in arteries and graft materials, the 
term „compliance‟ is used, encompassing  the changing mechanical properties 
depending on the haemodynamic pressure within the graft, unlike established 
 
WSS =R= 8ηL/πri
4 
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physical concepts such as Young‟s Modulus, E58, which increases with 
increasing pressure within the compliant graft lumen59. At a given pressure P in 
a vessel of diameter d and wall thickness t: 
  
E=stress/strain=(Pd/2t)/(d/d)   (4) 
Rearranging this: d/dP ie. Compliance = d/2Et   (5) 
 
 Compliance is therefore inversely proportional to vessel wall thickness, 
and manufacturing a synthetic graft with a thinner wall results in greater 
distensibility. Conversely, patients with peripheral vascular disease have 
increased intima-media thickness, contributing to their rigidity60. 
 The overall result of the viscosity of the arterial wall and its compliance 
(ie. viscoelasticity) is to convert the pulsatile ejection of the heart into a 
continuous flow, storing a part of the energy of propulsion in systole and 
restoring it to the circulation during diastole. Therefore, viscoelasticity is 
important in energy transfer and dissipation. All vascular tissues have greater 
dimensions during unloading than during loading, leading to a hysteresis loop 
when the pressure/diameter characteristics of the vessel are plotted on a graph 
(Fig. 2.2).  
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Fig 2.2. The hysteresis loop observed during repeated cycles of applying and 
removing a force from a vessel wall as would occur during pulsatile flow. 
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The area within the loop represents the loss of energy to the vessel wall 
and so viscosity. Very high viscosity may reduce distensibility under dynamic 
pressure conditions and arterial viscosity is higher in vitro than in vivo. 
Boutouyrie‟s group61 hypothesized that this was in part endothelium-dependent, 
the mechanism of control being via vascular smooth muscle (VSM) tone. They 
showed that de-endothelialization lead to a 40% rise in viscosity. However, the 
same department subsequently investigated the viscosity of arteries subjected 
to phenylephrine and sodium nitroprusside, and thereby providing a range of 
VSM tone62. They showed that there was no significant difference in viscosity 
with different VSM tone and found that viscosity rose with rising pulse pressure. 
This has been confirmed clinically with the arteries of hypertensive patients 
found to have greater viscosity than equivalent normotensive controls63. Other 
investigations of the mechanical properties of arteries that have not specifically 
concentrated on viscosity have measured the phase delay between pulse 
pressure and distension(ie. the dampening effect). This method demonstrates 
viscosity when considering a single pulse of flow. However, in physiological 
pulsatile flow, the alternating storage and discharge of energy by the vessel wall 
leads to an intrinsic energy capacitance as well as a continuous loss of energy, 
which is more accurately measured from hysteresis curves. 
 
2.3 Mechanical variables influencing graft success 
2.3.1 Compliance 
 
 There is widespread reporting of compliance mismatch being primarily 
responsible over geometric factors30 for IH and subsequent poor graft patency24 
(see Table 2.1). 
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 Compliance * 1 Yr % Patency 2 Yr % Patency 
Host artery 5.9 - - 
Saphenous vein 4.4 88 84 
Umbilical vein 3.7 83 80 
Bovine heterograft 2.6 65 59 
Dacron 1.9 65 42 
ePTFE 1.6 60 42 
*% radial change per mm Hg x10-2 . Adapted from Walden et al.64 
 
Table 2.1.  The positive correlation between graft compliance and patency when 
used in infrainguinal bypass 
 
However, rather than the compliance per se, it is in fact that the resultant 
haemodynamic flow changes cause increased shear stress to damage 
endothelial cells and reduced shear stress65 leading to areas of relative stasis 
and increasing interaction between platelets and vessel wall; pooling of 
chemokine factors66 promoting IH as well as increasing oscillatory forces. The 
aim of matching compliance is to minimise these disruptive flow characteristics. 
The creation of an anastomosis itself causes a local reduction of 
compliance at the suture line, as shown by Ulrich and colleagues67 on artery to 
artery end to end (ETE) anastomoses. A continuous suture technique causes a 
greater loss of compliance than interrupted sutures54 with greater concentration 
of stresses at the suture line tethering it against distension in the case of the 
former. Clips that do not penetrate the intima also results in an anastomosis with 
less compliance mismatch (CM)68. 
 It is postulated that the high flow at the proximal anastomosis is partly 
protective as it allows for the rapid dispersal of chemotactic factors released 
due to endothelial injury. It is the distal anastomosis where the majority of IH is 
seen. Here the artery is of small calibre, especially in an infragenicular bypass 
and even a slight thickening of the intima will cause a considerable stenosis, 
compared with a large calibre vessel (see fig.2.3/table2.2). 
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Fig 2.3. The consequence of a 1mm graft stenosis is much greater in a small 
caliber vessel than in a large caliber conduit.    
 
 
Graft diameter 
(mm) 
Cross-sectional 
area A (mm2) 
Cross-sectional area after 1mm 
stenosis a (mm2) 
A/a 
2  /4 0.25 
3 2.25  0.44 
4 4 2.25 0.5625 
5 6.25 4 0.64 
6 9 6.25 0.69 
7 12.25 9 0.73 
8 16 12.25 0.77 
 
Table 2.2. Proportional change in cross sectional area (A/a) due to a 1mm 
reduction of internal diameter. 
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The proportional change in cross-sectional area for a graft with diameter 
d and calibre reduction d is given by the equation: 
 
  1-2d/d + d2/d2   (6) 
 
  Stenosis due to IH promotes platelet adherence, thrombus formation and 
resultant graft blockage by causing abnormal flow disturbances as outlined 
earlier. 
 The vortices created by the compliance mismatch is further complicated 
by a perianastomotic hypercompliance zone (PHZ)54;68;69 (see Fig.2.4). This 
contributes to give the overall perianastomotic region compliance properties 
somewhere in between those of artery and graft (see Fig. 2.5).  
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Figure 2.4. Illustration of the para-anastomotic hypercompliance zone 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5. For an anastomosis between ePTFE and native artery, the per-
anastomotic compliance is intermediate between that of its constituent vessels. 
Adapted from Sonada et al.70 
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This has been confirmed experimentally by Sonada and co-workers70. 
The artery‟s J-shaped curve of compliance shown in Figure 6 demonstrates 
how it does not obey Hooke‟s Law when subjected to pulsatile flow. It is due to 
highly elastic elastin fibres controlling its distension at low pressure flow and 
relatively inelastic collagen fibres taking over at higher pressures71. At 
100mmHg only 5-6% of collagen fibres are recruited with progressive 
recruitment with rising pressure. Physiological influence causes recruitment of 
vascular smooth muscle cells in conjunction with some collagen fibres with 
elastin fibres bearing the remaining share of the stress72. 
 Design of alternative grafts to ePTFE has concentrated on achieving a 
compliant structure. This has been approached in several ways including 
porous „spongy‟ materials73 and co-axial double tubular grafts with a more 
compliant inner lining and a less compliant outer layer74. As these latter grafts 
are distended, they become progressively less compliant as the outer sleeve 
properties become more prominent. Our own unit has produced and 
characterized  porous compliant poly(carbonate)polyurethane (PCU) grafts 
(MyolinkTM)75-77 – see Fig 2.6. 
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Variation of compliance for different conduits
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Figure 2.6. Tai‟s investigation of compliance in a flow circuit showed the 
„anisotropy of compliance‟ for the external iliac artery – the distensibility is 
dependent on the pressure level at which the distending stress is exerted. The 
commercial bypass graft materials have low compliance compared to the artery, 
but saphenous vein also has low compliance, illustrating the importance of 
cellular and biochemical factors in graft success. PCU refers to poly(carbonate-
urea) urethane, which is the basis for the nanocomposite. 
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Another aspect of interest to graft designers is the long term change in 
compliance of a graft after implantation. The artery has an astonishing capacity 
to maintain its intrinsic compliance despite abnormal chronic physiological 
changes such as hypertension78. This is observed to cause wall thickening but 
compliance is unaffected due to intrinsic changes in the vessel wall properties79. 
Interestingly, when a vein graft is used, it undergoes wall thickening which also 
does not lose its compliance properties64. However, the effect of the 
surrounding tissues on an implanted prosthetic graft is to reduce compliance 
with time80. This is especially the case in porous structures with a pore size 
greater than 45m when considerable fibrous tissue ingrowth takes place81. 
MyolinkTM with its small pore size does not lose compliance after implantation in 
an animal model for 36 months82.  
A variety of methods have been employed to measure conduit 
compliance in the research setting, although it is not routinely investigated 
clinically. The majority of research carried out to date has been based on the 
measurement of diameter changes at given pressures. Accurate (blood) 
pressure measurement can be obtained through use of a pressure transducer 
device both in-vivo and in-vitro. In the former case, this requires invasive 
introduction of an arterial catheter which may have significant complications 
such as bleeding and embolism. 
The alternative in vivo and particularly in human studies is to use indirect 
blood pressure measurement via sphygmomanometry. This is less accurate for 
absolute pressures as well as temporally less precise. Peripheral pressure 
measurement does not completely reflect central blood pressure due to the 
physiological increase in pulse pressure between the central arteries and the 
periphery83. Interestingly, the loss of compliance in calcified vessels results in 
the disappearance of this difference, and in the elderly patient with peripheral 
vascular disease, peripheral blood pressure equals its central counterpart. 
 Multiple modalities have been used to measure the diameter of vascular 
conduits. These are again invasive or non-invasive. In vitro models have the 
advantage of having the conduit free of surrounding tissues. However, 
explantation or even surgical dissection of arteries in-vivo inherently changes 
the compliance properties being measured84.  The most invasive techniques 
involve placing electrical transducers against the internal vascular wall. 
Electromagnetic principles are used to measure internal diameters using 
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Intravascular Absolute Induction Angiometry in this way85. A pre-sized 
intravascular loop is introduced to line the artery wall in a circumferential 
direction. This loop is made up of 3 separate wires. One of these wires has a 
high frequency alternating current flowing through it. This causes the generation 
of an electromagnetic force which varies depending on the wire circumference 
and is transduced by the other two wires into precise internal diameter readings 
in real time. Exposed vessels can also be visualised closely using high speed 
camera technology and calibrated measurement software69 or scanning laser 
beams86 seeking out photocells on the far side of the vessel. These 
technologies however measure the external wall diameters. The difference 
between the two is roughly equal throughout and hence does not affect the 
resultant compliance significantly87.  
 Historically, human studies have involved the use of electrical 
transducers intraoperatively88 but these are individualised time intensive studies 
that could not be used in routine practice. More recent is the use of various 
ultrasound techniques, principally using wall tracking mode high frequency 
ultrasound89 or radiofrequency (RF) signal based systems, which requires 
equipment that is now widely available. Vernhet et al90 have evaluated the use 
of standard B mode ultrasound to measure compliance. This method gives 
lower resolution pictures and uses a simultaneous ECG trace for timing with 
average systolic and diastolic pressure changes. They have compared this 
system preoperatively against sonomicrometry postoperatively in a similar 
animal model. Their main difficulties were in ensuring perpendicular views of the 
aortas, correcting for respiratory movement and obtaining high quality artifact-
free views. Long and colleagues91 used similar tissue doppler imaging on 
human aortas and concluded that this was an accurate simple and quick 
process that could easily be used in routine clinical practice to measure aortic 
aneurysm compliance serially to give warning of the risk of rupture. Our unit has 
used wall tracking duplex ultrasound to study the compliance of peripheral 
vessels in a range of systemic conditions. The carotid and femoral artery intima-
media thickness (IMT) was higher in patients with known peripheral vascular 
disease (PVD) than age and gender-matched control patients60. These thicker 
vessels were also less compliant than normal, increasing cardiac afterload. 
These results were replicated in patients with PVD and abdominal aortic 
aneurysms compared with patients with aneurysms alone92, suggesting a way 
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of stratifying cardiovascular risk perioperatively. Similarly, a reduction in 
compliance of femoral and carotid arteries associated with increased IMT was 
observed in women with polycystic ovary syndrome93;94. Patients with 
scleroderma were found to have reduced carotid compliance but no apparent 
change in IMT95. 
 MRI technology has been utilised to measure aortic diameter and 
calculate compliance96 but it‟s use with small calibre vessels has not taken off 
yet due to prohibitive costs and the relatively poor quality of image. However, 
continuous improvement in MR magnet technology means that the resolution 
issues will be in time resolved. In the meantime, MR images have been used as 
a basis for computational fluid dynamic studies in smaller vessels97. 
Digital subtraction angiography (DSA) is widely used to assess the 
arterial system of patients. This has also been used by Seifalian and colleagues 
to accurately measure compliance of arterial segments both in vitro and in 
vivo98. Flow rate information can be obtained simultaneously with distension by 
measuring the intensity of the contrast bolus in an arterial segment or graft over 
time. 
Validation of their technique in flow circuits has revealed high accuracy of 
compliance measurement. Arterial catheterisation is required in order to perform 
an angiogram as well as to simultaneously measure blood pressure throughout 
the cardiac cycle. However, this does open up the possibility of accurate, 
routine clinical compliance studies in patients with peripheral vascular disease 
at the time of angiography, using equipment that is widely available in the x-ray 
department. 
 
2.3.1.1 The Importance of Correct Compliance Matching 
 
Compliance mismatch (CM) is thought to cause IH. However the 
evidence for this is still equivocal. The evidence for and against CM as the 
cause of IH is given below. 
 Hirayama et al. undertook a mathematical study of impedance to flow 
through infrainguinal arterial bypass grafts anastomosed to normal and calcified 
arteries99. Taking both wall tensions and the tethering effects of surrounding 
tissues into account with linear dynamical equations, they found that for an 
artery with high resistance, a correspondingly rigid, inelastic graft minimized 
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both impedence to flow and reflection coefficient. A compliant artery as in the 
healthy individual with no peripheral vascular disease had better flow 
characteristics if anastomosed with a similarly compliant graft. Perktold et al.100 
used Navier-Stokes equations to describe flow through an end to side (ETS) 
anastomosis, a Miller cuff and a Taylor patch. They showed that the vein cuffs 
reduced suture line hyperplasia by  geometrical modification to some extent, but 
more importantly by a decrease in the compliance mismatch as a result of vein 
interposition. Stewart and Lyman66 gave flow visualisation evidence for 
stagnation of flow near the distal anastomosis as a result of CM. In a numerical 
study using finite element simulations of ETE anastomoses, they subsequently 
showed that unusual concentration gradients of a model protein could build up 
at the anastomosis as a result of CM101, suggesting the possibility of pooling of 
chemotactic agents of IH. A mathematical model considering stress and strain at 
the artery wall with evolution equations to describe wall remodeling due to the 
deformation of the artery examined a compliance-mismatched anastomosis102 
showing that such a configuration causes abnormal axial and circumferential 
stress on the artery leading to remodelling including wall thickening with the aim 
of correcting the abnormal stress. This points to IH as a possible adaptive 
response to try to return shear forces towards baseline. An in vitro ETS 
anastomosis between artery and PTFE graft shows a greater concentration of 
fluctuation energy at the anastomosis than the same anastomosis using 
Ultraflex compliant graft103.  
There are a number of in-vivo investigations offering doubt on CM as 
cause for IH. Wu et al‟s104 animal model of ETE anastomoses showed no 
difference in IH levels between Dacron and carotid artery as graft material. 
However, the Dacron anastomoses were made with the carotid artery, whereas 
the arterial grafts were anastomosed to the femoral artery, making this a 
possible confounding variable. At 14 weeks, Uchida et al.105 also found no 
statistical difference in ETE anastomoses between artery and compliant/non-
compliant grafts. Okuhn et al.85 created abrupt changes in compliance by 
placing bands on segments of common iliac artery. They found no significant IH 
at 6 months. Vein-cuffed anastomoses have been considered, due to them 
reducing the sudden CM69 but Norberto et al.106 encircled vein cuffs with ePTFE 
jackets eliminating their high compliance properties and found no difference in 
IH compared to unjacketed cuffs. 
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Ballyk et al‟s107 theoretical model has demonstrated that a high CM does 
cause high anastomotic stress in ETS anastomoses, but does not do so in ETE 
configurations, which may explain why some groups found CM to be critical 
whilst others didn‟t. 
 
2.3.2 Conduit Calibre 
 
From Poiseuille‟s law, it can be seen that the pressure of flow for blood 
through a conduit is inversely proportional to the fourth power of its radius: 
 
  P  1/r4 
 
When considering an implanted bypass graft with no side branches, a 
purposeful tapering of the graft would lead to a massive concentration of 
pressure across the graft108 (P  1/r4). The natural tapering of the vasculature 
distally is workable without rises in pressure due to the extensive branching of 
the native vessels. Moore et al. showed in a numerical model simulation of an 
ETS anastomosis that graft-to-host diameter ratio was the most important of the 
geometric factors in determining WSS109. 
Treiman et al.110 have conducted duplex studies to show that utilising a 
larger diameter  venous graft is associated with lower distal graft velocity. In the 
case of above knee femoropopliteal bypass, it has been clinically confirmed that 
larger diameter grafts confer better patency rates than smaller conduits111;112. 
The same has been shown for coronary artery bypass grafts113.  
Abnormally high flow velocities are associated with changes in the 
pattern of wall shear stress, if not an increased mean or peak wall shear rate114. 
These haemodynamic flow changes are associated with the development of IH 
and indeed, doppler flow studies of the distal anastomosis revealing high flow 
velocity predicts stenosis due to IH115. This is a vicious cycle as stenosis results 
in a further increase in flow velocity . Papanicolaou et al.116 have used the 
observation to offer a clinical guideline on graft surveillance, suggesting that low 
levels of vein graft stenosis with a peak systolic flow velocity (PFV) of less than 
250cm/sec. on duplex scanning can safely undergo watchful waiting, whereas 
greater stenosis should lead to prophylactic revision of the revision of the 
bypass as this gives better results than if the inevitable symptoms of graft 
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occlusion are awaited. Papanicolaou et al.117 also give a mechanism by which 
occlusion results from a critical stenosis, by making a comparison of duplex-
derived pre-stenotic and stenotic PFV. They calculate that for a typical 80% 
diameter stenosis, a minimum perfusing blood pressure of 144mmHg is 
required to maintain flow across it. They hypothesise that failure to achieve this 
blood pressure at all times leads to stasis of flow and resultant thrombosis. 
Their calculations are based on the assumption that the lowest flow velocity 
seen clinically on duplex scanning is equivalent to the thrombotic threshold 
velocity. In reality this may be an oversimplification with flow velocity being only 
one of the determinants of thrombotic threshold as detailed in Virchow‟s triad of 
hypercoagulability, vessel wall damage and stasis, but the hypothesised 
mechanism for graft failure would still stand. However, a grossly oversized distal 
conduit will result in a sudden decrease in flow rate with relative stasis and flow 
separation. The resultant low shear rate is associated with IH as discussed 
earlier. Polo et al.118 showed that higher flow rates in arteriovenous dialysis 
access grafts was associated with less occlusion and lower frequency of rescue 
intervention.  
Hence the ideal diameter difference between graft and artery at the distal 
anastomosis  is a balance to maintain the ideal flow velocity and characteristic. 
Longest and Kleinstreuer29 used a theoretical ePTFE:ePTFE anastomosis 
model to calculate the ideal ETS geometric properties. By using ePTFE for both 
ends of the anastomosis, the potential confounding factor of compliance 
mismatch was avoided. They found that a 2:1 (proximal to distal) ratio was too 
great a difference with respect to favourable haemodynamics whereas 1.5:1 
predicted less anastomotic stress. 
 
 
2.3.3 Porosity 
In order to construct a bypass graft that mirrors the properties of the 
artery it is replacing, the concept of porosity has been considered. The artery is 
a selective permeable structure and a microporous architecture in a prosthesis 
has been shown to mimic arterial function119. 
 Endothelialisation of the luminal aspect of a graft comes about directly 
from the artery at the anastomotic site as well as via fibrovascular infiltration of 
the graft material from the surrounding tissues. It is this latter that allows speedy 
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uniform endothelial lining of a long graft. Zhang et al120 showed that with 
physiological pulsatile flow within an animal model, full ordered 
endothelialisation of a small diameter prosthesis is possible within 8 weeks, 
providing a pore size of 30m diameter. They also demonstrated that the 
external aspect pore size correlated with the rate of endothelialisation. White et 
al‟s81 review of pore size shows that the ideal pore size for fibrovascular 
infiltration is between 10 and 45m. However, larger pores allow too much 
surrounding fibrous tissue invasion risking a dramatic loss of compliance80. 
 Fujimoto et al.121 demonstrated that pore size was important for patency 
rate, but it was rather the density of pores which determined graft compliance. 
 In our department, Salacinski and colleagues122 showed that porous PCU 
promoted successful seeding of endothelial cells onto its surface. By isolating 
the effects of surrounding tissues and fibrovascular infiltration in a laboratory 
model, Giudiceandrea et al.123 showed that after initial seeding, a porous graft 
allows stronger endothelial cell adherence when exposed to pulsatile flow than 
smooth ePTFE. They hypothesise that this may be due to the luminal surface 
pitted with a “honeycomb structure”, as seen on scanning electron microscopy. 
  MacLeod and coworkers124 investigated the percentage porosity (a 
function of both pore size and pore density) of collagen based prostheses. They 
found a proportional relationship between porosity and vascularity at one and 
two weeks.  
 ePTFE grafts which have low porosity were explanted after a mean 
implantation time of 523 days, from human subjects and examined by Guidoin 
et al.125 They found that cellular infiltration into the grafts was poor, with mostly 
thin patchy fibrinous cover to the lumen. 
 The thrombogenicity of a graft‟s luminal surface is an important concept 
in prevention of early failure. Losi and colleagues126 found that platelet 
adherence to the lumen had an inverse relationship with porosity. This was 
elucidated by measuring the levels of circulating platelets and subtracting 
monitored platelet aggregation levels. The findings were then confirmed 
optically. Hence it was shown that a porous material may confer anti-
thrombogenic properties. The reasons for this are not clear. 
Therefore in the development of a new graft, the precise measurement of 
its porosity is critical. This has been addressed since 1961 when Wesolowski et 
al.119 used a machine to compress the graft wall and measure the rate of flow of 
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water through the wall at a water pressure of 120mmHg. They found this 
measure to be highly reproducible. 
Pore size measurement can be simply achieved from high resolution 
optical microscopy or scanning electron microscopy121 but this does not take 
account of pore density and is not a true reflection of porosity. Simple computer 
analysis using photo-editing software of the cross sectional structure can 
determine the proportion of area which is made up of pores as a percentage of 
the whole area120. Further computational extrapolation and 3D reconstruction 
can then correct for precise pore shape127. 
Pycnometry involves subtracting the mass volume of a substance from 
the volume of a fluid (gas or liquid) displaced, the resulting figure giving an 
approximation of porosity. A pycnometer128 utilises a cell with a known pressure 
of a gas inside. The porous structure is introduced into this cell and the resultant 
increase of gas pressure is accurately measured. Mass and volume calculations 
then reveal the density of the material. Gas adsorption techniques require the 
material under investigation to have all air removed from it by vacuum, and 
nitrogen or water vapour reintroduced – the amount taken up being an indicator 
of porosity129. 
 
  
2.3.4 Burst pressure 
This relates to the pressure that the vascular conduit can be subjected to 
before an acute leak develops and the conduit fails. The maximum force, f, 
applicable to any material is represented by: 
 
f = Pd/2t 
 
where P represents (burst)pressure, d represents diameter and t represents 
wall thickness58. 
Therefore it can be seen that the burst pressure decreases with increasing 
diameter and with decreasing wall thickness, since f is a finite entity. It is 
therefore very likely that the burst pressure for a small diameter graft will far 
exceed the physiological range of blood pressures possible in man. For 
example, the burst pressure of a typical carotid artery is in the region of 
5000mmHg130 and for a saphenous vein is around 2250mmHg131. Suture line 
 - 63 - 
weakness makes it far more likely that the anastomosis will fail before the 
conduit material. Burst pressure of porous polyurethane grafts have been found 
to be 1850-2050mmHg132, again much greater than any possible physiological 
blood pressure. 
 
 
2.4 Properties of bypass conduits in clinical use. 
 
2.4.1 Autologous vein. 
 
Unlike the arterial system, veins do not physiologically have to  deal with 
pressures greater than 75mmHg133, and have a lower compliance range than 
arteries due to a lower collagen-elastin ratio and much less smooth muscle. 
Their role is to maximize capacitance rather than to contribute to pulsatile flow 
transmission. However a venous graft anastomosed to an artery will suddenly 
overdistend to its limit. This will lead to immediate de-endothelialisation134. The 
sequence of events over the next 30 days is often termed „arterialisation‟135. 
This involves luminal wall platelet deposition; vascular smooth muscle cell 
(SMC) apoptosis and necrosis; monocytic infiltration; adventitial fibroblastic 
activity and angiogenesis; myointimal thickening with media SMC proliferation 
and infiltration. Finally there is re-endothelialisation. 
 From three months onwards, considerable remodelling of a venous graft 
in-situ has been shown to occur136. There is wall thickening with concomitant 
reduction in wall tension; lumen size changes proportional to the initial lumen 
size with lumens larger than 3.75mm in diameter actually getting smaller; and a 
significant increase in wall stiffness. These changes along with re-
endothelialisation equip the graft for use as an arterial conduit. This is reflected 
in the sizeable failure rate for venous grafts in the first year compared with 
subsequent annual occlusion rates137. 
As a result of low elastin levels compared to an artery, the overdistension 
caused by arterial blood pressure gives the vein poor compliance properties, 
making it in effect a rigid tube. Stooker et al.138 found lower leg saphenous vein 
to be more distensible than its upper leg equivalent in the venous pressure 
range. They could not show a histological explanation for this with similar 
proportions of extracellular matrix and SMCs in both areas. Davies et al.139 
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found however, that compliance of a vein was inversely proportional to both 
circular muscle hypertrophy and focal hyperplasia. They confirmed that the 
thicker-walled distal saphenous vein segments show less compliance. This 
latter study was an in-vivo investigation with all the effects of the surrounding 
tissues. Also studying vein grafts ex-vivo causes changes to exactly those 
mechanical properties which are of interest140. 
  
2.4.2 ePTFE 
 
ePTFE has shown to be very stable in vivo with no reported failures due 
to degradation of the graft125. It is a poorly compliant material made up of fibrils 
extruded into a tubular structure with moderate stiffness11. Perivascular reaction 
reduces its compliance further to only 14% of its pre-implantation level. The 
gaps between the fibrils form very small pores which are so small (<0.05m) 
that many studies consider it to be a non-porous material121. Because of this 
ePTFE grafts have very poor lumenal endothelialisation in vivo125. Higher 
porosity can be conferred to PTFE by constructing a graft with a larger fibril size 
(60m vs. 20m) leading to the promotion of transmural tissue growth141. 
    
 
2.5 Prostheses of the future 
 
 
2.5.1  Synthetic grafts 
 
The search for new compliant prostheses to replace ePTFE has 
concentrated on polyurethane materials73. The fundamental building block is a 
repeating sequence of urethane: 
 
  NH(CO)O
 
 Polyurethanes are formed by the reaction of a polyol (an alcohol 
containing more than two reactive hydroxyl groups per molecule) with either a 
diisocyanate or a polymeric isocyanate. The resulting product is termed the 
hard segment. A soft segment is mixed with this to give the desired mechanical 
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and degradation properties. These include polyesters, polyethers and 
polycarbonates. The hard and soft segments mix incompletely to allow 
microphase separation within the polymer73. Soft segments consisting of 
polyester groups are susceptible to rapid hydrolysis and hence are not suited to 
prolonged implantation in vivo. Polyether undergoes oxidative degradation and 
so is also unsuitable. Polycarbonate however, has low biodegradation when 
exposed to an adverse environment in vitro. In our department, the Pulse-Tec 
polyether based polyurethane was compared with a compliant poly(carbonate-
urea) urethane (PCU) which was developed in-house - MyolinkTM, in a variety of 
solutions simulating biological extremes142 and the PCU graft was found to have 
far greater stability and preservation of mechanical properties. Furthermore, 
comparative thermomechanical analysis77 also showed that the chemical 
changes evident in the case of Pulse-Tec were not present with MyolinkTM, with 
hydrolysis of the soft segment only achieved in an environment of glutathione/t-
butyl peroxide/ CoCl2. Implantation of PCU into an animal model suggested that 
it was appropriate for in vivo use82 with only minor hydrolysis of the soft 
segment after 3 years in situ and no change in mechanical properties. 
 PCU has yet to be used clinically as an infrainguinal bypass graft. Before 
this can occur, further research into PCU development with particular 
consideration of anti-thrombogenic properties and spontaneous 
endothelialisation in vivo is required. In addition, a host of different 
manufacturing processes have been identified and the most suitable one needs 
to be identified in terms of reproducibility and quality control. However this class 
of polymer is an exciting future prospect for the development of a compliant 
small caliber bypass graft. 
 
2.5.2 Tissue-engineered grafts 
 
It is realized that a biological arterial substitute incorporating the cellular 
layers of the native vessel could reflect the mechanical properties of the artery 
as well as providing  its inherent antithrombogenicity. In addition, the 
mechanical properties of the conduit would adapt to the prevailing 
haemodynamics from moment to moment precisely like an artery does, and in 
the long-term, remodel to suit its environment. Generally speaking, such tissue 
engineered grafts are created with a biodegradable scaffold to provide a 
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template on which the cellular components can align and the overall structure 
can mature. Those conduits where cells are seeded to a non-degradable 
scaffold are termed hybrid grafts – the mechanical properties of these vessels 
depend on the scaffold and these will not be considered further. 
Alternatively, the use of a biodegradable polymer scaffold to give 
temporary strength to a vessel and a template for culturing SMCs will lead to 
gradual replacement of the synthetic material by collagen. In contrast with 
hybrid grafts, permanent remodeling to suit the conditions of flow will be 
possible, potentially resulting in ideal mechanical properties in the long term143. 
The bioresorbable scaffolds used are based on polyglycolic acid (PGA), 
polydioxanone (PDS) or Polylactide (PLA)144. PGA forms a porous structure but 
is resorbed within 8 weeks and in order to slow degradation it is often combined 
with an adjuct such as polyhydroxyalkanoate, poly-4-hydroxybutyrate (P4HB) or 
polyethylene glycol145. Hoerstrup et al.146 used PGA coated with PH4B to form 
grafts which they subsequently seeded with myofibroblasts and endothelial 
cells. After 21 days these tubes achieved burst strength over 300mmHg and 
good suture retention strength. Greisler combined  PDS and PLA to achieve 
neo-arteries with burst pressure of 800mmHg147. Niklason‟s group148 
demonstrated the consolidation of burst strength of seeded PGA grafts with 
prolonged culture in-vitro before implantation (see Table 2.3). 
 
Culture time (weeks) Burst strength (mmHg) 
3 Too fragile to manipulate 
5   (n=4) 570 +/- 100 
8   (n=3) 2150 +/- 700 
 
Table 2.3. Prolonged culture increases burst strength of seeded PGA grafts 
(From Niklason et al.148. 
 
 Prolonged culture was also associated with a reduction in compliance of 
the resultant vessels, suggesting the need for an intermediate culture time to 
promote a clinically viable balance between the two mechanical properties. 
Natural scaffolds which can remodel as a result of haemodynamic 
conditions have been considered as the framework for TE materials. 
However, it is possible to create TE vessels without any scaffold in place 
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by forming tissue around mandrels implanted subcutaneously149 or 
intraperitoneally150. This technique uses the body‟s own foreign body reaction to 
form a myofibroblast and collagen matrix which is robust enough to be 
implanted as a vascular prosthesis in that same body. The resultant pulsatile 
flow causes matrix thickening with further collagen deposition and elastic 
lamellae formation; myofibroblast differentiation into SMCs along with their 
circular alignment150. However, ultimately this technology will require an 
invasive procedure to implant a foreign body intraperitoneally in a human, being 
dependent on an immune response against it. The consequences of infection 
would be very serious in patients with critical ischaemia especially since they 
are usually already at high medical risk. 
Therefore it would be desirable to construct a fully tissue-engineered 
graft made up of autologous cells ex-vivo. L‟Heureux‟s group151 achieved burst 
pressures of 2594+/-501mmHg with a tubular structure made from coaxial 
sheets of cultured vascular SMCs and human fibroblasts which was seeded 
with endothelial cells. This was as a result of a well organized collagen matrix 
with parallel fibres in perpendicular bundles. Elastin fibres were also seen. The 
overall structure was macroscopically and microscopically similar to an artery. 
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3 
 
Addressing thrombogenicity in vascular graft construction 
 
 
3.1 Introduction 
 
Clearly the main determinants of patency of vascular bypass grafts are 
thrombogenic potential and level of intimal hyperplasia (IH). Of these two, the 
former is arguably more important as it is responsible for earlier graft occlusion. 
Also IH is associated with the abrupt change in distensibility between native 
vessel and stiff prosthesis at the anastomosis152, but this causal link appears to 
be less clearly demonstrated for blood compatible vascular conduits than for 
thrombogenic graft surfaces35. It is obvious that synthetic graft development 
must not focus on mechanical properties in isolation, as blood/surface 
interactions and biological behaviour during graft healing and after incorporation 
are critical in the ultimate success of the implant. 
As discussed in the previous chapter, the currently used grafts for 
vascular bypass in small calibre (<6mm), low flow states are autologous vessels 
or if these are not available, polytetrafluoroethylene (PTFE) prostheses. The 
autologous vessels used are long saphenous vein in the case of infrainguinal 
bypass; for coronary artery bypass the preferred alternative to saphenous vein 
is the internal mammary (or internal thoracic) artery. The results of bypass 
procedures with autologous vessels are considerably greater than when 
synthetic alternatives are used (Fig 1.1) and every attempt is made to utilise the 
former. However, in as many as one third of cases, this is not possible due to 
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previous use, inadequate calibre or diseased vessel. 
Considerable research effort is being made to develop synthetic graft 
materials with a favourable blood compatibility. This is hampered by the 
relatively poor understanding of how surface properties relate to thrombogenic 
potential as well as the difficulties faced in surface modification technology.  
On implantation of a vascular graft, plasma proteins immediately adsorb 
to the wall. They present binding sites for integrin receptors which are to be 
found on platelets and many cells153. Adhesion to these as well as to the vessel 
wall itself may cause activation of the platelets. Surface modification to improve 
blood compatibility includes methods to reduce both plasma protein adsorption 
and platelet adhesion to the prosthesis wall. In addition, the interactions 
between plasma proteins and platelets that ultimately lead to platelet activation 
have also been targeted.   
The aim here is to present what is already known about. The topic of  
blood/ graft surface interactions could be exhaustively presented as a textbook, 
incorporating anatomy, biochemistry and physiology. However, I have examined 
the subject from the point of view of a graft developer – showing how grafts 
being researched have fared when tested for thrombogenicity in vitro and in 
vivo as well as discussing the main controversies in vascular surface 
thrombogenicity, illustrating with examples of the approaches used to address 
these issues. There is after all no point in developing a graft from a 
thrombogenic material. 
 
 
3.2 The Arterial surface 
 
 A theme of the mechanical considerations for potential vascular 
prostheses is to attempt to match the mechanical properties of the artery being 
bypassed. A similar philosophy holds true when considering the design of a graft 
from the thrombogenicity point of view. Arterial structure needs to be examined 
in more detail to appreciate its design features specifically geared toward 
enhancing blood compatibility. Much of this detail is at the biomolecular level. As 
a foundation we can return to the theme from the last chapter that the arterial 
wall is composed of a number of histologically separate layers, which allow a 
multitude of specialized functions, only one of which is blood compatibility (Fig 
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3.1). The innermost layer is a single layer of vascular endothelial cells (vEC) 
attached to a basement membrane. This layer is in close contact with the blood 
flowing through the vessel and so is intimately involved in preventing 
thrombosis. The vascular endothelium is non-thrombogenic. The basement 
membrane attaching it has moderate thrombogenicity; but it is the highly 
thrombogenic collagen154 of the subendothelial connective tissue which rapidly 
instigates platelet adhesion followed by the cascade of events leading to 
thrombus formation (Fig 3.2). Additional subendothelial components promoting 
platelet adherence include fibronectin, laminin and thrombospondin. Adherence 
is facilitated by the presence of Von Willebrand Factor, a platelet adhesive 
protein synthesized by vEC. Exposure of the subendothelium to blood 
components also reduces the expression and activity of antithrombin III. This 
design is to ensure speedy coagulation in the event of serious arterial damage 
which in conjunction with vasospasm prevents heavy bleeding. 
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Fig 3.1.  
The multilayered structure of the arterial wall 
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There are numerous biochemical pathways involving multiple cell surface 
receptors and intracellular signalling pathways by which vEC modulate plasma 
protein and platelet adhesion. Even with no physiological stimulus, vEC inhibit 
platelet aggregation. To some extent, this is prostacyclin mediated and can be 
reversed by application of non-steroidal anti-inflammatory drugs155. The 
remainder of this platelet aggregation inhibition is mediated by endothelium 
derived relaxing factor (EDRF). Anticoagulant factors present in the vEC 
membrane include heparin-like glycosaminoglycans (heparans), 
thrombomodulin and adenosine diphosphatase (ADPase). The heparans moiety 
is essential for antithrombin III activity. vEC also express procoagulant Tissue 
Factor (TF) to exert fine control over overall thrombotic tendency. Any trigger for 
thrombosis such as vascular injury tilts homeostasis towards increased TF 
expression and downregulation of membrane anticoagulants, particularly 
thrombomodulin156. This latter forms complexes with circulating thrombin, 
reducing its availability for fibrinogenesis. TF acts by binding Factor VII/VIIa 
causing the subsequent activation of Factors IX and X. Circulating low density 
lipoproteins (LDL), desmopressin157 and homocysteine enhance this activity. 
The oxidised form of LDL further enhances platelet adhesion158. To counteract 
TF and regulate its activation, the serine protease inhibitor Tissue Factor 
Pathway Inhibitor (TFPI) circulates alone or in complexes with plasma 
lipoproteins and acts to inhibit Factor X directly159 by binding to the TF/Factor 
VIIa complex. Its activity is reduced by LDL. Nitric oxide (NO) which has an anti-
aggregatory effect on platelets is released by vECs and by platelets themselves.  
 These are the principle mechanisms utilised by the vEC to regulate 
thrombogenicity. 
 - 73 - 
 
 
Fig 3.2. The clotting cascade. 
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3.3 Surface modification to attenuate the coagulation cascade 
 
Attempts have been made to reduce the inherent thrombogenicity of 
synthetic graft surfaces by incorporating some of the mechanisms employed by 
vECs. Conversely, the use of collagen as a graft sealant as the blood graft 
interface has had to be tempered due to it‟s thrombogenicity160. 
Membrane glycosaminoglycans may be simulated by the incorporation of 
heparin onto the graft surface. Results were initially mixed and dependent on 
the method of heparin bonding161 with covalent bonds with long half-life 
reducing the thrombogenicity of both PTFE162 and Dacron163. A transient coating 
however is one reason for failure of heparin to improve short term patency164. 
Current technology for heparin bonding has resulted in promising results for 
many groups (see Table 3.1). As well as discouraging coagulation heparin also 
reduces the proliferation of vascular smooth muscle cells in the media and 
intima, thus abating neointimal hyperplasia165. A recent clinical trial has shown 
heparin-bonded Dacron to be as good as PTFE in the long term for 
Femoropopliteal bypass12. 
Heparin elution from graft surfaces has also been considered, partly as a 
result of the observation that the antiproliferative effect of drug-eluting stents 
(medium term) seems to outlast the drug elution. However, in the case of stents, 
it is now becoming apparent that this benefit may not persist in the longer term 
with delayed thrombosis being increasingly recognised166, possibly in 
association with endothelial cell dysfunction and slow vessel wall healing167. 
Hence, anticoagulant elution may be more suited to intra-vascular catheters168. 
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Year Graft Study type Outcome Reference 
2006 Polycaprolactone in vitro ↓ vascular 
smooth 
muscle cell 
growth 
165 
2005 Thermoplastic 
polyurethane 
in vitro ↓platelet 
adhesion; 
thrombin 
inactivation 
161 
2005 PTFE retrospective 
clinical trial 
92% 2 year 
primary 
patency for 
below knee 
bypass 
169 
2004 Wire coiled 
polymer coated 
in vitro vEC layer 
promotion; 
↓thrombus 
formation 
170;171 
2004 PTFE animal model ↓platelet 
adhesion; 
↓intimal 
hyperplasia 
172 
2004 Carbon coated 
PTFE 
animal model ↓early 
platelet 
adhesion; 
↓late 
thrombus; 
↑patency 
173 
2004 PTFE animal model ↓platelet 
adhesion; 
↓intimal 
hyperplasia 
174 
2004 Collagen in vitro ↓thrombin 
generation 
175 
 
Table 3.1.  
Summary of research into heparin-bonded vascular grafts in the last two 
years. 
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Additionally, platelet activity has been directly targeted with covalently 
bonded dipyridamole (Persantin) attached to the polycarbonate urethane graft 
(Chronoflex)47, which acts by preventing cyclic adenosine monophosphate 
(cAMP) formation, an essential intraplatelet messenger signalling platelet 
aggregation. Although there was reduced platelet aggregation and a delayed 
thrombin reaction in vitro, this still translated to five goat carotid grafts being 
occluded within ten weeks. However, chronoflex may be unsuited overall for 
implantation due to considerable biodegradation noted within ten weeks in 
sheep.  
ADPase (adenosine diphosphatase) was first noted as a natural 
antithrombogenic agent in the renal glomerular capillary wall where blood is in 
contact with the relatively thrombogenic glomerular basement membrane. In 
addition, a form of ADPase is secreted in the saliva of ticks. Platelet derived 
ADP (adenosine diphosphate) interacts with vEC at the CD39 receptor to cause 
release of EDRF. ADPase coated polyurethane grafts have better patency in a 
rabbit carotid model than polyurethane alone176. However, recent indications are 
that the ADP effect on vEC is more important in small mammals than in man177. 
It is also becoming clear that the platelet inhibitory effect of ADPase does not 
solely function through vEC EDRF release. Costa and colleagues have 
demonstrated the anti-platelet effects of ADPase in rabbit arteries where the 
endothelium has been destroyed beforehand178. 
Factor X inhibition by TFPI has been exploited by attaching it to Dacron 
grafts. On implantation in animal models, reduced fibrinogen adherence was 
noted179 as well as a thinner neointima and lower thrombosis levels180 
compared with controls. However, the numbers included were small and it is 
unclear that a benefit remains in the long term as the half-life of TFPI is less 
than two hours, requiring constant replenishment whilst at the same time, the 
expression of TF increases over 12 months following implantation181.  
Hirudin is a thrombin inhibitor which is secreted in the saliva of leeches 
and genetically engineered recombinant varieties have been used 
therapeutically as an anticoagulant. As with heparin, its presence at vascular 
anastomoses reduces intimal hyperplasia182, suggesting thrombin inhibition is 
directly linked to prevention of IH. Dacron with covalently bonded hirudin shows 
less thrombus formation and thinner neointima than Dacron alone183.  
Nitric oxide(NO) is released by platelets to form a microenvironment that 
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is unfavourable to platelet adhesion184. Recently attempts have been made to 
manufacture NO-eluting vascular grafts due to its antithrombogenic and anti-
intimal hyperplasia effects185. The preliminary results are encouraging in animal 
models but the challenge of long-term NO production from a synthetic conduit 
needs to be addressed. NO effects are mediated by the cyclic 3′5′-guanosine 
monophosphate (cGMP) secondary messenger pathway. Phosphodiesterase 
inhibitors such as sildenafil cause the accumulation of cGMP, thus potentiating 
NO effect186 and the two may have a synergistic role in future anti-platelet 
grafts. However, as with TFPI, the importance of the role of NO as a platelet 
inhibitor has considerable interspecies variability with it having little relevance in 
mouse models187. 
 
3.4 Electrical charge 
 
 Amongst the esoteric properties which afford thrombogenicity, the issue 
of surface charge is refreshingly simple. Platelets have net electronegative 
surface charge, and it has been known since the 1950s that the blood vessel 
wall also exhibits a similar surface charge, as one would expect for their mutual 
repulsion for each other. Sawyer demonstrated that injury to the vessel wall lead 
to it gaining positive charge188. 
 PTFE has a weak negative charge too, but this is further enhanced by 
the fibrinous layer that forms on its luminal surface after implantation. As well as 
contributing to antithrombogenicity, this characteristic also has antibacterial 
properties, as those bacteria which are associated with graft infection have 
electronegative surface properties189. Carbon coating to PTFE further increases 
its electronegativity, and is in commonplace clinical use. 
 However negative electropotential alone will not ensure an 
antithrombogenic surface. The effect of surface chemistry is of paramount 
importance too. Collagen is very thrombogenic despite electronegativity. 
Therefore although electronegativity is a prerequisite for a non-thrombogenic 
surface, additional surface properties are also critical in determining the platelet 
reaction. 
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3.5 Surface wettability 
 
 As with negative electrical charge, a hydrophilic surface may confer 
thromboresistance but that is not to say that all hydrophilic surfaces are 
thromboresistant190. In fact, similar materials with different wettability may show 
no correlation with thromboresistance191. Van Kampen‟s192 assessment of 
poly(aminoacid) grafts revealed that platelet adherence to the wall was 
competing with leucocyte adherence which favoured fibrinolysis and eventual 
leucocytic endothelial transformation. Which component would prevail could not 
be predicted with surface characterisation.  
 PTFE‟s advantageous qualities include its biocompatibility, non-
degradation and strength. It is mildly electronegative, but unfortunately is 
hydrophobic and prone to thrombosis in low flow states. One method of 
reducing the hydrophobicity of a material is to covalently bond hydrophilic 
groups to its surface. Heparin is hydrophilic, contributing to its anti-platelet 
adherence properties and reducing the hydrophobic nature of collagen175 and 
PTFE (Table 3.1). Similarly, the use of compliant silicone rubber as a vascular 
conduit has been hampered by its hydrophobicity, affording it high affinity for 
platelets and fibrinogen. Julio et al36. covalently bonded hydrophilic monomers 
to these grafts to reduce short term thrombogenicity. 
 Polyethylene glycol (PEG) and polyethylene oxide (PEO) are hydrophilic 
flexible polymers which resist protein adsorption when bonded to the vascular 
surface. This translates to reduced thrombogenicity when they are used to coat 
vascular grafts193. The length and degree of branching of these polymers may 
correlate with the degree of platelet repulsion, due to their flexibility increasing 
thermodynamic interactions at the surface194. The great challenge with respect 
to these groups has been firm bonding to grafts with no translation to clinical 
application despite in-vitro and in-vivo study for over a decade. 
 However before platelet interactions with the prosthesis, fibrinogen may 
adsorb to the blood contact surface, and become activated as well as activating 
platelets. Fibrinogen has bonding sites for both hydrophilic and hydrophobic 
surfaces195. Amphiphilic surfaces can discourage fibrinogen binding196. This 
may be due to the different microdomains effectively cancelling each others 
effects197. They are also implicated in preventing platelet activation198, possibly 
by interfering with platelet binding with fibrinogen. Copolymerisation of 
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hydrophilic polymers such as PEO199 and PEG198 with hydrophobic counterparts 
result in materials which demonstrate these antithrombogenic properties. 
Polysiloxane and polycaprolactone-based amphiphilic copolymers have been 
commercially available for use as surface modifying additives for the 
extracorporeal circuits of cardiopulmonary bypass200.  
Fibrinogen adherence may be discouraged by creating conditions 
favourable to albumin attachment. The phospholipids membrane has a 
preference for albumin due to fatty acid chains, and in particular C16 chains. 16 
carbon acyl groups201 or alkyl groups form a characteristic steric conformation202 
which confers thromboresistance. A similar effect is seen with other specific 
configurations of carbon chains (C10203 and C18204). 
 
 
3.6 Mechanical Considerations 
 
 These have been dealt with in detail in Chapter 2. They have critical 
relevance in considering thrombogenicity. Turbulent haemodynamics as well as 
excessive shear stress promote platelet activation and thrombogenesis and 
graft selection needs to minimise these. There is considerable overlap with the 
mechanisms responsible for intimal hyperplasia which is responsible for graft 
occlusion in the medium and long term, whereas thrombosis is likely to cause 
graft occlusion in the early post-operative period. The mechanical factors 
involved can be separated into geometric factors and graft characteristics. The 
former includes accurate graft calibre matching29 and consideration of the angle 
of take off at an end to side anastomosis. Trials of tapering grafts108 (to reflect 
the native artery) have not been successful as they ignore the relative overall 
increase in vessel surface area brought about by increasing branching at the 
same time as diameter reduction distally. Graft kinking (a particular problem in 
long grafts where inadvertent twisting at the time of implantation is possible205, 
as well as those which cross joints) results in gross turbulence as well as 
stagnant areas, providing a highly thrombogenic environment, so this needs to 
be minimised by the use of relatively stiff materials and external reinforcing 
rings. However, very stiff materials lack the viscoelasticity of arteries, promoting 
intimal hyperplasia and occlusion. The anastomosis itself is paramount – 
suturing itself causes stress concentrations and poor surgical technique may 
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leave excessive suture material exposed on the luminal aspect of the graft wall 
as a thrombogenic nidus. Even worse is poor eversion at the anastomosis, 
resulting in direct blood contact with the highly thrombogenic arterial adventitia. 
 
   
3.7 Endothelialization 
 
 Rather than mimicking the vEC, encouraging a confluent endothelial 
lining to develop on the graft surface results in antithrombogenicity as well as a 
physiological layer that can respond to the shear forces exerted by the 
prevailing hemodynamic conditions. 
 Spontaneous endothelialisation of a synthetic prosthesis occurs by direct 
migration from the anastomotic edge, transmural migration of endothelial cells 
and by cell transformation from endothelial progenitor stem cells (EPC). The 
first of these is very limited in extent, with PTFE showing creeping confluent 
endothelialisation at a rate of 0.1mm per week from the anastomosis with rat 
aorta206. The second is responsible for the majority of confluent endothelium 
forming quickly in animal models. The third is only now starting to be 
appreciated as a mechanism of endothelial layer „housekeeping‟ in native 
arteries, being responsible for repair of minor damage to the intima207. This field 
of study is in early infancy – the identification and origins of EPCs are yet to be 
defined. Despite some evidence of the endothelialisation of vascular prosthesis 
in some animal models this is limited in the clinical situation. There are few 
large animal studies such as sheep and primate models, compared with small 
animals such as rat and rabbit, which endothelialise more readily, and so are a 
poor reflection of prosthesis behaviour in humans, where the major cell type 
migrating into the graft are smooth muscle cells.  Unlike EC smooth muscle 
cells do not prevent thrombogenesis but rather promote IH. 
Endothelial cell adherence and differentiation is not likely to occur in high 
flow conditions. This means that the blood in the vessel lumen is not an efficient 
source of vECs. A more likely source is newly formed capillaries as a result of 
perigraft tissue infiltration. In addition, endothelialisation is promoted by basic 
fibroblast growth factor which is secreted at the site of angiogenesis208. A graft 
that is porous throughout its wall will endothelialise faster and with more 
confluence than a non-porous tube. PTFEs poor endothelialisation is due to its 
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small pore size. Hazama et al.209 found that standard PTFE with fibril length of 
30μm did not allow for any transmural angiogenesis in rat aortas, whereas 
increased fibril length (and hence pore size) allowed capillaries to infiltrate the 
wall. The amount of cellular infiltration which correlated with thrombus free area 
was greatest for an intermediate pore size (fibril length 60μm). Even longer 
fibrils lead to a reduction of transmural infiltration. In humans there is little 
evidence of any endothelialisation of PTFE125.  Knitted Dacron is more porous 
than PTFE and forms a patchy endothelial layer after implantation in humans210. 
Animal models show spontaneous confluent endothelialisation much 
more readily than humans211 despite human vECs demonstrating good 
migration potential212. Apart from porosity studies, efforts have been made to 
enhance this in animals in the hope that it will translate to a greater endothelial 
coverage in human implanted grafts. Also, awareness of the difficulty of 
spontaneous endothelialisation has promoted the concept of endothelial cell 
seeding of grafts. Successful seeding requires a high uptake of vECs and has 
required a time consuming three stage procedure. However, a viable single 
stage seeding technique may be possible if a graft with a high capacity to firmly 
attach endothelial cells is developed. The various surface modifications 
undertaken to promote spontaneous and seeded endothelialisation are 
summarized in Table 3.2. 
 
3.8 Conclusion 
 
In the previous chapter an examination of how graft mechanical 
properties affect the ultimate performance of prostheses in small calibre 
vascular bypass was made. From this chapter it is clear that poor results are 
intimately related to unfavourable interactions between the luminal surface and 
blood components, causing a high rate of thrombosis. In producing the new 
generation of blood compatible grafts, surface properties must be carefully 
considered. Either a material with integral low thrombogenic characteristics or 
surface modification and composite coated grafts need to be considered. These 
modifications take the form of enhancing physical properties by addressing 
surface charge and hydrophilicity or by incorporating the biochemical 
mechanisms employed by arteries. This latter can be approached by 
assembling individual anti-thrombogenic constructs or by encouraging confluent 
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endothelialisation. 
However, unlike many animal models, spontaneous endothelialisation of 
long graft segments does not readily occur in humans. Therefore further surface 
modification to form a microenvironment favourable to endothelialisation has 
been considered, including microporosity, extracellular matrix deposition and 
specific factors which promote endothelial cell adherence and proliferation. 
Most recently, the peptide sequences involved in the latter have been isolated 
and used as surface modifiers. 
It is hoped that enhancing endothelialisation in animals will result in a 
viable endothelialising synthetic graft for humans. A concerted move away from 
the use of small animals as models of vascularisation and towards higher 
species will better represent potential graft behaviour before clinical trials. 
Tissue engineering advances the possibility of in-vitro endothelialisation of 
grafts before implantation – this technology will also benefit greatly from surface 
modification to facilitate rapid viable endothelialisation. This strategy accepts the 
difficulties encountered in achieving spontaneous endothelialisation in humans. 
In fact, tissue engineering as a research field has burgeoned over the years as 
developers have come to consider that it may be more feasible to go one step 
further than extra-corporeal endothelialisation and totally construct a biological 
conduit in vitro, than to create a synthetic product which can cope with the long 
list of requirements for success as a small calibre vascular implant. 
 
3.9 Future Directions 
The use of vECs from other sources has become an important field of 
study in the search for better vascular prosthesis. Mechanisms for this have 
included the harvest of cells from augmental fat and the use of endothelial 
progenitor cells from circulating blood213.  Studies using mesenchymal stem 
cells from the blood have proved useful in canine models and could provide a 
useful source of cells for clinical applications.  The study of tissue engineered 
vascular grafts has shown many advantages over synthetic grafts but cell 
sources remain uncertain. Nevertheless, this has become the mode of choice 
for many groups attempting to develop vascular grafts. The next chapter 
examines this third and final approach to vascular graft development.    
However the potential of segmented polyurethanes has not been fully 
realised. In particular, manipulation of the hard segment to optimise hydrogen 
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bonding and van der Vaal interactions with the adjacent soft segment could 
result in improved mechanical properties and hemocompatibility. To this end, the 
experimental work presented in this thesis investigates a novel nanocomposite 
polyurethane with antithrombogenic properties which incorporates polyhedral 
oligomeric silsesquioxane into the hard segment50.  
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1
  Endothelial cell adhesive peptide sequence 
2
  marker of collagen synthesis 
Graft Modifying additive Study 
type 
Outcome Reference 
PTFE P15 peptide in vitro ↑endothelialisation; 
↓IH 
214 
PTFE Anti-CD34 
antibodies 
animal 
model 
Rapid 
endothelialisation; 
↑IH 
215 
PTFE Vascular 
Endothelial Growth 
Factor 
animal 
model 
↑endothelialisation; 
↑IH 
216 
Poly(ether)urethane 
(Tecothane) 
Cholesterol in vitro ↑endothelialisation 
and resistance to 
shear stress; 
↑endothelial 
precursor cell 
adherence 
217 
PTFE Poly(amino acid) 
urethane 
animal 
model 
↑endothelialisation 218 
Fibrin Endothelial cell 
growth factor  
in vitro ↑vEC proliferation; 
↓early platelet 
adhesion; ↓late 
thrombus; ↑patency 
219 
Polyurethaneurea YIGSR1 in vitro ↑endothelialisation; 
↑transmural cell 
migration; 
↑hydroxyproline 
production2 
220 
PTFE Tumorigenic human 
squamous cell line 
animal 
model 
Confluent 
endothelialisation 
by 5 weeks 
221 
Dacron,PTFE, 
polypropylene, 
silicone, 
polyurethane 
titanium in vitro ↑vEC adhesion; no 
increase in 
inflammation 
222 
Dacron Collagen film in vitro Confluent 
endothelialisation 
223 
Dacron Collagen Animal 
model 
Largely 
endothelialised and 
thrombus free at 3 
weeks 
224 
Collagen Heparin in vitro ↑basic fibroblast 
growth factor 
(bFGF) binding and 
release 
225 
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Table 3.2. Summary of surface modification to enhance endothelialisation (in 
chronological order). 
 
 
 
Polyurethane bFGF/Heparin Animal 
model 
↑endothelialisation, 
neovascularisation 
226 
PTFE Nitrogen, oxygen 
(↑hydrophilicity) 
In vitro ↑endothelialisation, 
↑plasma protein 
adsorption 
227 
PTFE RGD cell adhesion 
peptide 
In vitro ↑immediate vEC 
adhesion; no long 
term advantage 
compared with 
fibronectin coating 
228 
Dacron Carbon In vitro vEC proliferation 229 
Polyurethanes and 
silicones 
Extracellular matrix; 
fibronectin;gluterald
ehyde preserved 
matrix (GPM) 
In vitro GPM provides 
optimal vEC 
proliferation 
230 
PTFE Fibronectin Animal 
model 
↑endothelialisation 
(both spontaneous 
and seeded) 
231 
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4 
 
Achieving the ideal properties for vascular bypass grafts using 
a tissue engineered approach 
 
 
4.1 Introduction 
 
  The ideal cardiovascular bypass graft requires a broad range of 
characteristics including strength, viscoelasticity, biocompatibility, blood 
compatibility and biostability232. It also needs to have the capability to adapt to 
the prevailing haemodynamic conditions, both immediately and in the long term. 
Till now, traditional synthetic material technologies have not been able to 
provide for all of these criteria11, despite a large volume of materials research in 
this arena. Expanded polytetrafluoroethylene (PTFE) was initially successfully 
used for small calibre arterial bypass by Matsumoto in 197320 and since that 
time, no convincingly superior alternative has emerged. This has translated 
clinically into poor medium to long term patency of synthetic grafts when used in 
low flow states and small calibre (<6mm) bypass. The 5 year primary patency of 
PTFE grafts which cross the knee joint is less than 30%233, resulting in 
considerable re-interventions and limb loss. Therefore in cardiovascular bypass 
surgery, when small calibre conduits are required, every effort is made to use 
autologous vessels. In the case of coronary artery bypass, the internal thoracic 
or internal mammary artery is the first choice graft; in distal bypass surgery, the 
great saphenous vein is harvested and used wherever possible.  However, 
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autologous vein is not available in a third of cases4 due to varicosity, previous 
use, incompatible calibre and diseased vein wall.  
  Acknowledgement of the huge difficulties involved in fulfilling the 
numerous ideal characteristics using traditional synthetic materials has lead 
biomaterials research towards the rapidly advancing fields of nanotechnology 
and tissue engineering. Nanotechnological avenues are concerned with the 
incorporation of manmade molecules into traditional materials to impart novel 
advantageous properties such as anti-thrombogenicity and biostability50. The 
mechanisms of action for these materials are not fully understood, being related 
to their unique quantal properties rather than the bulk properties of conventional 
materials234, hampering progress of their investigation and application. The graft 
material discussed in this thesis uses nanotechnology to attempt to confer 
advantageous properties to a well-established polyurethane. However, tissue 
engineered grafts have also been considered for several reasons. Firstly, it 
gives an excellent framework by which the various essential and advantageous 
properties of any bypass graft can be discussed. The success or otherwise of 
tissue engineering to fulfill these criteria is examined. Secondly, the advantages 
and disadvantages of the tissue engineered approach are considered. This will 
indicate whether it is the preferred avenue of research for small-calibre bypass 
grafts, or whether it is just too impractical, leaving nanotechnology as the only 
feasible option. Conversely if tissue-engineering is overwhelmingly 
advantageous and technically feasible, should effort be spent on using 
nanotechnology for graft development. Linked to this second point, the extent to 
which tissue-engineering has been developed into clinical practice and how 
near tissue engineered blood vessels are to clinical use is considered. The third 
reason for examining tissue-engineering is because the two technologies are 
not mutually exclusive. Investigators are currently using modifications of the 
nanocomposite as scaffold matrix for tissue-engineering purposes. 
  Tissue-engineering is an interdisciplinary field that applies the principles 
of engineering and life sciences to the development of biological substitutes in 
order to restore, maintain, or improve tissue functions235. Its ultimate trump card 
over synthetic materials is the inherent biocompatibility of the component 
biological materials. The field has captured the imagination due to the possibility 
of individualised specific grafts that can evolve according to haemodynamic 
parameters, and a large body of research has quickly built up. 
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   Thin engineered tissues such as skin236 and cartilage237 have been used 
clinically over the last decade. In addition, further stimulus has recently occurred 
with the successful clinical implantation of the first tissue engineered hollow 
organ238. A human bladder was developed, but more complex organ 
engineering is presently limited by the inability to „grow‟ the associated blood 
supply. Takei‟s group239 have used an elegant method to promote in vitro 
spontaneous three dimensional capillary growth in order to address this limiting 
factor. They have exploited the autonomous tube forming effect that collagen 
gel has on endothelial cells to persuade capillary budding into a collagen block 
from a tissue engineered microtube lined with bovine endothelial cells, using 
vascular endothelial growth factor (VEGF) as a stimulus. It is also now 
becoming clear that in the right conditions, engineered tissues can similarly 
promote angiogenesis, increasing their potential for manufacturing whole 
organs and ultimately connecting up with the host vasculature. Sekiya and 
colleagues tracked the autonomous organisation of ECs from random 
orientation to networks, along with the expression of angiogenic genes, 
including VEGF in sheets of cultured cardiac cells240. 
   Finally, the possibility of graft materials growing simultaneously with a 
patient opens up a whole new area of paediatric vascular surgery241.  
  This review highlights the development of tissue engineered vascular 
graft development with respect to the ideal graft characteristics which are so 
difficult, if not impossible to obtain from synthetic materials. It concentrates on 
recent advances in our knowledge, and is not intended to be a general overview 
of tissue engineered vascular grafts as this field has already been 
comprehensibly covered145;242-244. 
 
 
4.2 The major factors for consideration 
 
  The ultimate trump card of the fully tissue engineered graft is it‟s inherent 
biostability, with healing properties compatible with successful permanent 
implantation. The graft is continually moulded depending on the haemodynamic 
demands placed on it143. Thus it may be seen that the original ECM scaffolds 
used are not recognisable after being implanted for some time. However, as 
with most synthetic grafts, ECM scaffolds are vulnerable to unintended 
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biodegradation, leading to graft wall weakness, aneurysm and failure. This is a 
particular problem with elastin in decellularized xenograft scaffolds, which 
degrades despite gluteraldehyde-fixation due to its low opportunities for cross-
linking. Tannic acid is commonly used as a fixative for elastin before electron 
microscopy, and this can be used to prevent it‟s biodegradation by forming 
cross-linking hydrogen bonds between hydrophobic regions of the chain245. 
Unfortunately heavy crosslinking may adversely affect elastic properties. This 
illustrates the point that simple provision of autologous cells in an artificial ECM 
is not enough to automatically guarantee the desired biostability and careful 
selection of scaffold and cells is required. 
 
 
4.2.1 Scaffold 
  
  A multitude of approaches have been utilised to achieve the common 
goal of viable confluent sheets of cells anchored on a tubular scaffold. The 
scaffolds used are either synthetic or biologically sourced. In the case of the 
former, a non-degrading material will result in a hybrid graft rather than a wholly 
tissue-engineered graft and their mechanical properties will reflect those of the 
scaffold, with limited capacity for adaptation to changing blood flow conditions. 
Few such scaffolds have resulted in a clinically successful bypass graft246. 
These will not be considered further as the properties of such materials are 
dominated by the scaffold, thereby cancelling the potential advantageous 
effects of the completely tissue engineered graft. In addition, some of the main 
challenges facing tissue engineering such as ready availability and initial 
mechanical strength do not apply to them. Biodegradable scaffolds have been 
shown to provide a suitable environment for adherence, proliferation and 
organisation of cells. They provide primary mechanical stability while the cellular 
structures mature. As demonstrated in fig 4.1, the scaffold initially withstands 
the stresses of pulsatile flow. As the scaffold begins to degrade and formation of 
matrix occurs, the newly regenerating cells are gradually loaded with 
physiological stress thereby stimulating their appropriate alignment247 and 
further stimulating tissue regeneration. Eventually the scaffold completely 
degrades and the regenerated tissue bears the stress. Biological scaffolds may 
be transplanted tissues or specifically constructed, using extra-cellular matrix 
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components. An example of the former is the small intestinal submucosa (SIS) 
vascular graft which has been implanted directly into the vasculature of pigs, 
dogs and sheep, and proven to remodel as well as auto-seed with EC and 
smooth muscle cells (SMC)248-251. This gives the possibility of using SIS 
clinically as a vascular graft in cases with high graft infection risk252. Perhaps 
the ultimate transplanted biological scaffold is an autologous vessel. Saphenous 
veins are commonly used for arterial bypass and are observed to „arterialise‟ 
with smooth muscle cell hypertrophy and intimal thickening253. Clerin‟s group 
exposed the ex-vivo adaptability of small vessels, by subjecting them to 
extrinsic longitudinal stresses (to lengthen them) and precise internal flow 
programs (controlling wall thickness and vessel calibre)254. 
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Fig 4.1. The graph demonstrates the timeline for the development of a tissue 
engineered bypass graft using a synthetic biodegradable scaffold, which is 
gradually replaced by arterial matrix.  
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  Collagen is commonly used as an ECM, due to its high strength and the 
potential for auto-seeding of endothelial cells. Its use is discussed in relation to 
its mechanical properties later. Highly permeable biopolymers such as collagen 
gels are useful for holding cells in suspension and providing a favourable 
microenvironment for cell attachment and proliferation. These are the same 
roles which collagen performs biologically. They must always be matured in 
vitro, due to their low inherent mechanical strength. This is by promotion of 
collagen gel organisation and contraction around a suitable mandrel in 
conjunction with smooth muscle cells, resulting in a circumferential alignment of 
both SMC and collagen255 as well as application of pulsatile stress to 
consolidate this organisation. These processes are considered in detail below in 
relation to mechanical properties. However, as Isenberg points out242, collagen 
gels perform relatively poorly with overcontraction of the gel leading to reduced 
matrix permeability being a frustrating problem. . Lewus and Nauman have 
determined that this undesirable effect is reduced by including whole collagen 
fibres to the hydrogel matrix256. To date, acceptable mechanical properties 
achieved in a realistic timeframe are yet to be realised. 
  The other major natural cell substrate is fibrin. Surprisingly, the 
stimulation of fibroblasts to form collagen257  as well as elastin258 may be 
greater within fibrin gel than collagen gel, translating to increased mechanical 
strength and biomimetic elasticity. Isenberg has also found fibrin gel matrix to 
endothelialise well with good EC retention after simulated haemodynamic shear 
stresses259. 
  The use of elastin directly in the scaffold is hindered by the problems 
described above with rapid degradation. However, recognising it‟s importance 
not only mechanically, but also in subsequent regulation of endothelialisation, 
Wise and colleagues260 used its soluble precursor, Tropoelastin, in recombinant 
form (ie. synthetic) in a hybrid scaffold, which maintained its mechanical 
properties in a rabbit model for a month. They found subsequent endothelial cell 
attachment and proliferation along with platelet activation properties to be 
superior to the biodegradable scaffold alone, or in conjunction with albumin 
coating. However, they have not till date shown whether the recombinant 
tropoelastin has inherent biostability or whether the polycaprolactone scaffold is 
providing this, until remodelling occurs naturally in vivo and the scaffold 
degrades.         
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4.2.2 Cells 
 
  The cells in consideration are fibroblasts, SMC and vascular EC (Fig. 
4.2) which are present in histologically distinct cellular layers. Fibroblasts 
synthesise the extracellular matrix which is responsible for mechanical integrity; 
SMC have the ability to contract in response to specific haemodynamic 
conditions; EC present a non-thrombogenic layer at the blood-graft interface. 
However, there is considerable interaction between the different cell types to 
ensure these roles are fulfilled. This is another reason for the drive to implant 
grafts with all the cellular layers already present. 
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Fig 4.2. A living cellular matrix, comprising of Type I collagen & porcine smooth 
muscle cells, which is contracted on a central mandrel within a bioreactor. 
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  L‟Heureux261 has cultured human fibroblasts on gelatine to form sheets 
which resulted in organised ECM, without the initial involvement of SMC. 
Repeated rolling of these sheets around a mandrel resulted in acceptable 
mechanical strength. The resultant conduits were endothelialised and implanted 
in several animal models. SMC migration from the anastomoses as well as 
possible transformation of fibroblasts to myofibroblasts was observed. Excellent 
short term and good medium term in vivo results were obtained. 
  Unlike the above study, most other grafts composed of cellular layers 
have utilised SMC rather than fibroblasts, in the common aim of replicating 
arterial tissue. Difficulties have centred around the contraction of SMC and cell 
substrates, along with culture difficulties due to the early senescence of  
SMC262. 
  It is widely recognised that a rapid confluent endothelial layer protects a 
synthetic graft from thrombosis and early occlusion263. However, extensive 
endothelialisation has never been shown in clinical practice, despite the 
literature being replete with animal models demonstrating endothelialising 
grafts. This has contributed to the impetus behind endothelial seeding of grafts 
before implantation264, since physiological shear stress is a hostile environment 
for EC adherence and function265. Endothelial cells have intimate interaction 
with SMC, expressing transforming growth factor genes266, which are also 
responsible for SMC organisation and collagen secretion. The same growth 
factor signals EC apoptosis. A further role of EC is in angiogenesis, with their 
alignment into tubular structures. Asano and colleagues267 have demonstrated 
pore extrusion of EC via morphological changes and realignment through a 
collagen scaffold as a preliminary angiogenic bud. This was controlled by the 
shear forces exerted on EC by the blood flow.   
  The attachment of vascular endothelial progenitor stem cells is an 
exciting recent possibility268, aimed at rapid accumulation of appropriate cellular 
layers, including cell adherence from endogenous blood flow.   
 
 
4.2.3 Mechanical properties 
 
  Mechanical characterisation of the artery reveals an anisotropic nature 
with high elasticity at low pressures and greater stiffness along with low 
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distensibility at high pressures233. This is due to the multi-laminar arrangement 
of collagen and elastin. Collagen provides high tensile strength - porcine carotid 
burst pressure is in the region of 2000mmHg269 - as individual fibres are 
gradually recruited at increasing pressures270 - Gupta used electron microscopy 
to demonstrate the straightening out of elastin fibres, until 120mmHg when 
additional stress was exerted wholly on collagen271 – see Fig 3.1. The 
combination of strength and elasticity has been a particular challenge in 
potential synthetic graft development, with modification of traditional materials 
such as segmented polyurethanes allowing an improvement in one at the 
expense of the other by modification of the soft and hard segments40. It is 
thought that the inequality of elasticity (compliance mismatch) between native 
artery and graft material may be responsible for intimal hyperplasia66 which 
itself is the cause of medium to long-term graft occlusion of small calibre grafts. 
The common femoral artery has a compliance of 4-8 %/mmHg x 10-2 whereas 
this is only 1 %/mmHg x 10-2 in the case of PTFE71. It is essential therefore to 
consider an appropriate extra-cellular matrix (ECM) for TE grafts to mirror the 
strength and elasticity of arteries.  
  One principle by which to achieve this aim is to use a biodegradable 
hydrophilic polymer scaffold, with long term replacement by ECM. The 
bioresorbable scaffolds used are based on polyglycolic acid (PGA), 
polydioxanone or Polylactide144. PGA forms a porous structure but is resorbed 
within 8 weeks and in order to slow degradation it is often combined with an 
adjunct such as polyhydroxyalkanoate, poly-4-hydroxybutyrate or polyethylene 
glycol145. Cellular infiltration of these scaffolds is dependent on a highly porous 
open structure.  
  As discussed earlier, groups have considered collagen itself as the 
foundation for biological scaffolds, primarily because of the impressive strength 
it imparts. However, Weinberg and Bell‟s pioneering collagen-based scaffolds 
were very weak, requiring a Dacron mesh for initial strength272. Berglund273 has 
shown that elastin makes collagen tubes stronger - it may have a considerable 
role in distributing the stress across the TE vessel wall. Elastin also improves 
the viscous nature which again is generally thought to be due to collagen. This 
may be because without elastin‟s gradual stretching influence, the abrupt 
pressure wave on the collagen construct may not allow sufficient time for the 
viscous component to manifest itself. Berglund extracted elastin scaffolds from 
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an animal model by targeted enzymatic digestion of ECM. However, it is very 
difficult to incorporate elastin into engineered structures due to its low solubility. 
Leach‟s group274 have used water-soluble alpha-elastin in conjunction with a 
„molecular glue‟ to form „elastin-like‟ structures with similar mechanical and cell-
adherent properties. An added advantage is that the materials used are readily 
available off the shelf. 
  Collagen also derives strength from circumferentially arranged SMC 
layers which require prolonged culture to achieve as well as a porous collagen 
network. The orientation of the SMCs is paramount and can be optimised by 
pulsatile flow in bioreactors, causing circumferential stress as a stimulus275.  
  One way of obtaining a collagen scaffold with reasonable initial strength 
is by promoting the fibrous reaction against a mandrel placed 
subcutaneously149. However, the minimum burst pressure of 200mmHg was still 
far below the desired magnitude for clinical use. In addition, preparation of 
these “biotubes” required 4 weeks of subcutaneous implantation. Physiological 
flow on implantation results in further collagen thickening, elastin deposition and 
myofibroblastic reorganisation. 
  Other derivatives of biological structures which may act as temporary 
scaffolds, to be replaced by ECM are gaining prominence. Lepidi‟s work276 on 
hyaluronan, an esterified hyaluronate is promising, showing rapid accumulation 
of organised arterial cellular and ECM components in an animal model, with 
biodegradation of the scaffold over four months. The cellular reorganisation is 
undoubtedly helped by the scaffolds ability to maintain a loosely packed ECM. 
However, this success in microvessels has yet to be shown in the intermediate 
size of vessels (3-6mm) as the strength of the construct is strongly dependent 
on the ECM formed277. 
 
4.2.4 Blood compatibility – the endothelial lining 
 
  It is notoriously difficult to render a synthetic material non-thrombogenic, 
requiring the concomitant properties of hydrophilicity, electronegativity and 
inertness. Currently, the best hope is for the development of an endothelial 
lining. Unfortunately, although animal models readily endothelialise211, a 
synthetic graft with long confluent endothelialised sections in clinical practice is 
yet to be achieved. Although collagenous constructs obtained from small 
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intestinal submucosa have been successfully used as vascular grafts in vivo, 
collagen itself is thrombogenic154, and gaps in the endothelial sheet or absent 
basement membrane may be a focus for thrombus formation. Surface 
modifications of collagen such as heparin-bonding can be partially successful in 
reducing thrombogenicity175. Preliminary platelet reactivity studies have 
suggested that elastin exhibits less platelet adhesion than collagen278. These 
studies also uncovered good EC adhesion to both collagen and elastin. 
  Biologically sourced scaffolds can be seeded with variable ease, with 
autologous structures seeding readily compared with decellularized xenografts, 
especially if the latter have not been adequately treated, resulting in residual 
antigenicity279.  
  In keeping with the theme of replicating the biomolecular and cellular 
mechanisms of the structure being replaced, tissue engineering aims to provide 
low graft thrombogenicity via active seeding of the blood interface with 
endothelial cells (EC). Careful consideration must be given to the source of ECs 
along with the method of extraction. Enzymatic cell loosening using collagenase 
or trypsin requires careful timing to prevent extraction of other cell types such as 
SMC or fibroblasts. Mechanical stripping of endothelial linings damage EC. 
Recently investigated sources include veins, adipose and bone marrow.  
   
 
4.2.4.1 Veins 
 
  Although endothelial cell extraction has been successfully performed 
from the vein wall, optimal seeding and culture on synthetic scaffolds requires a 
turnover time of at least seven days280. However the degree of adherence and 
function of the seeded cells depends greatly on the scaffold material used. This 
is perfectly illustrated by Yeh and colleagues‟ study of endothelial cells seeded 
to different metallic stent materials281, showing the importance of considering 
not only attachment but also the level of function for these cells. The saphenous 
vein is a potential source of ECs which may be harvested if the vein calibre is 
too small for autologous vein bypass. Experimentally, the umbilical vein is used 
as a source of ECs – but this structure is not likely to be available at the time of 
TE graft requirement. EC can be extracted from the umbilical artery282, but the 
yield is low, due to the size of the vessel and extraction difficult. 
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  Of course it can be argued that using available vein as graft material is 
already successful in the case of small calibre vessel bypass, eliminating the 
need for tissue-engineering in these cases. 
 
 
4.2.4.2 Adipose 
 
  Oedayrajsingh-Varma283 has shown that adipose-derived stem cells with 
true proliferative potential could be harvested with greater efficiency from 
surgically excised adipose tissue than from ultrasound-guided liposuction. 
However, these cells differentiated into connective tissue rather than endothelial 
cells and it is not clear whether the same would apply for endothelial 
progenitors. In fact it is becoming evident that the differentiation potential for 
these adipose-derived stem cells may include several different lineages, 
dependent on biomolecular and biomechanical environmental cues rather than 
it being genetically predetermined284;285. 
 
 
4.2.4.3 Bone marrow 
 
  This is a ready source of pluripotent stem cells, which will be available at 
the time of surgery. Cho and colleagues286, seeded small calibre decellularized 
canine carotids with ECs and smooth muscle cells (SMCs) of bone marrow 
origin before implantation and found eight week patency as well as a 
regenerated arterial wall. However, these cells were cultured in vitro for three 
weeks meaning that bone marrow biopsy was required separately to operation. 
Shin‟oka‟s group287 have demonstrated endothelium-like cells on biodegrading 
scaffolds after fixing unselected bone marrow cells with fibrin glue and a 
maturation time of only four hours. However, their shear stress resistance after 
such short maturation is yet to be ascertained. 
 
 
4.2.4.4 Endothelial progenitor cells (EPC) 
 
  The most exciting development in EC sourcing is the seeding of EPC. 
Pluripotent cells are easily available from every patient (bone marrow) unlike 
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EC, and they may also autoseed grafts from the circulation. It is thought that this 
latter is promoted by the use of statin therapy288. Apart from the bone marrow, 
EPC can be sourced from fat (subcutaneous/omental) and umbilical cord blood. 
After careful consideration of the ethical implications, embryonic tissues may in 
the future be used as an additional source.  
  EPC differentiate into EC in response to signalling from the ECM and 
haemodynamic conditions. Unfortunately, the number of EPC decreases in 
some of those patients who are most susceptible to arterial disease- the 
elderly289 and diabetics290. Honold and colleagues found EPC to be mobilised 
by granulocyte colony-stimulating factor, but their functionality was poor291. 
Localised arterial damage, in particular causes the targeted attachment of 
endothelial progenitors, leading Sreerekha to hypothesise that the fibrin in 
thrombus is the homing structure292. This group coated synthetic grafts with a 
fibrinous lining and seeded them with nucleated cells isolated and cultured from 
bovine blood. PTFE showed greater initial attachment of these cells than 
Dacron, but subsequent proliferation of these cells was faster on the Dacron 
graft. These cells showed functionality by synthesising nitric oxide and after 96 
hours of culture, resisted the shear forces of haemodynamic flow. Lev et al. 
have shown an aggregative and potentiating effect of activated platelets on 
EPC, using human cells293. This indicates that there is a physiological role for 
circulating endothelial progenitors in humans.    
 
 
4.2.5 Off the shelf availability 
 
  Arterial bypass grafts are required on a semi-urgent basis for the relief of 
critical ischaemia and in some cases, urgently after the onset of acute 
ischaemia which may occur after interventional radiological procedures have 
been attempted. One great criticism levelled at TE grafts is the long time period 
required before an individualised graft can be made available.  
  Attempts to use readily available ECM components are being made but 
the use of ECM gels require prolongued maturation in bioreactors after seeding 
with SMC to form fibrous type collagen, followed by EC seeding and further 
maturation to ensure confluence as well as mechanical shear resistance of 
20dynes/cm2. In Isenberg‟s fibrin gel259, the initial matrix maturation required 5 
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weeks, whilst EC seeding numbers were optimal at 2 days, with good EC 
alignment and retention with 10dynes/cm-2 steady or pulsatile flow. However, 
even with 5 weeks matrix maturation, the mechanical strength was not uniform 
or adequate, with only short segments(3-4cm)  of graft being useable, and even 
these dilating irreversibly when exposed to low pulsatile flow.  
  Much of the time presently required for cell seeding is attributable to the 
two stage procedure of cell culture followed by seeding in a bioreactor. 
Niklason‟s group148 have demonstrated a direct correlation between the time for 
maturation and strength of the resultant graft, with their seeded biodegradable 
PGA scaffold having a burst pressure of 570mmHg after 5 weeks and 
2150mmHg at 8 weeks148. 
  To address this, a single-stage method aimed at simplifying and 
quickening the graft implantation process involves auto-seeding cells rather 
than relying on physical extraction of cells by enzymatic or physical means 
where cell yields are low and adhesive efficiency and then proliferation is 
limited. This latter yields different levels of differentiation of SMC lines 
depending on the method of extraction294. 
  Some biodegradable synthetic polymers have relatively poor cell 
adherence properties, making them very unlikely to auto-seed from peripheral 
blood. Binding these materials with collagen may enhance their cellularization 
capability greatly295;296, leading to the possibility of auto-seeding. The collection 
of large numbers of specific cells and their culture for seeding purposes is itself 
a long process. As outlined earlier, a possible future alternative to EC harvest, 
culture and then seeding is auto-seeding of EPC circulating in peripheral blood 
which could contribute to rapid endothelialisation of scaffolds297. Work on animal 
models in this area must be interpreted with a degree of caution as 
endothelialisation occurs less readily in humans. Also, the number of circulating 
EPCs in whole blood is low and the time taken for confluent endothelialisation 
by auto-seeding without cell culture is high. Notwithstanding this, Shirota‟s 
department has shown effective endothelialisation with human EPCs on 
collagen coated polyurethane conduits after four days seeding time298. These 
cells aligned and remained confluent when subjected to flow at 30dynes/cm2. 
The problem of low EPC numbers in circulating blood can be circumventing by 
rapid seeding of stem cell-rich bone marrow. Another alternative may be to 
persuade the bone marrow to mobilise larger numbers of EPCs, using 
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granulocyte colony stimulating factor and granulocyte-macrophage colony 
stimulating factor299 although there is debate as to the efficiency of the resultant 
EPC291. 
  Other mechanisms to improve endothelialisation efficiency include 
surface modifications with RGD-containing peptides300;301 and growth factors 
such as basic fibroblast growth factor302. The RGD moiety is also independently 
anti-thrombogenic303 and increases the feasibility of a single stage seeding 
procedure304.  
 
 
4.3 Conclusion and future directions 
 
  Tissue-engineering of vascular bypass grafts is a fast-advancing field 
stimulated by the large number of bypass procedures carried out without 
available autologous vein and the lack of synthetic prostheses with good long 
term results. It is also recognised that tissue-engineering of complex organs will 
only be possible when the intra-tissue blood supply can be secured. The final 
prize is an enticing one with the possibilities of replacement organs grown to 
order as well as, in children, the growth of vascular bypass prostheses as the 
individual grows. The large list of characteristics attributed to the artery which 
makes it ideal for purpose can not all be satisfied within a single synthetic 
prosthesis. It is clear to us that the proposition of a fully tissue-engineered artery 
has been particularly attractive as synthetic graft development using traditional 
materials has reached an impasse with the realisation that the many desirable 
(or even essential) properties cannot be simultaneously fulfilled. However, 
tissue-engineering can be used to „grow‟ an artery on an individual basis, 
demonstrating biocompatibility; blood compatibility; mechanical strength with 
simultaneous viscoelasticity for efficient propulsion of pulsatile flow; and the 
ability to react to short and long term changes to haemodynamic conditions. 
Endothelialisation through the graft wall can occur as part of graft healing, 
provided a precise porosity and pore distribution with the optimal pore size 
being 30μm206. Exact pore specifications present great challenges in scaffold 
engineering with the advances in computer-aided manufacture and rapid 
prototyping showing real potential for the future305. Using the micro-CT-centred 
screening techniques that Van Cleynenbreugel306 has employed on bone grafts 
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the resultant scaffolds need not be tested in vivo until their biomechanical and 
structural suitability have been assured using finite element simulations and 
high resolution computed tomography for structural analysis. Stem cell research 
is a very active avenue for investigation at present both for endothelial seeding 
as well as a source for all the cellular layers required in a neo-artery. Their use 
could potentially increase seeding efficiency; solve the cell sourcing difficulties; 
and reduce the time required in vitro. Ultimately, using the ability of stem cells to 
differentiate into different cell lines could be channelled into techniques whereby 
different tissue layers are engineered from the same original stem cell source. 
This will only be possible once the mobilisation and differentiation factors for 
stem cells are fully understood. A big challenge is to achieve this with the 
shortest possible graft preparation time, and a number of techniques are being 
developed to ensure this ease of availability. However, for all the appeal of a 
bespoke personalised graft, if the issue of quick availability is not resolved, 
tissue engineering will not be the able to become the main mode of small 
calibre vascular graft production.  
  The concurrent rapid increase in understanding and utilisation of 
nanotechnology in material science has begun to show direct and indirect 
effects on tissue engineering. Nanofibre manipulations of established polymers 
can achieve the favourable properties for biological implants, by mimicking the 
biological with the possibility of their use as improved synthetic scaffolds307. 
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5 
Materials and Methods 
 
 
5.1 Background 
 
Composite materials have become commonplace in all aspects of 
modern living. They involve the organised integration of two or more materials 
to bestow the properties of each component simultaneously. At the macroscopic 
level, concrete reinforced with iron rods reduces brittleness and allows 
skyscrapers the ability to sway considerably in the wind or at the extreme, 
during an earthquake. Another example is the use of carbon-fibre technology in 
the strengthening of the bodywork of sports cars. Epoxy resin is co-extruded 
with carbon fibres - or graphite - to give a light yet simultaneously strong 
structure. Here the integration is occurring between polymeric fibre chains at the 
microscopic level. However, the latest composite manipulation technology 
concerns the use of nanoparticles – molecular constructs measured in the 
nanoscale range (0.1nm to 100nm) as an additive to traditional bulk materials. 
Apart from the relative size, the difference between the two components is that 
bulk materials retain constant physical properties for all sizes, whereas 
nanoparticles exhibit size-dependent properties. A range of properties can be 
conferred, including favourable mechanical characteristics – the extreme 
hardness of copper nanoparticles, compared with bulk copper – or photo-optic 
properties, due to quantum confinement with applications in medical imaging of 
quantum dots, to name but a few. The attributes due to the nanoparticle are not 
necessarily predictable – they relate to the percentage of atoms at the surface 
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of the particle. In the case of bulk materials, the atoms at the surface are 
overwhelmed by the sheer number of atoms in the rest of the structure, this 
latter dictating the properties. There is a branch of physics dedicated to the 
special behaviour of materials at the atomic level – quantum mechanics, which 
acknowledges the difference with traditional (Newtonian) mechanics of bulk 
matter. At its most fundamental level, it explains the orbital behaviour of 
electrons around a nucleus – classic physics would predict electrons being 
drawn straight to the (positive) nucleus. The success of quantum mechanics 
has been in the accurate prediction of behaviour at the atomic and sub-atomic 
level. However, this esoteric theoretical branch of physics has not been invoked 
in the conceptualisation and synthesis of the polymeric material used to 
manufacture PCUPOSS.   
Nanotechnology is concerned with manipulation at the molecular or 
atomic level to provide useful applications. The field was popularised with the 
discovery of the fullerene structure – an alternative carbon molecule to graphite 
and diamond. This important discovery by Harold Kroto in 1985 at the University 
of Sussex highlighted that different molecular configurations of the same atoms 
gave widely different chemical and material properties. This concept underlies 
the whole of nanoengineering. It is a rapidly expanding field and still very much 
in its infancy with wide-ranging material science applications being developed 
including within the medical field. So far, particular promise has been shown in 
the medical technology fields of novel drug delivery systems, gene therapy and 
tissue engineering. Yet another molecular arrangement of carbon – the carbon 
nanotube has so far been the most investigated nanoparticle for potential 
biomedical applications308. However, they are limited by in vivo cytotoxicity and 
would not be suited to prolongued implantation309. 
PCUPOSS is a nanocomposite material covalently bonding a 
polyurethane with a silsesquioxane „nanomolecule‟ with the aim of exploiting the 
advantages of both moieties. The initial aim was to modify polycarbonate based 
polyurethane to improve its biostability with a view to using it as a long term 
implant material, but as has been discussed above, it was not known exactly 
what properties would ultimately be conferred. Silsesquioxane technology was 
targeted due to previous incorporation of siloxane (Si-O chains) in the form of 
polydimethylsiloxane (PDMS) – see Fig 5.1 - into polyurethanes. This itself was 
stimulated by two observations: siloxane groups are biologically inert and have 
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similar bond properties as ether groups within polyurethanes. 
 
CH
Si
CH
O
3
3
n  
 
Fig 5.1. The repeating monomer of polydimethylsiloxane (PDMS). A large 
number of repeats (n) reduces viscosity. 
 
 Optimum levels of PDMS as a crosslinking agent as well as incorporation 
into the polyurethane backbone reduces biodegradation and the extent of the 
inflammatory response to the polymer310. However, this incorporation also 
contributes to a reduction in strength despite similar bond strength as polyether. 
The loss of tensile properties is due to macrophase separation as a result of the 
poor solubility of the PDMS311.  
 
5.1.1 Silsesquioxane 
 
This word literally indicates one silicon atom for 1.5 oxygen atoms. It 
represents a class of silicone-oxygen compounds which include the polyhedral 
oligomeric silsesquioxanes (POSS). This latter comprises cyclical rings of 
alternating Si-O atoms in layers. In order to preserve the Si2O3 ratio, only 
specific ring/layer combinations are possible. PCU-POSS contains one of the 
most widely used POSS structures, namely the Octahedral-Dimeric 
Silsesquioxane – Fig 5.2. 
 
 
 
Fig 5.2.  Chemical structure of trans-cyclohexanediolisobutylsilsesquioxane, the 
POSS moiety used in PCUPOSS. 
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5.1.2 Polyurethane. 
 
This is a class of polymer with very widespread applications in all 
industries. This is a reflection of the huge variety of properties which can be 
conferred on it, depending on the constituent components. There has been 
widespread use of polyurethane materials as in-vivo implants due to their 
favourable biocompatibility. They came into prominence as medical implants 
from research aimed at producing the „artificial heart‟, due to their high tensile 
strength, repetitive stress fatigue resistance and inherent low thrombogenicity.  
 
 
5.1.2.1 Poly(ester)urethane 
 
The initial polyurethanes to be evaluated had polyester soft segments. 
However, their use as medical implants was short-lived when it was realised 
that these underwent rapid hydrolysis in the biological environment, limiting 
them to roles where in vivo exposure was less than a few hours.  
 
 
5.1.2.2 Poly(ether)urethane 
 
When considering permanent non-degrading graft materials, polyether 
macroglycol appeared to be more suited, with no hydrolysis of the soft segment. 
A number of polyether urethanes have been produced commercially for clinical 
implantation – see table 1. However, ether links are susceptible to oxidative 
degradation when exposed to reactive oxygen species produced by 
macrophages. The extent of degradation is proportional to the number of ether 
links present, although at a much slower rate than polyester degradation. These 
mechanisms of degradation are discussed in detail in chapter 10. 
 
 
5.1.2.3 Poly(carbonate-urea)urethane (PCU) 
 
Our group has concentrated on the use of polycarbonate macroglycol. 
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This largely eliminates ester and ether groups, rendering the polyurethane 
relatively biostable. Initial in vitro biodegradation studies of PCU showed that a 
range of physiological solutions simulating the biological environment and its 
degradative mechanisms caused less degradation than polyether and polyester 
soft segments. However, specific hydrolytic enzymes such as cholesterol 
esterase as well as exposure to oxidative solutions have shown in vitro 
degradation. Monocyte-derived macrophages could hydrolyse polycarbonate 
urethanes as predicted by in vitro cholesterol esterase action312. However, in 
vivo, macrophage-derived oxidative compounds are also released which may 
be protective against hydrolytic degradation.  
 It is often stated that the biostability of polyurethanes is determined by 
the polyol used. However, it can be inferred from the relative biodegradative 
potentials of the above three PU classes that this is a simplification. If 
macroglycol degradative susceptibility reflected that of the PU, PCU would be 
highly susceptible to hydrolysis. In fact PCU is protected from degradation by 
the shielding effect of the hard segment. This is brought about by extensive 
hydrogen bonding between the carbonate groups and the hard segment at the 
urethane moiety.   
 To understand the structure of our nanocomposite, a basic understanding 
of polyurethane chemistry is required. 
 A polyurethane is a chain of repeated monomers (ie. a polymer) each 
linked to the next by a urethane group: 
 
  
C
O
N
H
 
 
 This link forms the bond within the hard segment of the polymer. Hence 
the term polyurethane is in a sense misleading as it does not consist mainly of 
repeating urethane groups. The „co-polymer‟ is composed of hard segments 
and soft segments which exist in microphase separation – they do not mix 
completely with each other; giving rise to the term „segmented polyurethane‟ – 
see Fig 5.3. A polyurethane with a preponderance of hard segment is described 
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as „crystalline‟ whereas if the soft segment dominates, it is termed an 
„amorphous polyurethane‟. 
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Fig 5.3. Molecular schematic to describe the segmented structure of 
polyurethanes. The ordered hard segments are highly polar groups with strict 
alignment and strength. These float in a „sea‟ of soft segment, which allows 
considerable movement. Hence the combination can be elastic and 
simultaneously strong. 
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 The hard segment incorporates a urea bond, formed by reacting  –NH2 
groups of a diamine with –NCO groups on a diisocyanate; or a urethane bond 
by reacting diol –OH groups with the -NCO, whereas the soft segment is a 
macroglycol such as polyester, polyether, polycaprolactone or polybutadiene 
which is also reacted with the diisocyanate -  the -OH groups of the macroglycol 
with –NCO on the diisocyanate - to form further urethane links. The hard 
segment is the highly ordered and  tightly packed crystalline component with 
polar groups capable of multiple H-bonding and van der Waal attractions to 
adjacent groups whereas the soft segment forms an amorphous matrix with 
random intertwined coils within which the hard segments float. One 
consequence of microphase separation is that an increase in the hard segment 
to increase strength will affect the soft segment too resulting in a reduction of 
elasticity as a result of increased „virtual crosslinking‟ of the crystalline segments 
with each other and with the matrix. Although it is not clearly understood at 
present, it is also thought that microphase separation is also responsible for the 
low thrombogenicity seen with many polyurethanes, due to irregular nanoscale 
surface geography313. 
 The oxygen atom of hydroxyl groups is slightly electronegative due to its 
propensity to pull electrons away from its neighbouring hydrogen atom. The 
cyanate group consists of  a carbon atom with electron-greedy nitrogen and 
oxygen either side of it, making it relatively electropositive, and therefore readily 
reacting with the oxygen of the hydroxyl group. The result of this reaction is to 
leave the carbon satisfied but the adjacent nitrogen remains electronegative. 
The nitrogen donates a pair of electrons to the hygrogen atom of the hydroxyl 
group which is now next to it, forming a urethane bond. This reaction is 
summarized in Fig. 5.4. 
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Fig 5.4. The formation of the urethane bond. See text for details. 
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5.2 Synthesis of PCU-POSS 
 
 72g of dry poly-hexamethylene carbonate diol (2000 molecular weight) is 
mixed with 2g of trans-cyclohexanediolisobutylsilsesquioxane (Sigma-Aldrich) – 
the POSS, in a 500ml reaction flask equipped with a nitrogen inlet and 
mechanical stirrer. The mixture is heated to 125OC to dissolve the POSS in the 
polyol and then cooled to 60 OC gradually by removal of the heat source. 
Constant stirring is performed throughout. 18.8g of flake methylene 
diisocyanate (MDI) are added to the polyol blend and then reacted, under 
nitrogen, at 75 OC for 90 minutes to form a pre-polymer. This consists of POSS 
moieties with MDI attached at each of its hydroxyl groups, and polycarbonate 
with MDI reacted to the diol groups on either end. 156g of dry 
dimethylacetamide (DMAC) is slowly added to the pre-polymer to form a 
solution, which is then cooled to 40 OC. Chain elongation is carried out by drop-
wise addition of a mixture of 2g ethylenediamine and 0.05g diethyamine in 80g 
dry DMAC. The former‟s two amine groups cause chain extension by the 
formation of urea groups, and the latter having one amine, terminates the 
predominantly linear chain. Finally a mixture of 4g 1-butanol and 80g DMAC are 
added slowly to the polymer solution.  
 
 
5.3 Tensile Stress Testing of Graft Material 
 
 
5.3.1 Introduction 
 
Tensile testing is the universally recognised technique for mechanical 
characterisation of any material. However, testing of small elastic specimens 
with low magnitudes of failure requires high attention to detail to ensure 
accuracy and reproducibility. The basic premise is to apply a strain to the 
sample, monitoring extension and stress within the material. The strain may be 
gradually increased until the sample breaks to give information about material 
strength.  Standard apparatus for tensile testing is designed for larger 
specimens than the 5mm graft and require considerable modification. Also a 
consideration of the biological environment is required to validate the test 
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procedure. The viscoelastic behaviour of a tissue depends on the temperature 
of the environment, so testing needs to occur at 37°C. 
 
 
5.3.2 Stress-strain behaviour 
 
This relationship fundamentally describes the mechanical behaviour of 
the overall graft. It requires the appreciation of any possible directional 
anisotropy. This relates to the mechanical properties in one direction being 
different to those in another direction. Therefore it is of paramount importance to 
measure tensile properties in the circumferential plane, and compare the results 
with the longitudinal direction. In reality, grafts are never subjected to steadily 
increasing deformation. Nevertheless, it provides baseline data on the strength 
and elastic properties of the material. 
Stress is a ratio of applied load on the material to its cross-sectional area 
(Force/Area). The highest stress achieved before the material breaks is termed 
the „ultimate strength‟ or „ultimate tensile strength‟. This is not necessarily the 
stress immediately before fracture of the sample – see Fig 5.5 
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Fig 5.5. A typical stress-strain curve. 
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Strain relates to another ratio – that between the stretched length and the 
original unstretched length, and so has no units. The initial relationship in the 
curve above is linear, following Hooke‟s Law, which states that for an elastic 
material, the stress is proportional to the strain. The relevance of this portion is 
that removal of the stressor would result in a reduction in strain exactly along 
the same line. It is important to know the pattern of stress unloading as pulsatile 
flow entails a continuous loading and unloading of stress on the vessel wall.  
 Artery segments do not distend and relax along the same line on the 
stress-strain curve. They do not show linear stress-strain relationships as 
discussed in chapter 2. The extrusion-coagulated grafts may be considered to 
be foams, due to the high pore density and size which is demonstrated by 
scanning electron microscopy in chapter 6. It is not strictly accurate to speak in 
terms of stress with foams as the specimen cross-section thickness is largely 
pores, rather than the polyurethane material. Instead, force may be used to 
show the same relationship with strain. Force-strain characteristics for foams 
have a characteristic shape – Fig 5.6 
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Force
Strain
   
Fig 5.6. The typical tensile test curve for foam structures. 
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 In fact, this curve is not dissimilar to the more commonly performed 
compression test of a foam – see Fig 7.1. The initial part of the tensile curve 
simulates the J-shaped curve found for arteries and one reason for the selection 
of highly porous polymer constructs (ie. foams) as alternative compliant grafts. 
 
 
5.3.3 Stress Relaxation 
 
 This is defined as the reduction of stress over time under a constant 
strain. It is a measure of the viscous component of mechanical properties. 
Together with elongation, it demonstrates viscoelasticity of the test sample. In 
many polymer applications it is a highly undesirable property. Generally 
speaking, these include applications which require long periods of strain 
maintenance such as the screw-top lid on a plastic jar. However, viscoelasticity 
is an inbuilt feature of the arterial wall as discussed in chapter 2. The usual way 
of quantifying the results of a stress relaxation test is by plotting the decay of 
stress with time. Dividing the stress at a given time by the strain gives an 
apparent modulus, which can then be re-plotted as a function of time314.  
 
 
5.3.4 The longitudinal sample 
 
The traditional sample for tensile testing is „dog-bone‟ shaped – see Fig 
5.7. 
The wide ends are placed within the grips of the apparatus. The reason 
behind this shape is to ensure that the highest stress concentrations do not 
build up at the grip ends themselves. It must be assumed that application of any 
grip will place additional stresses on the sample in the vicinity of the grip 
margin, potentially weakening the graft at this point. Hence on applying strain, 
the sample can fail prematurely at the grip edge, misrepresenting the actual 
ultimate tensile strength of the material. By widening the ends of the sample, 
the stress concentrations are greatest in the central narrow part which is 
unaffected by the grips (stress = force/area). This area is known as the „gauge 
length‟. 
Extraction of the „dog-bone‟ from the graft is not a simple affair. The graft 
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is first opened longitudinally. However using a template and cutting the sample 
out of the graft with a scalpel blade introduces variable stresses to the edge, as 
it is impossible to follow the template smoothly with the same pressure 
throughout. The method used is punching the sample out of the graft wall using 
a razor-sharp cutter and a mechanical press. The cutter needs to be sharpened 
regularly to ensure that the cutting process is identical for each sample. To 
eliminate this possible variable, some authorities recommend that the cutter 
design should not be razor-sharp, accepting the slight side-shear that will occur, 
as this will at least be the same for all samples cut. 
Even with this technique there is the possibility of non-uniformity due to 
the elasticity of the graft and its shape-memory for a tubular form. The pressing 
action of the cutter on the graft can stretch it as it cuts. To preserve uniformity of 
the cut edge, the graft material was sandwiched between two polyurethane 
sheets. This ensured the specimen was flat without being stretched. The sheet 
above the sample was 0.5mm thick whereas the sheet below was 3mm thick. 
The cutter depth was set such that at its lowest point it rested 2mm within the 
substance of the lower sheet to ensure it has completely transected the graft 
sample. The press was lowered manually with a swift action.  
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Fig 5.7. The dimensions of the dogbone specimens used (not actual 
size). 
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5.3.5 The testing grips 
 
 The ideal grip characteristics are to be as light as possible whilst offering 
a secure grip with no slipping of the specimen315. The grips used were 
constructed specifically for the graft material using pairs of flat blocks of nylon 
which could be opposed together tightly using thumb-bolts with the „dog-bone‟ 
end sandwiched within them. These ensured no slippage in the tensile range 
before failure. The relative advantage which the graft specimens had was that 
they were not brittle, so the grip strength could be high without fear of sample 
breakage. In addition, due to the low force range in which the graft specimens 
were to be tested, the errors created by the slight „give‟ in the load cell and load 
frame were negligible. The upper grip rested on two screw threads projecting 
upwards from the lower grip, to align the two grips precisely, and to prevent any 
stress on the sample at the start of the test. Fig 5.8a and 5.8b show the grip set-
up. To further ensure vertical alignment and prevent side loading or bending 
moments, the samples were loaded into the upper grips first, then allowed to 
hang down before inserting into the lower grips. However, this was not 
adequate to ensure that the specimens were placed exactly neutrally, without 
initial slack. An alternative technique was also used, whereby a template was 
made of the dogbone from inelastic acetate, which was then placed alongside  
the dogbone in the grips. The template was pre-cut across the narrow area of 
the dogbone, and the length held by surrounding flanges. 
 
 
5.3.6 The circumferential sample 
 
The extrusion-coagulation process used may result in anisotropy of the 
graft. Testing in the circumferential direction is necessary for comparison with 
the longitudinal characteristics. 
 The problems posed here are due to the small size of the specimens 
involved. One method of circumferential stretching is to place a hoop of test 
material between two pins and pull the pins apart (Fig 5.9).  
 However, the pins would need to be very small themselves. A suitable 
grip for this was designed using stainless steel links from a wristwatch bracelet, 
along with the pins which hold the links together (Fig 5.10a and 5.10b). 
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Fig 5.8a. The longitudinal sample held in the neutral position within the 
nylon block grips. 
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Fig 5.8b Close-up of the grips used for longitudinal dogbone samples 
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Fig 5.9. The concept of hoop testing of tubular structures. 
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Fig 5.10a. The use of links and bracelet from a stainless steel wrist-watch 
band to design the rig for hoop testing of circumferential samples. 
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Fig 5.10b. Close-up of the hoop testing rig. 
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One difficulty when using this system is assessing the starting point for 
the test. The hoops neutral position is circular in cross section, but the pins can 
be moved further apart before stress is exerted on the material itself. To prevent 
a pre-stressed starting point, it was decided to start the test with the hoop 
resting on the upper pin, but not in contact with the lower pin. This was difficult 
to perform due to the buoyancy provided by the water environment. Another 
difficulty arising from this issue was determination of the initial unstretched 
dimensions for calculating strain. An approximation would be to use  
 
π x radius  (1) 
 
which is half the circumference. A justification for this approximation 
follows: 
 
 Imagine a thread looped to make a circle with radius r. The length of that 
loop of thread is  
 
2 x π x r (2) 
 
 If opposing ends of the circle were now pulled taut, they would 
effectively leave a double thread whose length must be half the length of the 
original thread 
 
π x r  (1)   
 
   Another concern is that the stress due to the pins themselves will be 
very large at high strains such that they will tear through the hoops, 
underestimating true strength. For this reason, it was decided to manufacture a 
cutter for small „dogbone‟ specimens to be pressed in the circumferential 
direction as well. This was created from the casing which surrounds quartz 
crystals on electronic circuit boards. These were selected due to their sharp 
edge as well as their appropriate size. The cutter consisted of two such cases in 
parallel, held 4mm apart. This cutter worked well initially but quickly became 
blunt, so a new cutter was made to order.  
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5.3.7 The environmental chamber 
 
 Viscoelastic properties of a material are dependent on the temperature 
used. This can be explained in terms of the entropy in the system. Stretching an 
elastic material involves alignment of its molecules and an overall reduction of 
disorder, which is against the universal trend towards an increase in disorder 
(entropy). This discrepancy manifests as the force with which the elastic 
material attempts to contract back to its original state. At higher temperatures, 
the entropy of the molecules is greater due to their greater energy and so strain 
is resisted more than at low temperatures. It is therefore essential to test the 
graft samples at the in vivo temperature. 
A clear perspex tubular tank surrounding the grips was filled with water at 
37°C immediately before the test was carried out. This tank was screwed into 
the base of the lower grip with an intervening O-ring to ensure a watertight seal 
– Fig 5.11. 
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Fig 5.11. The tensile test including environmental chamber filled with 
water at 37°C. 
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5.3.8 The Tensillometry Machine 
 
The Hounsfield H5K-S UTM is a benchtop mechanical testing machine 
with a 250N load cell attached with a force accuracy of +/- 0.5N. It is a vertical 
Universal Testing Machine consisting of a single screw load frame with a 
750mm extension limit. A PC with operating software for the machine is 
attached. 
 
 
5.3.8.1 Method 
 
5.3.8.1.1 stress/strain and tensile strength 
 
 The „dog-bone‟ sample was secured in the upper grip with thumb-bolts. 
The upper grip was placed on the guide-rail to align it with the lower grip and 
the lower end of the sample was secured in the lower grip without tension. The 
ensemble was then threaded through the base of the water-tank and then 
screwed onto the testing frame. The load cell was latched onto the upper grip 
via a hook and loop, ensuring that no strain was applied to the sample. The 
environmental chamber was filled with water at 37°C.  Hounsfield operating 
software was used to extend the sample at 60mm/min until it failed. A tensile 
force/extension curve was generated and ultimate stress and elongation 
recorded. 
 This procedure was repeated for six longitudinal and six circumferential 
samples. 
 
 
5.3.8.1.2 stress relaxation 
 
 A 70% elongation strain was applied to three longitudinal and three 
circumferential samples in the environmental chamber. The reducing force was 
recorded manually using a stopwatch at five second intervals to start with and 
then gradually over longer intervals until no further stress relaxation was seen 
over 90 seconds. 
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5.4 Compliance measurement 
 
5.4.1 Introduction 
 
 As outlined in the review of mechanical properties previously, the concept 
of arterial compliance is necessary due to the complex nature of elasticity of all 
biological tissues. In particular, the elastic character is determined both by the 
degree of stretch that has already been exerted on the vessel (preload) and 
also, the rate at which the vessel is being stretched. It follows that compliance 
may be considered as the degree of further distensibility at any given preload, 
and cannot be stated without including a description of the preload under which 
it is measured. 
 Different groups have used a variety of methods to determine 
compliance316. Arterial waveform analysis with mathematical algorithms allow 
for the determination of overall compliance for the whole arterial tree; pulse 
wave velocity and pressure/distension relationships can be used to consider 
short vessel segments individually.  The assessment of local graft segments 
extra-corporeally can be grouped into quasi-static and dynamic tests. The 
former involves slowly increasing the pressure within the conduit being tested 
and monitoring the rate of distension change. The result is usually stated at 
120mmHg to present uniformity and allow comparison. However, this test, 
although useful for mechanical characterisation when formal tensile testing data 
is not available, does not truly reflect compliance as it assumes a purely elastic 
sample, with no viscous component. For simplicity, it neglects the increased 
stiffness of arterial specimens at high rates of pressure change. The elastic 
character of vessels tested in this way may be a significant overestimate due to 
the low rate of pressure change utilised compared with the physiological 
pressure waveform of pulsatile flow. 
 For this reason, a more rational assessment of viscoelastic material 
elasticity is to test it in the environment in which it works – ie.  in-vivo. This may 
be non-invasive testing of compliance, using ultrasound for distension data and 
a percutaneous blood pressure sensor. However, for grafts at an early stage of 
development, it is ethically desirable to address mechanical properties before 
implantation. To achieve this, the graft requires placement within a biomimetic 
flow circuit. Real time pressure and distension data with pulsatile flow can be 
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used to calculate compliance: 
 
C = dsys-ddias/ddias x 1/psys-pdias 
 
(C is compliance; dsys is systolic diameter; ddias is diastolic diameter; psys is 
systolic pressure; pdias is diastolic diameter) 
 
 The strain proportion is worked out as a percentage by multiplying by 100 
and the percentage compliance is calculated. A further multiplication factor of 
100 converts the compliance to the universally used units of %/mmHg (x10-2).  
 In fact, this method defines volumetric compliance, which is a composite 
of radial (or circumferential) compliance and longitudinal compliance317. 
 
 
5.4.2 Method overview 
 
 An 8cm length of prosthetic graft was mounted horizontally on a fixed 
frame and tied with 3/0 silk via bespoke PTFE interconnects to silicon rubber 
tubing. The graft and frame were immersed in a waterbath at 37°C. The 
proximal graft end was connected via tubing to a jacketed reservoir which was 
held at variable height to control mean pressure in the circuit. The distal graft 
end was connected via tubing to the inflow channel of a phantom pulse 
generator (Harvard apparatus Model 1421, South Natick, MA, USA). The output 
from the pump poured into the reservoir. Ultrasound with wall tracking software 
was used to visualise and measure the inner wall movements resulting from the 
flow in the circuit. Fig 5.12 shows a schematic diagram of the circuit set-up.     
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 Fig 5.12. Schematic diagram of the flow circuit used to measure dynamic 
compliance. 
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5.4.2.1 Fluid in the circuit 
 
 600ml of fluid was needed to fill the circuit. Initially, in order to achieve 
the non-Newtonian properties of blood, donated packed red blood cells made 
up with SAGM (Sodium/adenine/glucose/mannitol) additive – see Table 5.1 - 
from the London Transfusion Service was used. The blood was collected in a 
CPD (citrate/phosphate/dextrose) anticoagulant solution – see table 5.2. 300mls 
of plasma was removed after centrifugation from 450mls of donated blood and 
the cells resuspended in 250mls of SAGM. These units were one day past their 
expiry date, so as to be clinically obsolete and would otherwise be discarded. 
Blood from different blood groups were not mixed. The blood was warmed in the 
jacketed fluid reservoir to 37°C over ten minutes, during which time the outlet 
was clamped. A mercury thermometer monitored the temperature of the blood 
and at 37°C, the clamp was removed to allow the blood to fill the circuit. All air 
bubbles were eliminated by coaxing them upwards into the reservoir. 
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Component Concentration (mmol/L) 
Sodium chloride 150.0 
Adenine 1.25 
Anhydrous glucose 45.4 
Mannitol 28.8 
 
Table 5.1. The composition of SAGM additive. 
 
Component Concentration (g/L) 
Sodium citrate (dehydrate) 26.3 
Dextrose (monohydrate) 25.5 
Citric Acid (anhydrous) 3.27 
Monobasic sodium phosphate (monohydrate) 2.22 
 
Table 5.2. The composition of CPD anticoagulant. 
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5.4.2.1 Consideration of blood‟s viscous flow in the circuit. 
 
 The use of a blood product in the flow circuit was aimed at modelling the 
mechanical graft/blood interaction which would occur in vivo. Blood is a 
suspension of cells in plasma, with its own viscoelastic properties. This means 
that its physical behaviour is dependent on the rate of stress exerted, and in 
particular, it‟s flow characteristics are dependent on shear rate. This property is 
termed „Non-Newtonian‟ behaviour, unlike homogenous fluids such as water, 
which exhibit „Newtonian‟ behaviour – see Fig 5.13. Bloods viscosity is therefore 
increased in low flow states. At the same time, viscosity will determine the 
shearing forces at the vessel wall to some extent. It is this point which suggests 
the rationale for the use of a fluid which demonstrates the viscous properties of 
whole blood. 
 However, a number of additional factors would question the need and 
validity of using blood products in the circuit. 
 When considering flow in an artery with an internal diameter greater than 
100μm, the effect of viscous forces are greatly overwhelmed by inertial forces 
on the cellular components which are the principle determinant of the flow 
characteristic318. There is an important difference between the two parameters. 
Viscosity relates to the ease with which one lamina of fluid slips over the 
adjacent laminae and is greatly influenced by plasma rheological properties. 
However, the inertial forces to consider in larger vessels relate to the rigid 
structure of cells and their proportion in the blood, as well as the attractive 
forces between red cells which are all dependent on the flow velocity. The 
inertial force is given by the product of mean flow velocity and vessel diameter.  
 Although it is true that blood‟s viscosity is dependent on shear rate, the 
shear rates in the circulation are sufficiently high to ensure minimum (and 
constant) viscosity. This means that flow conditions keep the bloods properties 
at the right side of the shear stress/ shear rate graph. It is therefore not 
important to consider variable viscosity in the flow circuit, where both vessel 
diameter and flow rates are high, and the use of fresh blood would not greatly 
contribute to the accuracy of measurements. 
 Furthermore, our initially chosen alternative was to use donated blood, 
after warming it to 37°C. Its viscosity would be expected to be lower than that of 
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fresh blood due to the age of the red cells319. Also, blood viscosity is greatly 
dependent on the haematocrit level318. Donated units of packed cells have a 
variable haematocrit which may be 25% greater after extraction of plasma and 
resuspension in SAGM. In order to address haematocrit standardisation, a 
variable amount of isotonic solution would be required each time the circuit was 
filled. This was impractical and in view of the reasons outlined above, the 
precise non-Newtonian behaviour of blood seemed irrelevant. Therefore, the 
viscosity of whole blood was determined by testing a 2ml citrated sample of 
freshly donated blood in a rheometer using a 4° cone and plate system at a 
constant shear rate of 200s-1. This rate reflected the magnitude of wall shear 
rate to be found in physiological conditions320. 
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 Fig 5.13. The viscous relation to shear rate for Newtonian and Non-
Newtonian fluids. The gradient of the lines correspond with viscosity, so a 
Newtonian fluid maintains the same viscosity for all shear rates, whereas a 
Non-Newtonian fluid (blood) has a low viscosity at high shear rates (high flow 
rates). 
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5.4.2.2 The biomimetic pulsatile flow generator 
 
 The Harvard Apparatus Model 1421 is designed to simulate the pulsatile 
output from the ventricular system of the heart with features to minimise 
haemolysis. It utilises a positive piston actuator, which in combination with ball-
type unidirectional valves ensure that there is a constant flow rate even when 
there are variations of resistance in the flow circuit – Fig. 5.14. All materials 
which come into contact with the blood in the circuit are inert – silicone rubber, 
acrylic plastic and PTFE. The ball valves are stainless steel, coated with 
silicone. 
 The systolic phase (piston compression) comprises 35% of the cycle 
duration, with diastole (rarefaction) taking up the remainder, to closely model 
the cardiac output. The pump has been previously validated as the pulsatile 
source for a laboratory model of the circulatory system by Levy and Zieske321. 
 Both pulsatile rate and pulse pressure can be varied independently when 
using the pump. A pulse pressure of 40mmHg was used throughout the testing 
as an approximation of the physiological norm. The „afterload‟ was provided by 
the height of the blood in the reservoir, which was physically moved to 
manipulate mean pressure. 
 The piston was lubricated after each hour of use using Fomblin®, a 
perfluorinated polyether high performance inert lubricant. 
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INFLOW
OUTFLOW Variable pulse pressure
Variable rate  
 Fig 5.14. Schematic diagram of the biomimetic pulsatile flow generator 
used in the circuit. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Fig 5.15. Distension and pressure waveforms through the compliant 
grafts in the biomimetic pulsatile flow circuit used for compliance testing. The 
waveform data was generated from the wall-tracking duplex and Millar probe 
placed within the graft respectively. 
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5.4.2.2.1. Consideration of the biomimetic waveform 
  
 As a result of the pump‟s output and the influence of the tubing, 
interconnects and graft in the circuit, the pressure waveform as measured by 
a Millar Probe catheter transducer placed within the graft was not completely 
representative of the pressure waveform within a human artery – see Fig 
15.15. 
 
 
5.4.2.3  Accessory tubing 
 
 All of the tubing used was made from silicone rubber, which although 
elastic, had negligible distensibility in the physiological pressure range. This 
was verified by connecting samples of the tubing into the circuit in place of the 
test sample to show, using the ultrasound probe, that there was no distension 
up to the maximum systolic pressure used. 
 
5.4.2.4 Ultrasound 
 
 A 50mm 7.5MHz linear array probe connected to a Doppler ultrasound 
machine (Picus, Pye Medical) was aligned longitudinally along the graft with its 
tip within the waterbath. This position was adjusted to give the sharpest 
possible B-mode image of the graft wall edge. The sharpest possible image 
corresponded with visualisation of the wall at its maximum width, indicating its 
true diameter. 
„Linear array‟ relates to the linear arrangement of piezoelectric crystals along 
the probe length which vibrate to produce parallel streams of ultrasound waves. 
This allows a two dimensional image of the graft length to be built up – Fig. 
5.16. The B-mode setting is used to show this two dimensional image by 
converting the reflected ultrasound signal into a signal whose intensity 
(brightness) is proportional to the energy of the reflected signal received. 
 The M-mode (motion mode) setting provides a continuous temporaneous 
ultrasound image for a single piezoelectric reflected signal, which is plotted on a 
linear time-frame. 
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  A trackerball interface was used to select the exact point along the length 
of the graft segment at which the wall movement was to be assessed in real 
time. This point was principally determined by the clearest signal with least 
reflections. Reflections were also eliminated to a large extent by electronically 
dampening the reflected signals outside the area bounded by the graft walls. 
Reflections in the region of the graft wall could be reduced significantly by 
thoroughly degassing the graft by prolonged emersion in de-ionised water 
before testing, until the graft no longer floated in water. This required 24 hours, 
and could be speeded up by immersing in absolute ethanol for 30 minutes 
instead.   
 
5.4.2.5 Wall Track System 
 
 M-mode ultrasound gives a visual representation of wall movements 
resulting from pulsatile flow. The principle role of the Pie Medical Wall Track 
System II (WTS) is to provide an automated continuous calculation of anterior 
and posterior inner wall movement leading to distension data without any user 
interface. This is particularly important for small calibre grafts as the movements 
concerned are very small ones, leaving great scope for user error if manually 
measured from the M-mode image.  
 The software also eliminates a large proportion of reflections by 
analysing signal similarity and paradoxical movements. However, this feature is 
not fool-proof, and every effort was made to minimise reflections. It was also 
critically important that the ultrasound wave passes through the full diameter of 
the graft, so as to ensure that the distension is in the plane of the wave so that 
wall movements were not underestimated – see Fig 5.17. In practice, a non-
centred graft resulted in a considerably noisy distension waveform.  
 Another advantage of the wall track system was that each time 
distension readings were repeated, the same signal points could be sought out 
to represent the inner walls. This had two important consequences. Firstly, it 
reassured that exactly the same points on the wall were being assessed with 
each measurement, allowing fair comparison. If the measuring point was set 
manually each time a reading was taken, it was an impossible task to be 
completely consistent, due to the constant pulsatile movement of the graft wall. 
The second consequence was that once a crisp ultrasound image was obtained 
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and the WTS picked out the true wall edge, the investigator could carry out a 
series of measurements without rechecking the computed edge, provided 
neither the ultrasound probe nor the point along the graft length used for 
measurement was moved. For these reasons, manual edge recognition and 
human judgement were eliminated. Measurements were only pursued if the 
WTS automatic edge detection concurred with manual positioning. If this was 
not the case, the reading was rejected, and repeated after addressing the 
cause. Once a series of measurements was started, no changes were made to 
probe position, graft position or measuring point. If there was an unforeseen 
mishap, such as leak from the tied graft end, the whole series of measurements 
were abandoned and repeated.      
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 Fig 5.16. A two dimensional image of the graft can be built up by utilising 
a linear array of piezoelectric crystals emitting parallel waves. 
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 Fig 5.17. By centering the graft precisely under the ultrasound probe, 
distension will be in the plane of the ultrasonic wave, leading to accuracy of 
measurement and elimination of a noisy signal.  
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5.5 Burst Strength Testing / Longitudinal Strain 
 
   A high pressure syringe pump (Harvard Apparatus PHD 2000 
Programmable) containing freshly de-ionised water (pH 7.0) was connected via 
a transducer (Honeywell Component No. 22PCCFB6G) to highly compliant non-
porous latex tubing lining 8cm lengths of vertically suspended graft (Fig 3) with 
distal clamping and weighted to ensure10% longitudinal stretch. The transducer 
was pre-calibrated by connecting it to a standard clinical sphygmomanometer 
and a voltmeter to record voltage readings at 0mmHg, 100mmHg and 
200mmHg from which offset and gain figures were calculated and entered into a 
personal computer with bespoke software for recording the pressure at a 
sample rate of 10Hz. The transducer was connected via a 10v power source to 
the personal computer. Water was expelled from the pump with the graft 
unclamped to allow the apparatus to be filled completely, whilst ensuring all air 
was eliminated from the apparatus. The clamp and weight was applied and the 
graft was filled till the pressure within it was 0mmHg. Parallel horizontal marks 
were made with a permanent marker on the anterior wall at the midlength of the 
graft. 0.2ml/minute infusion rate was used to raise the pressure slowly until the 
graft failed. A 2 megapixel digital camera (Olympus Camedia) was used to take 
serial images of the pre-drawn marks at regular pressure intervals. 
 Image analysis software (Carl Zeiss KS400 Version 3.0) was used to 
measure the gap between the marks to indicate longitudinal strain as a result of 
circumferential stress. 
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6 
Extrusion-phase inversion of a small calibre compliant 
graft. 
 
 
 
6.1 Introduction 
 
 A multitude of different methods have been utilised to manufacture 
porous grafts for vascular bypass. These include salt leaching132, 
electrospinning322, electrospraying with phase-inversion323, excimer laser 
ablation324, the replamineform method325, dip-coating and extrusion326. Each 
method has its benefits and drawbacks.  
 
 
6.2 Techniques currently used for polymeric vascular graft construction 
  
Electrospinning can achieve a precisely controlled overall porosity, but is 
only possible using highly viscous polymers which are able to „spin‟ into a 
flowing fibre from the „Taylor Cone‟. This cone is generated by an electric field 
applied to a metal capillary through which the polymer extrudes. The 
electrostatic repulsion effect due to the electric field allows the spun fibre to be 
whipped and thinned simultaneously to be collected on a surface (See Fig. 6.1). 
The degree of thinning can thus be accurately controlled. If a low viscosity 
polymer is subjected to the same electric field, a spray effect is generated as 
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the electrostatic repulsion forces the droplet to disperse in an aerosol – this is 
known as electrospraying and is generally used for thin sheet formation with 
lower mechanical strength than would be required in a potential vascular graft  
 
 
 
 
Fig 6.1. Electrospinning as a method of producing a porous graft from a liquid 
polymer. 
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Salt leaching methods are usually used as a method of imparting 
porosity. They entail the formation of a product incorporating a salt in crystalline 
form which can be ionised in solution and washed out to leave pores where the 
crystals previously existed. It is commonly combined with polymer casting 
where the solvent is evaporated from the polymer solution. As the pore size is 
reflected by the original crystal size, in theory the pore size is controllable. 
However in practice many problems were encountered when considering this 
method of imparting porosity to the nanocomposite polymer. Firstly the crystal 
size required for ideal microporous graft formation was an order of 10 
magnitudes smaller than the smallest available salt crystals, requiring 
mechanical grinding and ultra-fine sieve separation to produce crystals smaller 
than 100nm in size. In addition, the salt particles need to be uniformly 
distributed throughout the polymer solution, which was difficult to achieve. Even 
if this could be managed by thorough mixing with an electric homogeniser, the 
salt aggregated at the bottom of the polymer if not used immediately. However, 
immediate use is never possible as agitating the polymer for mixing results in a 
large number of bubbles which need to be excluded – the fastest way was to 
apply vacuum suction to the polymer – requiring at least one hour.  
 Excimer laser ablation is used commonly by ophthalmologists for ablation 
of the cornea and lens with minimal thermal damage to surrounding tissues. It is 
the ability to generate defects of extremely precise size that makes it suited to 
pore formation in cast polymer. However, the formation of pores by such 
mechanical means will inevitably lead to structural weaknesses at the pore 
edge which could theoretically be propagated into critical cracks and 
macroscopic weakness on repetitive stress cycles. Long term fatigue testing 
results are required to assess the safety of this method. 
 Porosity is desired as a structural mechanism – to provide graft 
elasticity327; to enhance adherence of endothelial cells to the graft lumen; as 
well as encouraging transmural support for successful cellular integration328. 
Neovascularisation through the wall may also have a role in limiting neointimal 
hyperplasia and atherosclerosis, by preventing hypoxia of cells attached to the 
lumen329. However, very high porosity adversely affects handling properties by 
requiring graft pre-clotting before implantation; increasing thrombogenicity; and 
causing massive fibrovascular infiltration330 which soon leads to a loss of 
compliance. 
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 Dip-coating actually refers very simply to the immersion of a scaffold into 
polymer in order to coat it. This requires an additional process to solidify the 
result. His may be by casting (ie. solvent evaporation) or phase inversion by 
swapping the solvent for a non-solvent. Freehand dip-coating can cause great 
variability between grafts produced, and for adequate quality control, a 
mechanised dipping process is necessary. Kannan has produced microvessels 
from the nanocomposite using a semi-mechanised dip-coating followed by 
phase inversion331. His work involved dipping mandrels (green needles) via a 
mechanical arm into polymer solution, then allowing a capillary action to act and 
distribute a thin coating of polymer uniformly before dropping into a coagulant. 
This gave good results in terms of wall uniformity and mechanical properties. 
The technique used for the manufacture of small calibre vascular grafts was 
essentially a modification of this method which has already been proven using 
the nanocomposite. 
 
6.3 Extrusion-phase inversion 
 
Strictly speaking, extrusion refers to the pressured drawing of a material 
(usually a polymer) through a template to form a three dimensional model with a 
cross section mirroring the template. This requires a highly viscous polymer 
which will hold its shape after drawing out. The pressure is usually provided by 
a screw system pump. The technique used here depends on a layer of polymer 
coating a mandrel as it passes through it, with shape being given by the exit 
aperture. In this respect, this is extrusion. However, the viscosity of the polymer 
is much lower than that used in typical extrusion. If phase inversion is not 
immediately commenced, the polymer will flow off the mandrel.  
The concept of phase inversion can be best explained by consideration 
of the nanocomposite as pure polymer with a variable amount of solvent in 
which it is dissolved. The lower the amount of solvent, the higher the viscosity 
(ie. the more solid). Phase inversion relates to the controlled removal of solvent 
by swapping it for a non-solvent – see Fig 6.2. 
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Polymer
Solvent Non-solvent
Coagulation
Solution  
Fig 6.2. The ternary model of phase inversion. The polymer can exist in a 
solid phase, dissolved phase or any intermediate phase, depending on the 
amount of solvent present. A non-solvent can exchange with the solvent to 
control the polymer phase precisely, making the system a combined interaction 
between three constituents. 
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 The technique of extrusion combined with phase inversion is not novel – 
it is used in the manufacture of the Chronoflex graft which is commercially 
available as a vascular access graft, utilising the patented method of 
Charlesworth332. However, this is a horizontal extruding system which requires a 
constant rotational torque during phase inversion to ensure evenness of the 
graft walls. The idea of using a vertical extruding system relying on gravity for a 
uniform graft wall thickness lead to the development of a novel bench-top 
extruding device. However, it had proven impossible to produce uniform lengths 
of graft with the integrity required for any research use. 
My initial aim was to examine the reasons for the failure of this device, 
correct the problems and achieve tubular conduits with sufficient integrity for 
subsequent in vitro and in vivo research. 
 
6.3.1 Technique 
 
A mechanical arm driven vertically downwards at 10mm/sec by a motor 
was positioned such that it held a 5mm diameter stainless steel cylindrical 
mandrel within the exit aperture of a polymer chamber (Fig 6.3). This latter 
structure, encased within a perspex block, was also made from stainless steel, 
comprising of a circular 5mm entry aperture superiorly; a luer-lock syringe 
compatible polymer introduction channel laterally (Fig 6.4); and a 6mm circular 
exit aperture inferiorly which could be surplanted by a 5.5mm aperture adapter 
(Fig 6.5).The perspex block was held in a bracket to allow the descending 
mandrel to pass through the entry and exit apertures.  
 
 With the mandrel‟s base centrally placed and level with the exit aperture 
(Fig 6.6), nanocomposite was injected slowly into the polymer chamber. For this 
step it was imperative that the syringe contained no air bubbles. The syringe 
was allowed to settle for 15 minutes after drawing up polymer to ensure that any 
air bubbles which were present could rise to the nanocomposite‟s surface and 
be excluded.  
A vertical column of coagulant solution was placed directly below the exit 
aperture leaving a 5mm gap between the two. The cover was opened and the 
mandrel driven downwards vertically into the coagulant at 10mm/sec 
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immediately afterwards (Fig 6.7). A pressure switch on the mechanical arm 
ensured it stopped descending when it reached the polymer chamber. The 
alignment was checked during this extrusion by visually comparing the layers of 
nanocomposite coating either side of the mandrel within the coagulant solution 
in the moments before coagulation occurred. This was undertaken in two planes 
perpendicular to each other about the longitudinal axis of the mandrel, and was 
facilitated by viewing against a natural light background. 
 The column was undisturbed for 20 minutes after which time the mandrel 
was disconnected from the mechanical arm and placed en-bloc bathed within 
the coagulant solution in the fridge at 5 0C for a minimum of 12 hours. 
Thereafter, the mandrel was removed from the coagulant and dried with paper 
towels, before transferring to an absolute ethanol bath for degassing over 10 
minutes, thereby facilitating removal of the formed tube from the mandrel. This 
latter step was carried out by gently loosening the conduit from the rod along its 
whole length with small circular and longitudinal stresses after which the whole 
tube easily slid off without excessive strain. 
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Fig 6.3. The bench-top extrusion-phase inverter device. 
 
 
 
 
Fig 6.4. The polymer chamber, showing the entry aperture through which the 
mandrel fits snugly. The polymer inlet can be seen on the right side of the 
perspex block. 
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Fig 6.5. The undersurface of the polymer chamber showing the exit aperture 
along with three adaptors for varying the aperture size. 
 
  
Fig 6.6. The mandrel is positioned such that there is an equal gap around it in 
all directions. Its lower level is flush with the lower border of the exit aperture. 
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Fig 6.7. The mechanical arm has lowered the mandrel through the polymer 
chamber, in so doing coating it with the nanocomposite. The exit aperture 
controls the thickness of this coating which further descends into the coagulant 
solution, causing phase inversion. 
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To assess for ideal extrusion conditions, the process was repeated for different 
concentrations of DMAC and ethanol in distilled water and coagulant 
temperature range from 0 to 50 OC, using scanning electron microscopy to 
visualise the detail of the wall cross section and pores. 
 
6.3.2 Troubleshooting  
 
It was apparent that the greatest control of wall thickness was achieved 
when the mandrel was used to drive the polymer through the exit aperture, as 
opposed to the polymer running down the mandrel wall. This required high 
enough viscosity to prevent the polymer from spontaneously dripping out from 
the exit aperture when the mandrel was in place. This always occurred from the 
right side of the exit aperture, which was near the polymer entry port. Therefore 
the polymer was leaking out even before the polymer chamber could be filled. In 
order to exploit the effect of gravity to form a uniform wall, it is necessary to 
have an equal weight of nanocomposite in the polymer chamber surrounding 
the mandrel. These concepts are illustrated in fig 6.8. 
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Fig 6.8. The polymer must not be so viscous that it starts to pour past the 
mandrel before the polymer chamber has had a chance to fill up (above). It 
must also be driven down by the mandrel into the coagulant rather than slide 
down the mandrel (below). 
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6.3.3 Rheological consideration 
 
 Clearly the flow characteristics of the polymer used was paramount. 
Furthermore, the flow of different batches of polymer would need to be identical 
to ensure identical product dimensions and to proffer a fair comparison between 
different polymers. Therefore rheological testing of the polymer solutions was 
undertaken. 
 
6.3.3.1Inter-batch variability 
 
 In theory, different batches of polymer synthesised using the same 
protocol would be identical to each other. However, this assumes several things. 
Firstly it assumes that the raw materials obtained from the suppliers are 
identical each time. It assumes that there is no transformation of the raw 
materials due to suboptimal storage. It also depends on there being no change 
in the flow properties of the polymer on storage. These natural assumptions 
make it important to investigate different batches of “the same polymer”. 
Rheological testing of the polymer was undertaken using a Bohlin CVO 
Rheometer (Malvern Instruments, Malvern, United Kingdom), a typical cone and 
plate tester – see Fig. 6.9. 
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Fig 6.9. Bohlin CVO Rheometer – 4° cone and plate type, with full rheological 
testing capabilities including temperature adjustment using a Peltier plate 
system. 
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Fig 6.10. The viscosity of the three batches of nanocomposite when 
measured using an up-down shear rate ramp 
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Three batches of the nanocomposite were tested. One batch which was five 
months old, as well as two batches made on consecutive days, using the same 
raw materials. 
The test performed was a simple one. The rotation of the cone was 
programmed to exert a gradually increasing shear rate from 0 to 100 s-1 via a 
shear ramp and then back down to 0. The behaviour of the fluid under these 
conditions of shear are of interest, and one way of quantifying this is to use the 
rheometer to measure the shear stress on the fluid as a result of this applied 
shear rate. Viscosity is defined by the ration of shear stress: shear rate 
(analogous to elastic modulus = stress:strain) and is an appropriate measure of 
flow behaviour. 
The first observation was that for the majority of the test, the fluid 
behaviour appeared Newtonian – the relationship between shear stress and 
shear rate was constant ie. the viscosity was the same, whatever the level of 
stress applied to the polymer – see Fig 5.12. However, at the very lowest shear 
rates, the viscosity appeared to creep up significantly. This may be artifactual 
with frictional forces such as air resistance acting on the rotating cone coming 
into prominence at the lowest shear rates. A Newtonian behaviour would be 
expected in a homogenous solution like the dissolved nanocomposite.    
Figure 6.10 shows that batch 3 had considerably lower viscosity than 
either batch 1 or 2 which has serious implications for quality control of the 
product, since identical procedures were followed during synthesis. This may be 
because of the difference in reagents used, or due to the prolonged storage of 
batch 3. To investigate the effect of storage, batch 1 was retested using identical 
parameters after four months – Fig 6.11.  
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Fig 6.11. The increase in viscosity seen after storage of nanocomposite 
(batch 1) for four months. 
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These results show that after storage, there was in fact an increase in 
viscosity, rather than the reduction which we would expect if storage was the 
cause of the difference between the three batches. Therefore, the differences 
seen were more likely to be due to small variations in the original raw materials 
used, if one assumes the manufacturing process was completely standardised. 
Despite an airtight container, an increase in viscosity may be due to evaporation 
of DMAC from the polymer solution into the air-space within the bottle. An 
equilibrium within the airspace is not maintained due to the repeated opening of 
the container each time a sample of nanocomposite was required. A second 
observation was that there was a non-Newtonian aspect to the polymer‟s 
behaviour after prolongued storage – the viscosity was no longer constant 
through the range of shear rates and there was a definite reduction in viscosity 
at high shear rates. Due to these results, it was decided that every batch made 
would have a baseline viscometric test and used to make conduits within two 
weeks of synthesis. Viscosity of 3 PaS was achieved for each batch produced. 
This was accepted as the standard as at this viscosity, no polymer flowed out of 
the polymer chamber when the 5mm mandrel was in place for ten seconds 
which was enough time for the polymer chamber to become uniformly filled with 
polymer. Modified polymers were synthesised to the same viscous profile by 
manipulating the amount of DMAC used to dissolve them.    
As well as using solvent to standardise the viscosity of the polymer 
solution and so prevent it from leaking from the exit aperture, the perspex block 
was redesigned to incorporate an exit aperture cover which was a simple PTFE 
sliding cover running in a groove under the block – Fig 6.12 and 6.13. 
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Fig 6.12. Exit aperture cover closed. 
 
 
Fig 6.13. Exit aperture open. 
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The amount injected was important as too little gave a very short thin 
graft. Too much was wasteful as it resulted in a large globule of polymer at the 
dependent end of the mandrel. To determine the optimum amount of polymer, a 
graft was produced using a range of polymer amounts. The uniformity of the 
wall was assessed by image analysis (Carl Zeiss KS 400 version 3.0), and 
variability >10% from the mean was rejected. The length of uniform-walled graft 
was recorded along with the mean wall thickness along the usable length. The 
results are summarized in table 6.1. The balance between incomplete coverage 
of the mandrel and excessive polymer wastage was found when using 3.5ml 
polymer per graft. 
 
 
Amount of 
polymer (ml) 
Usable length 
(mm) 
Mean wall 
thickness (mm) 
Notes 
2.0 11 0.42 Incomplete coverage of mandrel 
2.5  18 0.50 Incomplete coverage of mandrel 
3.0 69 0.54 No excess polymer after coating 
3.5 86 0.54 Small excess after coating 
4.0 64 0.59 Large excess globule 
4.5 65 0.60 Large excess globule 
 
Table 6.1. The effect of amount of nanocomposite injected on the uniform 
usable length of conduit produced. 
 
 
6.3.4 Reproducibility of graft manufacture 
  
 Using distilled water at 0 OC as the coagulant, 5 conduits were extruded 
with a 5.5mm exit aperture and a further 6 with a 6mm aperture. Extrusions 
were consecutive with no selection of „best specimens‟. The image analysis 
software  was used to measure the uniformity of wall thickness at 72 points 
distributed equally around the circumference, so assessing the reproducibility of 
the extrusion process. The results are summarised in Table 6.2, fig 6.14 and 
6.15. 
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 Mean wall 
thickness(mm) 
Minimum 
(mm) 
Maximum 
(mm) 
Standard 
Deviation 
Coefficient 
of variation 
Thin 1 0.33 0.25 0.44 0.05 0.15 
Thin 2 0.34 0.27 0.4 0.026 0.08 
Thin 3 0.34 0.2 0.43 0.057 0.17 
Thin 4 0.34 0.22 0.42 0.046 0.14 
Thin 5 0.32 0.23 0.4 0.04 0.12 
 
 Mean wall 
thickness(mm) 
Minimum 
(mm) 
Maximum 
(mm) 
Standard 
Deviation 
Coefficient 
of variation 
Thick 1 0.48 0.38 0.6 0.067 0.14 
Thick 2 0.52 0.37 0.72 0.107 0.21 
Thick 3 0.52 0.48 0.59 0.030 0.06 
Thick 4 0.5 0.37 0.61 0.063 0.13 
Thick 5 0.51 0.43 0.62 0.048 0.09 
 Table 6.2. The variation of wall thickness for each graft based on image 
analysis at 72 equally spaced points around the circumference 
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Fig 6.14. The intra and inter-graft variation in wall thickness for the thin-walled 
grafts. 
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Thickness of thick-walled grafts (with standard deviation)
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Fig 6.15. The intra and inter-graft variation in wall thickness for the thick-walled 
grafts. 
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Fig 6.16.  The compliance of grafts manufactured from PCUPOSS using 5% 
Na(HCO3)2 filler and surfactant (n=6). Compliance characteristics of human 
external iliac artery (n=6) and PTFE (n=1) were measured by Mr Mike Mikhael 
and Mr William Khor and have been included with permission for comparison.  
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6.4 PCUPOSS incorporating porosifier and surfactant. 
 
  Initial attempts to produce a graft were utilising the PCUPOSS with 5% 
finely ground sodium bicarbonate (Na(HCO3)2) thoroughly mixed in along with 
Tween 20 surfactant. The coagulant used was water at 50°C. The reason for 
this was to impart uniform porosity through the wall of the resultant phase 
inverted graft. The Na(HCO3)2 would not dissolve in the polymer solution as 
DMAC is not a solvent for it. Instead, Na(HCO3)2 crystals would float in the 
polymer and during phase inversion, the water would cause them to dissolve, 
leaving pores in the space they previously occupied. The surfactant would aid 
the penetration of water through the polymer. This is therefore a salt leaching 
technique which is being used to impart porosity. The Chronoflex prosthesis 
used a similar technique of using a water soluble porosifer and a surfactant to 
impart porosity throughout the graft. The sodium chloride grinding was achieved 
using a standard mortar and pestle until a finely ground powder resulted. The 
resultant graft was highly porous. As a result, it‟s compliance was found to be 
extremely high, averaging 15.4%/mmHg x 10-2 – Fig. 6.16. 
Physiological flow in a healthy human achieves a typical mean pressure 
of 80 to 100mmHg with a pulse pressure of 40mmHg, suggesting that matching 
arterial compliance would require a value nearer 3-5 %/mmHg x 10-2. Therefore 
the compliance of this graft was unnecessarily high. This would cause 
excessive dilatation of the graft during pulsatile flow with consequences on both 
blood flow profile as well as wall stress. Firstly, the flow of blood from the artery 
into the relatively dilated graft would cause a calibre mismatch, concentrating 
stress at the proximal anastomosis as explained in Chapter 2, as well as flow 
separation, abnormally low wall shear stress as well as pooling and stasis of 
blood. This would be similar to the behaviour of flow experienced at the distal 
anastomosis between artery and PTFE graft, as would be expected to lead to 
the same pattern of intimal hyperplasia as the heel and toe of an end-to-side 
anastomosis. Secondly, the high degree of distension during each cycle of 
pulsatile flow would make the graft susceptible to fatigue, due to the repeated 
rapidly changing stresses. 
  This graft had several other major problems. It required pre-clotting with 
blood due to the high porosity. This is a time consuming and messy affair during 
bypass surgery. The idea of promoting clot formation on the lumen of a graft 
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designed to be anti-thrombogenic is somewhat perverse. Drying the specimens 
in an oven at 60°C caused them to rapidly shrivel. Air drying also led to 
corrugation and reduction of internal diameter. This could be due to the collapse 
of pores with weak inter-porous walls. This theory suggests that the inter-porous 
walls were so weak that it was the surface tension of the water lining the pores 
which kept the pores from collapsing. Although the burst pressure of the graft 
was not tested formally, it was clear during the compliance testing that the grafts 
were bursting at mean pressures of only 140mmHg. This is within the 
physiological range for many hypertensive patients. In summary, a less porous 
structure was required. 
 
6.5 PCUPOSS grafts 
 
 To test the theory that the problems with the porosifier/surfactant-
incorporated PCUPOSS were due to the high porosity of the grafts, it was 
decided to manufacture grafts from PCUPOSS without any porosifier. 
All the grafts produced were 18cm in length with a minimum of 10cm 
useable length with uniform wall thickness. The 6mm aperture adaptor was 
used to ensure thick-walled prostheses. The coagulant solution was deionised 
water at 50 OC. Surprisingly, these grafts also shrivelled on drying. If the 
assumption that phase inversion without the aid of a porosifier would lead to a 
graft with low porosity was correct, this would mean that the grafts instability in 
air was not due to pore collapse. To investigate the cause of this instability, 
scanning electron microscopy (SEM) was undertaken for PCUPOSS grafts 
made with and without porosifier. This required sequential dehydration of the 
grafts using graded solutions of ethanol, causing them to shrivel. Despite the 
shrivelling, it was apparent from the SEM images that the grafts were highly 
porous even without porosifier – Fig 6.22.  
 
This finding led to the hypothesis that pore size and distribution was a 
result of the precise dynamics of exchange between solvent and coagulant. It 
would follow that affecting these dynamics would influence the pores. One way 
of doing this would be to modify the coagulant solution.  
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6.6 The effect of coagulant temperature on porosity 
 
Coagulant temperature may have a bearing on the rate of exchange of 
solvent and coagulant. Therefore the extrusion-phase inversion process was 
repeated for temperatures between 0 and 50 OC. The results were all 
dehydrated with serial ethanol solutions in order to prepare them for SEM– see 
Fig. 6.17-6.22. Grafts extruded into warm coagulant solutions were susceptible 
to shrivelling on dessication. Only conduits formed in coagulant at 0 OC showed 
no distortion after storing in dry conditions. This allowed unimpeded 
visualisation of the pore structure. The wall was composed of four distinct layers 
– Fig 6.23 – comprising from lumen outwards: a lumen skin with small pores – 
Fig 6.24; large interconnecting pores in high density forming the majority of the 
cross section; small pores in high density near the outer edge; a non-porous 
outer skin with microscopic ridges throughout – Fig 6.25.  
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Fig 6.17: Coagulant is deionised water at 00C (scale bar 2mm) 
 
 
 
 
Fig 6.18: Coagulant is deionised water at 100C (scale bar 2mm) 
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Fig 6.19: Coagulant is deionised water at 200C (scale bar 2mm) 
 
 
 
 
Fig 6.20: Coagulant is deionised water at 300C (scale bar 2mm) 
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Fig 6.21: Coagulant is deionised water at 400C (scale bar 2mm) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 6.22: Coagulant is deionised water at 500C (scale bar 2mm) 
 
 
 
 - 174 - 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 6.23: Four-layered structure of the graft wall (scale bar 250microns) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 6.24: Lumen of graft (scale bar 125 microns) 
 
 
 
 - 175 - 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 6.25: Outer skin of graft demonstrating microscopic ridges throughout the 
surface (scale bar 125microns) 
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However, an alternative explanation to optimisation of exchange 
dynamics exists for the relative resistance to shrivelling of grafts coagulated at 
higher temperature. This was initially realised by accident when a graft was 
extruded using a mandrel which had been pre-heated in an oven at 100 OC. The 
polymer was seen to slip rapidly down the mandrel faster than the mandrels 
descent into the coagulant. It was clear that the high temperature resulted in a 
reduction in the nanocomposite‟s viscosity. Therefore, it is possible that the graft 
stability seen at low temperature coagulation is simply due to an effective 
reduction on the polymers viscosity which in turn results in a thinner graft. To 
investigate the effect of temperature on the nanocomposite further, further 
rheological tests were performed using a peltier plate to heat the polymer while 
continuously measuring viscosity. The results are shown in fig. 6.26.   
This confirmed the exponential reduction in viscosity with increasing 
temperature. Image analysis was used to measure the wall thickness of grafts 
phase inverted at the different temperatures. As the pore size and distribution 
could not be analysed directly by SEM, alternative methods were required. 
Direct visual analysis was attempted by close-image photography of the 
cross section of the grafts. However, the resolution of this method was not good 
enough to uncover small changes in porosity – Fig 6.27.  Therefore an indirect 
method of assessing overall porosity was sought. Graft density is a good 
indicator of the amount of nanocomposite in the conduit. Therefore it has an 
inverse relationship with overall porosity. However, density (mass per unit 
volume) requires an accurate measurement of graft volume. This presents great 
difficulties in itself. Measuring the dimensions of the graft requires very precise 
cross sectional thickness measurement throughout the length of the graft. This 
is possible using image analysis for individual cross sections, but in order to 
factor in the slight wall thickness changes through the length of the graft, the 
graft would require cross sectional measurements at many points along its 
length. The alternative method for measuring volume is using a volume 
displacement technique in a fluid. However, immersion in water will not give an 
accurate volume due to the displacement of air within the pores which would 
occur on immersion. This would lead to an under-estimate of volume. To 
simplify the problem, it was decided to use unit weight as a measure of amount 
of nanocomposite and hence inverse relation with porosity. This is an 
industrially accepted standard for the quantification of porosity of irregularly 
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porous foam structures. The graft can also be considered to be a foam due to 
its open pore structure. Therefore, the weight of 1cm length of graft was 
measured for each coagulant temperature, using  bench-top electronic scales. 
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Fig 6.26. The temperature dependence of viscosity for the three 
nanocomposite batches. 
 
 
0°C 30°C 50°C 
0.034 0.031 0.022 
0.034 0.033 0.028 
0.035 0.030 0.024 
0.034 0.031 0.024 
0.034 0.029 0.021 
Mean 0.034 grams Mean 0.031 grams Mean 0.024 grams 
 
Table 6.3. The actual and mean weight (grams) of 1cm lengths of graft 
extruded into water coagulant at different temperatures. Lighter grafts resulted 
from higher temperature coagulation suggesting greater porosity at high 
temperature coagulation, in view of the similar graft dimensions. 
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Fig 6.27. High resolution macro-photography in an attempt to show the 
specific pore structure of the graft cross section. 
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The effect of temperature does not act by modifying the thickness of the 
grafts formed. Therefore the exit aperture size is directly responsible for the wall 
thickness of the grafts and there is no difference in the behaviour of the polymer 
once it has coated the mandrel and is lowered into the coagulant (whatever the 
coagulant temperature).  
 Although four distinct laminae were observed, these are not separate 
entities, as they were produced en-bloc in a single step extrusion process. This 
removed the possibility of weaknesses developing between the different 
laminae due to relative shear stress during the prolonged repetitive strains 
involved in physiological flow. Preliminary attempts at increasing the burst 
strength of these conduits by dip-coating the completed graft secondarily in 
polymer solution was abandoned after it was evident that the interface between 
the resultant two coaxial tube structures showed signs of separation after 
prolonged exposure in a biomimetic pulsatile flow circuit. This illustrates the 
advantage of the single en-bloc manufacturing process. Soletti‟s group333 
recently reported their coaxial polyurethane tube with a cast/salt-leached inner 
tube covered by an electrospun fibre, which was claimed  to have no detectable 
“delaminations”. However, this scanning electron microscopy observation was 
not repeated after haemodynamic conditions. 
 
 
6.7 The effect of DMAC in the coagulant 
 
In order to investigate the dynamics of The effect of increasing 
concentrations of DMAC in the coagulant solution was to visibly slow the 
coagulative process. This resulted in an increase in maximum pore size at the 
luminal aspect, but did not noticeably affect the other layers.  
20% ethanol caused some shrivelling on drying, but below this 
concentration, ethanol‟s effect was to increase the luminal surface pore size as 
well as increase the uniformity of pore size at the lumen. These results are 
summarized in Table 6.4. Ethanol‟s effect of reducing variation in pore size has 
been shown previously by Chen et al132, albeit at much higher concentration 
than here. Khorasani and Shorgashti334 have found a similar pore size 
standardising effect with alcohols. However, at very high alcohol concentrations, 
the expected reduction in size and number of the largest pores (which they 
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have termed “macrovoids”) was not seen with our polymer. This may reflect the 
different technique used for phase inversion - Khorasani coated glass plates 
with polymer which were then immersed in waterbaths; alternatively, the 
properties of the polymer itself may be responsible; also, Khorasani used N,N-
dimethylformamide (DMF) rather than DMAC as solvent. Very high ethanol 
concentrations rendered our developing graft unstable at the phase inversion 
stage. 
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Additive to 
coagulant 
Maximum pore 
size (microns) 
% large pores in 
wall cross-section 
Lumen surface 
pore size (microns) 
5% DMAC 236 89 0-4.5 
10% DMAC 389 85 0-13.5 
15% DMAC 278 87 0-13.5 
20% DMAC 347 89 0-18 
    
5% EtOH 250 60 4.5 
10% EtOH 390 88 6.7 
15% EtOH 305 92 8.9 
20% EtOH 305 85 22.3 
  
 Table 6.4. Effect of different coagulants on composition of the graft wall 
 
 
6.8 The mechanical and physiological implications of the grafts‟ pore 
structure. 
 
High porosity in the graft wall allows for a highly compliant prosthesis. It 
can be described in terms of pore size and pore density, and a comprehensive 
description requires both parameters to be addressed. However, phase 
inversion resulted in a graft with changes in porosity through the wall. Therefore 
an overall pore size or distribution is not meaningful. Overall, the pore size was 
greater near the lumen than the outer wall. This means that the principle elastic 
strain due to blood flow will be exerted at the lumen, compressing the vessel 
wall, rather than radial expansion of the outer aspect. The static outer wall 
would allow optimal incorporation into the surrounding tissues on 
implantation335. Low porosity of the outer aspect may reduce fibrovascular 
infiltration from the surrounding tissues which is responsible for loss of 
compliance properties after infiltration. However, a complete absence of pores 
resulting in a smooth outer surface can cause a florid capsule formation around 
the prosthesis resulting in a profound loss of compliance37. This may be a 
frustrated cellular attempt at successful integration of the graft into its 
surrounding tissues as a result of a smooth surface providing no tethering 
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points. The graft provides plentiful tethering points via its regular expanse of 
ridges and troughs on its external surface. We have preliminary results showing 
absent external capsular formation on implantation of this nanocomposite in an 
animal model. 
Low porosity of the luminal aspect is associated with poor spontaneous 
endothelialisation as well as reduced neointima formation336. The relative 
importances of both of these graft healing characteristics have been extensively 
explored with groups investigating grafts with both high and low porosity and a 
pore size of 10 to 45 microns is required for spontaneous endothelialisation81. 
However, spontaneous endothelialisation is only seen in animal models of 
synthetic vascular prostheses120; implantation in humans result in a fibrinous 
neointimal lining without confluent endothelialisation125. To date, 
endothelialisation of a synthetic prosthesis in humans has yet to be achieved 
and this challenge has been approached by some groups with attempts to 
actively seed endothelial cells to grafts prior to implantation264. At the same time 
nevertheless, work continues to explore the endothelialisation characteristics of 
animal vascular models. Lumsden et al.337 showed that a non-porous lumen in 
PTFE grafts was associated with reduced NIH in canine and baboon models. 
Their experimental design ensured no potentially confounding difference in the 
surface chemistry between porous and non-porous PTFE segments within the 
same conduit. 
 
 
6.9 Conclusion 
 
A small calibre microporous conduit has been developed using an 
extrusion-phase inversion technique. This method is an amalgamation of two 
well-established methods. The benefit of using this hybrid method is to ensure 
uniformity of the conduit wall by utilising the constant downward force exerted 
by gravity in combination with the precise extrusion enabled by a careful 
alignment between the descending mandrel and the exit aperture. By modifying 
the exit aperture, it is possible to change the wall thickness. This is important as 
it presents variables to manipulate when attempting to achieve the optimal 
mechanical properties. 
This technique shows that it is possible to create a porous conduit by 
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phase inversion without the use of a porosifier. Although a porosifier has been 
shown by others to make the pore size uniform, this was not the case with the 
nanocomposite. This was largely due to the difficulty in grinding the porosifier 
into uniformly small crystals. This resulted in large cavities which made the graft 
very weak and inappropriate for physiological stresses. 
Another variable which affected overall graft integrity was the coagulant 
used. Although some pore size equalising effect was seen with ethanol, this 
was much less than that shown by Chen132. Ethanol did appear to slow phase 
inversion down, as did the introduction of DMAC into the coagulant solution – in 
both case, this caused an increase in the size of the outermost pores only. The 
greatest beneficial effect was seen on using low temperature phase inversion. 
This ensured the grafts maintained their form on natural drying and imposed 
dehydration. This has profound implications for graft storage as well as 
demonstrating better graft integrity – if the pores rely on water‟s surface tension 
to prevent their collapse, the interporous wall must be very weak. 
As the basic biostability, cytotoxicity and thrombogenicity of the 
nanocomposite has been previously demonstrated, the grafts may now be 
tested for mechanical performance, in order to assess their potential for 
subsequent in vivo implantation, which is the ultimate aim for these conduits 
manufactured in the laboratory.  
 - 184 - 
7 
Mechanical characterisation of the graft 
 
 
7.1 Introduction 
 
The reasons for mechanical characterisation of any novel material are 
outlined in the introduction to this thesis. The primary objective of mechanical 
characterisation in this case was to observe the behaviour of the material under 
stress. This was a necessarily vague aim, as until the investigations were 
completed, the material‟s properties could not be predicted or second-guessed. 
It could be surmised that because the material is a polyurethane, high strength 
is expected. However, this holds true for cast sheet preparations, but 
introducing porosity as for the phase inverted coagulated conduits weakens the 
material, whilst increasing elasticity. Equally, the latter material could be 
expected to be more elastic than the cast sheet. Compression studies would be 
required for complete characterisation but were not performed as the principle 
stresses from haemodynamic flow are tensile.   
Secondary objectives were more focused. A comparison of the graft‟s 
properties with the current industry standard synthetic graft, PTFE was sought. 
The reproducibility of the mechanical properties was analysed as a method of 
batch testing for the extruded grafts. Any difference in tensile properties 
between the longitudinal and circumferential directions (mechanical anisotropy) 
was investigated. Finally, although industry-standard reproducibility was not 
expected from conduits made from a small bench-top device, mechanical 
characterisation could give an indication of whether the product had the 
structural integrity to be able to consider progressing to the next stage of 
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development, namely animal model work. 
 
 
7.2 Tensile testing protocol 
 
 There are several international standards for materials testing which 
could be applied to the nanocomposite cast sheet and graft. As a result, any 
appropriate protocol is accepted in the scientific community, as long as it is 
clear as to which standard is being used. The ISO 37 standard for tensile testing 
of rubber (vulcanized or thermoplastic)338 was selected as it was designed 
specifically for very elastic materials which are simultaneously strong. The 
protocol allowed for the same test conditions for both cast sheet and porous 
graft; also it prescribes the use of ring specimens for circumferential tensile 
testing, which was simpler than trying to cut any measure tiny dogbone samples 
across the graft circumference; thirdly the dogbone cutter for Type 2 samples 
(Fig 5.7)  was readily available in the department. The test was conducted at 
500mm/min as stipulated in the protocol. However, this standard was 
subsequently substituted for ISO 7198 – Cardiovascular implants; tubular 
vascular prostheses339. This was because of concerns over the high load arm 
speed (500mm/min) which was associated with a high level of sample slippage 
within the grips. Furthermore, haemodynamic flow would not cause stress at 
this higher rate. This standard uses a load arm extension rate of 50mm/min and 
is specific to vascular grafts, incorporating the functional tests described in 
chapter 8 too.    
 
 
7.3 Porous sample testing  
 
 A foam may be considered to be an aggregation of hollow cellular 
structures which may or may not be interconnected. The graft wall porosity was 
high and can be described as a foam structure. Most foam structures are 
utilised for compressive rather than tensile purposes. As a result they are 
usually characterised using compressive forces and unlike tensile testing, the 
behaviour of foams in compression is well recognised. 
 The typical compression stress-strain relationship for a foam is given in 
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Fig 7.1. 
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Fig 7.1. The typical stress-strain relationship found on exerting compressive 
forces to a foam. 
 
To aid understanding of this curve, a honeycomb illustrative model is used - Fig 
7.2. 
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Fig 7.2. Compression of a foam structure. 
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The points A-D on the stress-strain curve correspond with the letters in figure 
7.2. During the initial stages, the cells are compressed together (A) until the 
point when the cell edges parallel to the axis of compression buckle (B). Here 
there is a sudden easing of stiffness, manifesting as a reduction of elastic 
modulus – the gradient of the curve suddenly falls. Further compression 
increased the buckling effect, causing a tighter organised crystalline structure 
(C). This is reflected in an increased elastic modulus. Finally, if further 
compression is possible, the cell edges perpendicular to the compressive force 
may fracture, with failure of the overall structure (D). 
 The tensile behaviour of foam structures are not similarly predictable. 
When tensile tests are conducted on foams, the force applied is often described 
rather than stress. This is because the cross-sectional area of a foam is not the 
same as the area over which stress is applied. Instead the area is determined 
by the pattern of porosity, and stress is applied to the material only. 
Furthermore, stretching a porous sample causes such elongation and flattening 
of the pores that the whole specimen becomes much thinner than a non-porous 
structure with the same initial dimensions. Therefore the stress measurements 
calculated using graft sample thickness were valuable for comparison between 
different graft specimens; however, they were unlikely to be fully accurate. 
 
 
7.4 Failed Tests 
 
As discussed in the methodology of tensile testing, for a tensile test to be 
deemed accurate and successful, a number of criteria needed to be observed. 
Overall, only one in four tests conducted was deemed successful.  
 
 
7.4.1 Noise 
There was a particularly high incidence of premature test abortion on the 
Hounsfield tester. It was observed that at whichever rate of ascent of the test 
arm (50-500mm/min) the action was not smooth. The test was programmed to 
abort at the moment when there was a reduction in force. This criterion was set 
to detect a sample with a flaw such as a defect caused by an air bubble leading 
to early failure. It ensured that even a slightly weakened sample could not be 
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passed as a successful test. There were multiple reasons for this „roughened‟ 
curve (which I have termed „noise‟), with contributions from critical weaknesses 
in the samples; extremely high sensitivity of the load cell; poor lubrication of the 
load arm; as well as minute oscillatory waves initiated in the water of the 
environmental chamber which exerted very small forces on the sample. This 
jerky motion is demonstrated in fig. 7.3 in the bitmap format generated by the 
Hounsfield software. 
Despite the micro-oscillations, the test represented in Fig 7.3 completed 
to breakage of the sample. However this was often not the case. Fig 7.4 shows 
a typical example of premature halting before sample failure. 
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Fig 7.3.  The serrated appearance of the tensile test curves generated 
with initial samples on the Hounsfield Universal Tester. 
 
 
 
 
 
 
Fig 7.4. Premature halting of tensile test – the sample had not achieved its 
failure point.  
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 The strain achieved was only 165.7% compared to the range for samples 
which were tested to failure within this group of tests (n=10) of 193.1% to 
279.6% with mean strain at failure of 240.4%.   
 
7.4.2 Initial graft placement 
A further error demonstrated in Fig 7.4 was in placement of the graft for 
initialising the test. This is represented by the test curve not starting at the axis 
origin. At test commencement an extension of 2 mm occurred without any 
increase in stress. This indicates that the slack in the specimen was not 
completely taken up at the start of the test. The result was (a small) inaccuracy 
in strain determination and confusion as to the initial shape of the curve. When 
considering this in the context of small calibre graft function, the behaviour of 
the graft at low stress was critically important to investigate accurately as this is 
the order of stress which the graft would be constantly exposed to in 
haemodynamic flow.  
The ring specimens presented a problem when it came to establishing 
the starting neutral position. The rings had shape memory which held them in a 
hoop structure when no force was exerted. However, this could not be defined 
as the neutral position, as the pins were able to pull apart for approximately one 
millimetre before force was being exerted. This is demonstrated in Fig 7.5. The 
test represented in fig 7.7 was started with the graft already under slight tension 
(approximately 0.3N). This was an avoidable error. 
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Fig 7.5. Typical tensile test obtained from a ring specimen when the pins 
were aligned at the initiation of the test such that they were both in contact with 
the ring, but without deforming it.  This results in an extension of approximately 
one millimetre before significant stress is applied to the sample. 
 
 
7.4.3 Slippage 
 
 This was a fundamental problem at the interface between sample and 
grip. The grip design was neither optimal for the cast sheet, nor the porous 
graft. A tight grip on small samples without concentrating pressure unduly within 
the area of test was a great challenge, and the commercially available grips for 
the Hounsfield tester were not adequate. Fig 7.6 shows obvious slippage of the 
sample within the grips. When this occurred, it was almost exclusively at the 
beginning of the tensile test, with the test usually continuing to completion 
without further slippage. This observation lead to the hypothesis that the 
slippage was occurring due to poor initial „purchase‟ between the PTFE blocks 
in the grip and the sample. In order to increase the friction across the area of 
the sample within the grips, thereby increasing the purchase, squares of printed 
circuit board (PCB) were interposed between the graft and the grip. This mainly 
eradicated the problem with slippage although the new sandwich arrangement 
introduced an additional interface at which relative movement was possible. 
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Slippage was far less frequent as a result, but when it occurred, it was even 
more dramatic with visible displacement of the PCB relative to the PTFE block – 
Fig 7.7. Excoriating the PTFE block surface would have improved the friction 
without adding another interface but risked damaging the bespoke grips 
irreversibly. 
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  Fig 7.6. Slippage of the graft within the grip leading to a period of apparent 
extension with no increase in load. The initial steep gradient before the slippage 
may represent the graft not being placed exactly perpendicularly in the grips, 
hence the stress was not uniformly across the whole cross section of the 
sample. The placement error may also have contributed to there being residual 
force on the specimen before commencement of the test, as one side of the 
specimen could still have appeared slack to the investigator‟s eye.  
 
 
Fig 7.7. Dramatic slippage of the PCB within the PTFE blocks leading to a sharp 
decrease in stress during the tensile test.  
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7.5 Tensile test results 
 
7.5.1. PTFE 
 
One of the principle attributes of PTFE contributing to its success as a 
vascular conduit is its mechanical strength. Fig 7.8 shows the typical stress-
strain relationship obtained for a longitudinal specimen of commercially 
available small calibre expanded PTFE ( 4mm diameter carbon-impregnated 
IMPRA® Carboflo®  thinwall vascular grafts – C R Bard, Tempe, Arizona). 
Although the highly crystalline structure endowed it with an extremely high 
tensile strength, the elasticity in the physiological range was very low. There 
were two distinct phases of elastic modulus (E) – an initial low modulus lasting 
for 10-15% elongation of the specimen followed by extremely high elastic 
modulus. These results were extremely reproducible for repeated tests – see 
table 7.1.  
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Fig 7.8. Tensile test of expanded PTFE. 
 
 
Specimen Initial E 
(MPa) 
Final E 
(MPa) 
Transition strain Ultimate Strength 
(MPa) 
1 2.51 42.25 0.17 11.52 
2 2.43 40.88 0.13 11.27 
3 2.58 43.21 0.14 11.52 
4  2.6 42.76 0.13 11.59 
5 2.55 41.09 0.15 11.47 
 
Table 7.1. Youngs Modulus (E) and Ultimate Tensile Strength for five sections of 
4mm ePTFE sourced from same graft.   
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7.5.2 PCUPOSS cast sheet 
 
Initial testing of the nanocomposite cast sheet showed even greater 
strength and great distensibility, with graft failure occurring at nearly ten times 
the original length. However, at low stress, the elasticity was low (Fig 7.9).    
These results were similar to those for simple PCU sheets – Fig 7.10 but 
incorporation of POSS was expected to increase the ultimate strength 
considerably. 
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Fig 7.9. Tensile test of initial cast sheet of 2% POSS nanocomposite. 
 
 
 
Fig 7.10. Tensile test of PCU with no POSS moiety incorporated. The 
maximum stress achieved was in the range 20.74 - 28.17 MPa; SD 2.745; 
mean 25.57 MPa. 
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Due to this lower than expected strength, further examination of the 
polymer synthesis method was undertaken, as it was felt that the ideal 
stoichiometry was not being realised. It was noted that there was a fine powder-
like layer on top of the cast sheets being produced, even when using fresh 
reagents to manufacture the polymer. One theory was that this was unreacted 
MDI. This would certainly affect the stoichiometry of the preparation, as would 
spontaneous dimerisation of the MDI reducing the availability of NCO groups for 
reaction with diamine or diol – Fig 7.11. 
MDI dimerisation was avoided by storing the solid flakes at 0°C and each 
batch of MDI was examined by melting it – pure MDI was completely 
translucent; however any dimerisation led to significant opacity in the solution, 
which was then rejected. Improving the polymer manufacture process thus led 
to a threefold increase in ultimate tensile strength – fig 7.12. 
Compared with initial nanocomposite sheets as well as with PCU, this 
resulted in a threefold increase in maximum stress to the range 58.05 – 
68.68MPa; SD 3.908; mean 65.29 MPa.  
 
7.5.3. PCUPOSS graft 
 
Once the extrusion-coagulation technique could produce consistently 
uniform conduits, they were subjected to tensile testing. However from the 
outset, there appeared to be considerable variation in the results obtained. This 
was in stark comparison to the strict reproducibility of tensile testing of multiple 
cast sheet specimens as demonstrated in Fig 7.10 and 7.12. Most of the initial 
samples resulted in J-shaped stress/strain curves – Fig 7.13 and 7.14. This 
curve represented a desired property, suggesting that aneurysmal change 
would not occur prominently at high stress levels. These samples showed much 
greater elasticity at low stress than either PTFE or the cast sheet. Introducing 
porosity reduced ultimate tensile stress compared with the cast sheet greatly, 
but this still remained above physiological levels. Mechanical anisotropy was 
suggested with testing in the circumferential direction revealing lower ultimate 
strength than longitudinal testing. Extrusion processing of polymers is known to 
cause this pattern of mechanical anisotropy.The EDXA results confirmed that 
the anisotropy seen was not due to a molecular redistribution of the POSS 
nanocage, leaving the hypothesis of polymer chain alignment expected from 
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extrusion and preserved during phase-inversion. However, the graft elasticity 
was similar in circumferential and longitudinal directions. The initial stress-strain 
behaviour suggested very little difference in elasticity (as shown by the 
gradients of the graphs near the origin) between the thin and thick-walled grafts. 
Once appreciable strain has developed, however, the elastic modulus for the 
thicker specimens were higher than their thinner-walled counterparts, 
suggesting lower distensibility for the former.  
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Fig 7.11. Spontaneous dimerisation of MDI stored at room temperature in 
its solid state. This can be avoided by storing at 0°C  or in melted state at 50°C. 
 
 
 
  
 Fig 7.12 Tensile test of the POSS-incorporated nanocomposite, using 
non-dimerised MDI.  
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 Fig 7.13. Tensile test of thin and thick-walled porous grafts in the 
circumferential direction. 
 
 
 
  
 Fig 7.14. Tensile test of thin and thick-walled porous grafts in the 
longitudinal direction. 
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However, many other samples demonstrated convex curves, as in Fig 
7.3. This was a worrying finding, as it showed that the final product was not 
reliably reproducible despite all previous attempts at standardisation of the 
manufacturing process. Furthermore, convex curves were more likely to be 
prematurely terminated due to oscillatory noise than concave curves; hence by 
selectively discarding these results, this was introducing a reporting bias. The 
standardisation of graft manufacture was revisited. There was variation 
occurring at least one of the steps leading to test results: 
 
a. polymer synthesis 
b. graft manufacture 
c. test specimen preparation 
d. tensile test 
 
In order to formally evaluate the extent of this variability, 6 thick-walled 
and 6 thin-walled grafts were manufactured from a single batch of polymer 
which had been synthesised 48 hours previously and stored in a dark dry 
cupboard. The reasons for these conditions have been discussed in Chapter 6 
when considering polymer batch testing. At this stage, it had not been realised 
that there was significant dimerisation of the MDI leading to unfavourable 
stoichiometry of the final polymer. Longitudinal and circumferential (ring) 
specimens were prepared from each graft and dimensions were collected pre-
testing, along with dry weight data after completing the tensile tests. The test 
protocol was changed to follow ISO 7198339, the first difference being the 
change in load arm extension from 500mm‟min to 50mm/min. This rate was of 
the order experienced in haemodynamic flow, and it was hoped that there would 
be less slippage of the graft within the grips at this more gradual extension. Also 
this new standard did not include the stipulation that the test should be 
terminated if there was a reduction in force. This removed the bias against 
convex curves which were previously being prematurely terminated more 
frequently than those with J-shaped (concave) curves. In this way, variation at 
each of the four stages which may have accounted for the differences in the 
end results was addressed. The option to alter circumferential testing from ring 
specimen testing to dumbbell testing was not taken up however, as the 
dumbbell specimens would need to be very small, requiring a new bespoke 
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cutter as well as causing difficulties in specimen thickness measurement. Also, 
testing very small specimens usually results in inflated results for ultimate 
tensile stress338.  
In fact none of the curves obtained after changing the test conditions as 
above were J-shaped. The ring specimen curves were all sigmoid shaped, 
being concave initially with a convex shape after an inflection point – see Fig 
7.15 and 7.16. 
The dogbone specimens were similar although the initial J-shaped 
curve was subtle (Fig 7.18) or even absent (Fig 7.17). One explanation for this 
slight difference is that the pronounced initial J-shape of the ring specimens 
would have had significant contribution from the uptake of slack from the 
circular specimen before strain was fully manifesting as stress across the test 
sample. 
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 Fig 7.15. Typical tensile test curve for a thin-walled ring specimen. 
 
 
   
 
 Fig 7.16. Typical tensile test curve for a thick-walled ring specimen 
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 Fig 7.17.  Typical tensile test curve for a thin-walled dogbone specimen 
 
 
 
 
Fig 7.18. Typical tensile test curve for a thick-walled dogbone specimen 
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Ring 
specimens 
Mean 
thickness 
(mm) 
Dry 
weight 
(g) 
Ultimate 
Tensile 
Force 
(N) 
Ultimate 
Tensile 
Stress 
(MPa) 
Strain 
(%) 
      
t1 0.4 0.007 2.8 0.698 272 
t2 0.43 0.0074 2.732 0.641 265 
t3 0.36 0.0072 3.016 0.832 305 
t4 0.39 0.0074 2.467 0.635 230 
t5 0.38 0.0067 2.616 0.696 246 
t6 0.41 0.0072 3.032 0.737 305 
      
f1 0.53 0.0106 4.515 0.851 272 
f2 0.58 0.0109 4.275 0.742 285 
f3 0.53 0.0107 4.3 0.819 268 
f4 0.56 0.0102 4.135 0.738 283 
f5 0.54 0.0097 3.884 0.725 276 
f6 0.55 0.0089 3.376 0.609 203 
 
Table 7.2. Results obtained from circumferential tensile testing of ring 
specimens taken from thin-walled (t) and thick-walled (f) grafts. 
 
Dogbone 
specimens 
Mean 
thickness 
(mm) 
Dry 
weight 
(g) 
Ultimate 
Tensile 
Force 
(N) 
Ultimate 
Tensile 
Stress 
(MPa) 
Strain 
(%) 
      
T1 0.36 0.0283 1.332 0.927 228 
T2 0.33 0.0244 1.225 0.92 166 
T3 0.31 0.0219 1.168 0.943 193 
T4 0.27 0.0165 1.033 0.967 280 
T5 0.29 0.0217 1.133 0.99 229 
T6 0.35 0.0267 1.482 1.05 274 
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F1 0.73 0.0544 2.624 0.895 254 
F2 0.63 0.0454 2.068 0.827 234 
F3 0.47 0.049 2.2 1.169 231 
F4 0.76 0.0427 2.217 0.733 258 
F5 0.62 0.0411 2.007 0.811 226 
F6 0.56 0.0405 2.017 0.895 250 
 
Table 7.3. Results obtained from longitudinal tensile testing of dogbone 
specimens taken from thin-walled (T) and thick-walled (F) grafts. The shaded 
samples were technically failed tests due to graft slippage (T2) and sample 
failure occurring at the grip edge rather than within the test area (F1). 
 
7.6 Addressing mechanical anisotropy 
 
7.6.1 Ultimate Tensile Stress 
 
These results confirmed that there was a significant difference in ultimate 
strength between longitudinal and circumferential tensile testing, as suggested 
in the preliminary testing (p=0.0001; 2 tailed unpaired t-test). However, there 
was still apparent variation in the ultimate stress achieved. This could be 
because of inaccuracies in the measurement of the sample thicknesses. This 
lead to the consideration of whether specimen thickness was a valid parameter 
by which to base the stress across the test segment which was effectively a 
non-uniform foam. Unlike weight, graft thickness was not an accurate measure 
of the amount of polymer in it, as this measure was dependent on porosity as 
well. A better measure of amount of material in the sample was its weight.   
Figs 7.19 and 7.20 show the relationship between wall thickness or dry 
weight of the tested specimens and tensile strength for samples of different wall 
thicknesses. There was a stronger linear correlation between the dry weight and 
tensile strength than wall thickness for both longitudinal (R2 value 0.9561 vs 
0.856) and circumferential (R2 value 0.9059 vs 0.6165) test specimens. This 
was especially true for the circumferential specimens. 
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Fig 7.19. The linear relation between graft specimen dimensions and 
longitudinal strength. 
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Fig 7.20. The linear relation between graft specimen dimensions and 
circumferential strength. 
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 Therefore, one reason for lower ultimate stress for circumferential 
specimens could be because of a consistent over-reading of thickness 
measurement in these specimens compared with longitudinal samples. To 
investigate this, it was necessary to compare the measured thickness of each 
sample with the weight. As longitudinal and circumferential samples were of 
different sizes, unit weights were considered, by dividing the sample weight by 
the flat area of the specimen – 255mm2 for longitudinal dogbones and 62.8mm2 
for circumferential rings. The relationship between measured thickness and unit 
weight are demonstrated for dogbone and ring specimens in Fig 7.21 and 7.22 
respectively. 
 These two best fit lines suggest that there is no large difference between 
thickness measurements for longitudinal and circumferential specimens. In fact, 
the small gradient difference shows a slightly lower measurement of thickness 
for circumferential compared with longitudinal specimens rather than over-
reading. Furthermore, the best fit line correlated better with the measured data 
in the case of the circumferential rings than the longitudinal dogbones (R2 = 
0.85 and 0.79 respectively). 
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Fig 7.21. The direct correlation between measured thickness and unit weight for 
longitudinal graft samples. 
 
y = 3397.1x
0.000
0.100
0.200
0.300
0.400
0.500
0.600
0.700
0.800
0 0.00005 0.0001 0.00015 0.0002 0.00025
Unit weight (g/mm2)
T
h
ic
k
n
e
s
s
 (
m
m
)
 
Fig 7.22. The direct correlation between measured thickness and unit weight for 
circumferential graft samples. 
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7.6.2 Curve shape 
 
Using different types of sample (dogbone and ring) for longitudinal and 
circumferential testing respectively introduces a possible reason for the 
difference in the curves generated in tensile testing. One hypothesis for the 
sigmoid shaped curve for ring specimens is that the initial hoop shape of the 
specimen is responsible for gradual application of stress to the wall as the hoop 
is flattened out. This is not the case for the dogbone specimens where the strain 
is taken up as stress in the wall immediately and uniformly. In order to test if the 
initial concave shape (J-shape) is due to the ring configuration, a smaller 
specimen cutter was commissioned and used to cut specimens in the 
circumferential direction across the longitudinally opened graft. Although the 
stress calculations were not felt to be accurate as the size of the specimens did 
not allow for precise thickness measurement, all of these curves were similar to 
the longitudinal dogbones, rather than the circumferential rings – see Fig 7.23. 
Therefore, it was concluded that the sigmoid curves generated from the ring 
specimens were artifactual and that there was no real difference in the shape of 
the tensile curve in longitudinal and circumferential directions. 
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7.23. Tensile testing in the circumferential direction using a dogbone cutter. 
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7.7 Viscoelasticity 
 
Standard tensile testing gives an indication of the distensibility of the graft 
material under the conditions of the test. However, it does not acknowledge the 
effect of any viscous element on the material‟s character. Significant viscosity 
influences the elasticity demonstrated during the tensile test, with the magnitude 
of this effect being dependent on the rate of graft extension. Almost all materials 
exhibit some degree of viscoelasticity, and especially biological tissues. 
Polymers are well known for their viscous component. Stress relaxation is one 
way of demonstrating viscous nature. It relates to the dissipation of stress which 
occurs once a defined strain is applied. Fig 7.24, 7.25, and 7.26 show this 
phenomenon for PTFE, thick-walled longitudinal dogbone specimens and thin-
walled dogbone specimens respectively after they have been rapidly extended 
(500mm/sec) to 70% strain. 
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Fig 7.24. Stress-relaxation of a PTFE longitudinal dogbone specimen. 
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Thick-walled dogbone longitudinal stress relaxation 
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Fig 7.25. Stress-relaxation of a thick-walled longitudinal dogbone specimen. 
 
Thin-walled dogbone longitudinal stress relaxation
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0 50 100 150 200 250 300 350 400
Time (s)
F
o
rc
e
 (
N
)
 
Fig 7.26. Stress-relaxation of a thin-walled longitudinal dogbone specimen. 
 
Another way of demonstrating viscosity is to apply and maintain a 
predetermined force to the material. In a viscous material, in order to maintain 
the force, continuing deformation of the material will be necessary. This 
phenomenon is termed „creep‟. Therefore if tensile forces are applied to the 
material, a constant force will cause gradual elongation of the material.  
There are several implications of the viscous element in material 
characterisation. Firstly, the viscosity is of course a fundamental mechanical 
characteristic. Secondly, viscosity affects the tensile test with the result being 
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dependent on the rate at which the tensile test was performed. An extension 
rate of 50mm/min was used as it was indicated in the standard being followed, 
and this was a reasonable magnitude when considering haemodynamic 
pulsatile flow. However, it is clear from the stress-relaxation curves that the graft 
may achieve a higher elastic modulus and ultimate tensile stress if the tensile 
rate is higher. Thirdly, exerting repeated tensile forces as in haemodynamic flow 
may magnify the effect of the viscosity or even set up complex unpredictable 
oscillations of forces. Therefore, simple tensile testing may not give much real 
indication of the graft‟s true behaviour in haemodynamic conditions.         
 
  
7.8 Conclusion 
 
Basic mechanical characterisation of the graft material was undertaken 
via tensile testing. The results have been presented in the form of an 
investigative journey as the methodology and even the polymer used evolved 
during the course of the study. 
Although some initial tensile tests gave J-shaped curves, it became clear 
that once the graft manufacturing and testing processes were fully 
standardised, the curves obtained were not J-shaped, but convex. The 
explanation for the initial results was the methodology being used (ring 
specimens rather than dogbones for circumferential specimens) and also the 
automatic premature termination of tests detecting a reduction of stress during 
the test, which resulted in a selection bias against convex results. 
The porous grafts were far more elastic than either ePTFE or PCUPOSS 
cast sheets in the physiological range of stresses. This was at the expense of 
graft strength. Simple tensile testing does not predict how the graft will behave 
in haemodynamic conditions. Elasticity cannot be translated directly into 
compliance data due to the viscous element that has been demonstrated here. 
Similarly, ultimate stress does not have a simple relationship with 
haemodynamic stress as blood pressure exerts forces in all directions 
simultaneously (circumferential, radial and longitudinally). Therefore dynamic 
testing of the graft is essential, and studied in chapter 8.  
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8 
The functional mechanical properties of porous poly(carbonate) 
urethane based nanocomposite grafts. 
 
  
8.1 Introduction 
 
The fundamental mechanical characterisation described in the previous 
chapter affords a description of how the nanocomposite graft material behaves 
under stress. However, this is not tailored to the specific use for which the graft 
is intended. Although the information is essential for a baseline in developing 
any new material, the surgeon who will ultimately use the graft will not be able 
to easily use the information as the results do not immediately translate to an 
indication of mechanical safety under the physiological stresses of pulsatile 
flow. In order to undertake this translation, some understanding of the stresses 
acting on the graft wall is desirable, and this has been discussed in chapter 2. 
However, analysis of flow velocity profiles and viscoelastic interaction with the 
graft wall would be required to quantify the precise stress vectors. Each of these 
is in itself a complex field requiring sophisticated theoretical models which have 
not been conclusively described so far, and simpler alternatives have been 
sought. One such alternative is to simulate the potential stresses on the wall by 
mimicking pulsatile flow. This removes the need to define exactly what the 
stresses are and where they act. The flow circuit used here and described in 
detail in Chapter 5 does this. Another option is to simplify the components of 
pulsatile flow down to its constituents. The measurement of burst pressure 
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addresses the maximum radial/circumferential stresses which the graft can 
bear, and is a direct indicator of graft strength, given in units familiar to a 
surgeon (mmHg). An additional layer of complexity is in the measurement of 
graft durability which has not been considered here. This requires pulsatile 
testing over the period of the required lifespan of the graft. In this case, an 
expectation of 30 years use is reasonable. However, insistence on thirty years 
of mechanical testing before consideration for clinical use would be counter-
productive. Accelerated life testing can be achieved by increasing the frequency 
of the pulsatile cycle even to 20Hz. However such rapid stresses have a huge 
effect on the behaviour of any viscoelastic material. For this reason, fatigue 
testing has not been effectively performed for the grafts which have been used 
clinically. Partly as a result of this, long term mechanical weaknesses have only 
been uncovered after a period of implantation, and even now, it is not clear what 
the lifespan of PTFE and Dacron grafts is. 
 
 
8.2 Compliance 
 
8.2.1 Compliance of lower limb arteries 
 
The compliance of human external iliac artery was found to range from 
almost 20 %/mmHg x 10-2 at a mean pressure of 25mmHg to less than 5 
%/mmHg x 10-2 at 100mmHg mean pressure by Tai using a similar flow circuit to 
the one used here. 
Bergel‟s classical measurement of Young‟s modulus in the canine arterial 
tree showed reducing distensibility more distally along the aorta340. However, 
the difference was prominent at lower pressures only. He did not find a 
significant difference in elasticity between the abdominal aorta and either carotid 
or femoral arteries. However, Tai341 has measured human superficial femoral 
artery compliance in-vivo, demonstrating a drop from 14.1 %/mmHg x 10-2 in 
the common femoral to 1.9 %/mmHg x 10-2, suggesting a reduction of 
compliance distally. Using the ultrasound probe with wall tracking, human 
arterial compliances were re-evaluated in a healthy volunteer – Table 8.1.  
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Artery Systolic 
diameter 
(μm) 
Diastolic 
diameter 
(μm) 
Diameter 
difference 
(μm) 
Pulse 
Pressure 
(mmHg) 
Compliance 
(%/mmHg x 
10-2) 
Femoral 8611 8478 133 45 3.486 
High SFA 6878 6780 98 45 3.21 
Low SFA 3929 3901 28 45 1.595 
Popliteal 4065 4035 30 45 1.65 
AT 3118 3097 21 45 1.51 
PT 3667 3647 20 45 1.21 
DP 2742 2728 14 45 1.14 
 
 
Table 8.1. Non-invasive dynamic compliance as measured in a healthy young 
adult volunteer at a brachial blood pressure of 110/65 mmHg. SFA – superficial 
femoral artery; AT – anterior tibial artery; PT – posterior tibial artery; DP – 
dorsalis pedis artery. 
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Fig 8.1. The increase in systolic pressure along the arterial vasculature resulting 
in increased pulse pressure in the smaller arteries. Concept for diagram taken 
from Nichols and O‟Rourke342. 
 
 - 220 - 
Brachial systolic and diastolic blood pressures were measured 
simultaneously and assumed to be equivalent to the pressure in the vessels 
being measured. In fact in young healthy individuals, there is a slight increase in 
pulse pressure distally, due to an increasing systolic pressure – see Fig. 8.1. 
However, the assumption is reasonable in those with arterial disease, including 
the elderly. In young people however, assuming brachial pressures are the 
same as distal pressure can result in an overestimation of compliance 
measurements in the smaller vessels, relative to the more proximal larger ones.  
A circular cross section was assumed for each vessel, so the maximum 
internal diameter measured was defined as the true diameter. As can be seen in 
table 1 there was an apparent increase in internal diameter from the low SFA to 
the popliteal artery. It was also difficult to visualise the low SFA. The scan was 
performed in the presence of a vascular technician, who then verified the 
diameters independently. There was a general trend towards reducing 
compliance distally. The compliance figures are considerably less than those 
found by Tai for the external iliac artery. However, these latter studies were 
performed on excised specimens without the physical constraints of 
surrounding tissues. Furthermore, the in-vivo assessment corresponded to a 
mean pressure of 80mmHg – at this mean pressure, Tai‟s own findings were a 
dramatic reduction of compliance to the order of 5%/mm Hg x 10-2. Cheng‟s 
measurement of femoral compliance in 21 healthy volunteers was of the same 
order of magnitude as found here (6.04+/-4.14%/mmHg x 10-2)95. The majority 
of patients requiring distal bypass prostheses with have mean pressures of at 
least 80mmHg.   
It is also evident from these results that there was a large drop in 
compliance along the SFA with the upper SFA being far more elastic than 
distally. Taking all these different sources together, it can be seen that there is 
decreasing compliance distally in the lower limb arterial tree. The rate of 
decrease is somewhat variable between individuals. These figures do not 
support the theory of compliance mismatch being fully responsible for IH, as the 
distal anastomosis is especially vulnerable but has the least compliance 
mismatch. However, bearing in mind the difference in compliance between 
implanted and explanted artery, it is not known whether the compliance of PTFE 
reduces after implantation, possibly to zero, thereby bringing compliance 
mismatch back into play. 
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8.2.2 Compliance of PCUPOSS grafts 
 
ePTFE is a rigid material with compliance in the region of 1 %/mmHg x 
10-2. In order to minimise progressive intimal hyperplasia, compliance akin to 
superficial femoral artery is desired. However, at the same time, using high 
degrees of porosity to achieve elasticity can result in poor mechanical strength, 
and a balance between the two mechanical properties is required. This is 
illustrated by our early attempts to include Na(HCO3)2 porosifier and surfactant 
in the nanocomposite solution during phase inversion. The rationale behind this 
was to produce hyperelastic grafts (10-20 %/mmHg x 10-2) which would match 
the highest compliances achieved by Tai. The result was very compliant weak 
conduits which burst at mean pressure of only 140mmHg. This pressure level is 
easily achieved in the hypertensive patient. The compliance results from 5cm 
lengths of 5mm diameter of this weak graft is shown along with our own 
measurement of explanted swine common femoral artery compliance in Fig 
6.16 which is reproduced here again as Fig 8.2. The arterial segment was of the 
same dimensions and prepared immediately after slaughter with a saline wash 
followed by gluteraldehyde preservation to preserve mechanical properties. It 
was tested within 6 hours of explantation. 
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Fig 8.2. The hyper-compliant conduit achieved by using 5% Na(HCO3)2 
porosifier and surfactant mixed in with the polymer solution before 
extrusion/coagulation. The coagulant used was de-ionised water at 50°C. This 
graft matched the compliance at low mean pressure of the explanted swine 
common femoral artery but failed at a mean pressure of only 140mmHg. The 
standard deviations shown relate to 3 readings taken at equally spaced points 
along the graft. 
 
The integrity of grafts manufactured from PCUPOSS without any 
porosifier using deionised water at 0°C as coagulant appeared much stronger 
from basic handling observations, tensile testing and behaviour on dehydration 
and its compliance was determined using the flow circuit described earlier. A 
compliance of the order 3-6%/mmHg x 10-2 was hypothesised as the desired 
range for compliance matching at the proximal (femoral) anastomosis. 6 grafts 
of each wall thickness were tested – Table 8.2.  
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Fig 8.3. The compliance profiles of thick and thin-walled 2% POSS 
conduits.  
 
Fig 8.3 shows the compliance range for PCUPOSS tubes. The thin grafts 
were more compliant than their thicker walled counterparts, as would be 
expected from the derivation of compliance (C) from elastic modulus (E) which 
demonstrates an inverse proportion relationship between wall thickness and 
compliance. The derivation for this relationship is shown in equations 4 and 5 in 
chapter 2. 
 
 
Other groups manufacturing polymeric vascular conduits have made 
similar findings322. Arterial wall thickness also shows a link with compliance - a 
direct correlation has been made between arterial stiffness and intima-media 
thickness, stimulating measurement of the latter to assess cardiovascular risk60. 
However, in this case, it is not due to a mechanical mass effect; rather a result 
of cellular adaptation to the prevailing haemodynamic conditions, similar to IH. 
 
The thick walled conduits were in the predetermined desired range. 
However, it is important to consider the compliance across the range of 
pressures. As discussed in chapter 2, arterial compliance reduces at higher 
stresses in vivo. In physiological terms, at high blood pressures, the vessel is 
stiffer. This is a consequence of the gradual recruitment of collagen at higher 
 - 224 - 
pressures. It is a safety feature preventing over-distension in the face of the 
repetitive abrupt changes in stress involved in pulsatile flow. This variation of 
elastic properties is one reason why it is not adequate to consider elasticity of 
the arterial material at a single stress level, requiring the concept of incremental 
elastic modulus or compliance.  
The ideal graft would conform with arterial compliance at all physiological 
pressures, not just for reasons of compliance matching but also to prevent over-
distension. The bypass prostheses in current use do not have the problem of 
over-distension due to their inelastic status. However, development of elastic 
alternatives requires incorporation of the composite model demonstrated in 
arteries by way of the complementary systems of elastin and collagen. The 
issue has been addressed at both molecular and macroscopic levels. 
At the macroscopic level, Sonada developed a compliant graft with a co-
axial “tube inside a tube” system74. This was effectively a microporous 
compliant graft made from poly(ether)urethane with a less porous outer sleeve. 
The wall thicknesses of each was designed to confer the high compliance due 
to elastin (inner conduit) at low pressure and low compliance due to collagen 
(outer sleeve). This concept is demonstrated in Fig 8.4. 
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Fig 8.4. Initial distension of highly compliant inner conduit until the less 
compliant outer sleeve is abutted results in a composite stress strain 
relationship which can approximate the „J-shaped‟ stress-strain curve of artery. 
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Theoretically, the same behaviour can be expected of elastomeric polymers via 
the phenomenon of strain crystallisation. The initial high distensibility is due to 
the aligning of the hard segment chains within the soft segment matrix. Once 
the former is aligned longitudinally along the plane of extension, the subsequent 
distensibility is low, representing the stretching of the hard segment chains 
themselves. 
 However, the thin walled grafts were displaying the opposite 
phenomenon. At higher mean pressures, there was an increase in compliance. 
This quality may predispose these grafts to aneurysmal behaviour over time. It 
is also represented by the convex shape obtained in the tensile test curve for 
the same graft – Fig 7.15 and 7.17. The thick-walled grafts showed a uniform 
compliance of 5%/mmHg x 10-2 which is also represented by the linear 
(Hookean) elastic relationship shown in the initial part of the tensile tests for this 
graft – Fig 7.16 and 7.18.  
In order to understand the reasons for the increasing compliance of 2% 
POSS thin grafts, the original shape of the stress-strain relationship needs to be 
reconsidered – Fig 8.5. 
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Fig 8.5. The typical sigmoid curve generated from tensile testing of 
polymeric samples. Tangential points are included to demonstrate the 
incremental elastic modulus at different parts of the curve. 
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This shows that there is a varying incremental elastic modulus (Einc) at 
different points along the curve, as given by the gradient of the tangent. 
Therefore Einc2 > Einc1. It can be seen that until point A, there is an increasing 
Einc. Between A and B, Einc is constant and subsequently, it falls. The 
relationship between Einc and compliance is inversely proportional as seen in 
equation (3), so at the lowest pressures, compliance is reducing, followed by a 
section of uniform compliance and finally, at the highest pressures before 
failure, the compliance increases. 
From this it can be seen that it is desirable to remain in the range between the 
origin and point B, as the region of increasing compliance is immediately before 
mechanical failure. This would suggest weakness and therefore unsuitability of 
the thin walled 2% POSS conduit for physiological use. However, the 
compliance graph needs to be seen in the context of the tensile test for the 
same graft, represented in the previous chapter – Fig 7.15, 7.17 and 7.23. 
These are not typical polymer stress-strain relationships. In each instance, the 
inflection point B arrives early in the tensile test with the majority of the stress 
loading until failure of the sample occuring after this point. In fact there is a long 
period of Hookean (uniform) elasticity after inflection point B. Therefore it is not 
a foregone conclusion that the 2% POSS grafts would not be able to withstand 
high pressure haemodynamic flow over the long term. 
It was hypothesised that the reason why thin PCUPOSS grafts did not 
show the desired reduction in compliance through strain-crystallisation at higher 
mean pressure may be due to the highly porous structure with the very thin 
interpore walls failing at relatively low stress, and in doing so, rapidly increasing 
the stress across the remaining graft wall. If the pore structure resulting from the 
coagulation-phase inversion technique was to be utilized, a stronger but equally 
compliant polymer was required. As the introduction of POSS to the PCU 
polymer has been shown in tensile testing to strengthen the nanocomposite 
structure a new polymer was synthesised with an increased concentration of 
MDI and POSS, with the aim of strengthening the soft segment. Due to 
stoichiometric considerations, 6% POSS was the next level of nanomolecule 
incorporation to maintain the polyurethane chemistry. The results are shown in 
Fig 8.6.  
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Compliance as a function of mean pressure within 6% POSS grafts
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Fig 8.6. The compliance profiles of thick and thin-walled 6% POSS 
conduits 
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Just like the thick-walled 2% POSS conduits, the thin-walled 6% conduits 
demonstrated uniform compliance through the range of pressures, correlating 
with the favourable section of the tensile curve between point A and B (Fig 8.5). 
However, the 6% POSS grafts were less compliant than their 2% POSS 
counterparts at comparable dimensions. So although for the same wall 
thickness, there is the desired shift towards the left in the tensile curve, the aim 
of doing so whilst simultaneously maintaining high compliance, was not 
achieved.   
 
Increasing the proportion of hard segment would theoretically give a 
similar effect as increasing the proportion of POSS, as the hard segment acts to 
strengthen the relatively weak soft segment. The polymer was synthesised with 
increased MDI and ethylene diamine to investigate this. As expected, the 
consequence of increasing the hard segment proportion in the nanocomposite 
was to reduce it‟s compliance – Fig 8.7. This is also what occurs when the hard 
segment is increased in traditional segmented polyurethanes343. Thick walled 
equivalents were discounted from further testing as poor compliance was 
expected. 
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Compliance as a function of mean pressure within 2% POSS grafts with
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Fig 8.7. Increasing the hard segment results in a reduction of 
compliance. 
 
Rather than increasing the hard segment, hard segment modification 
was then considered. Disrupting the strict linearity and hence crystallinity of this 
phase was achieved by replacing the ethelene diamine chain extender with 1,3 
diaminocyclohexane. The effect was to create branched hard segment chains 
rather than straight chains. Fig 8.8 shows the compliance of grafts made from 
this polymer. 
 
Compliance as a function of mean pressure within grafts with a disrupted hard
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Fig 8.8.  Chain-disruption of the hard segment results in a maintenance 
of compliance. 
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The thin-walled grafts showed the desired feature of reducing 
compliance at higher mean pressure. The effect of this improved safety profile 
on the burst strength of the graft compared with the original linear chain hard 
segment graft was investigated. 
 
 
8.3 Burst Pressure 
 
Fig 8.9 shows the burst pressures obtained for each graft type. 
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Fig 8.9. Burst pressures and standard deviations for each graft type. 
 
 
 The strength of the final structure is determined by the pore structure as 
well as the precise alignment, H-bonding and „virtual crosslinking‟ between the 
amorphous and crystalline phases. The cast sheet with no pores is very strong 
(tensile strength ≥ 60MPa) suggesting a high degree of interaction between the 
hard and soft segments. However, this method of manufacture allows copious 
time for the two phases to achieve optimal order. In contrast, coagulation is a 
considerably faster process with coagulant rushing into the polyurethane 
substance in exchange for solvent132 with a solid structure forming within 
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seconds. This may not give the time required for positioning of the two phases, 
which along with the porous character may lead to a weak conduit. These are 
possible reasons for the low burst pressures obtained for the 2% and 6% POSS 
thin walled conduits. The latter did not achieve the expected increase in 
strength over the 2% POSS graft. On the other hand, increasing the total 
proportion of hard segment did double the burst pressure to 400mmHg. In 
comparison, the burst pressure for the internal carotid artery is approximately 
5000mmHg232. PTFE was introduced by Gore as a vascular prosthesis with a 
burst pressure of 600mmHg51. One way to strengthen the conduits is to 
increase their wall thickness, as the maximal force applicable to a cylindrical 
vessel, f is given thus: 
 
t
Pdf
2
  
 
where P is the burst pressure, d is the vessel diameter and t is wall 
thickness. As f and d are constant, the burst pressure P would ordinarily be 
directly proportional to wall thickness t; however, this is only true for a cylinder 
with a homogenous wall whereas our grafts demonstrate a gradient of porosity 
through the wall. Nevertheless, an increased wall thickness did lead to a 
dramatic loss in compliance.  
Hence, without modification of the hard segment, a stronger yet 
simultaneously compliant graft was not possible using this the extrusion-
coagulation manufacture technique. A higher POSS concentration in the hard 
segment did not significantly affect strength for the porous structure. Increasing 
the hard segment proportion did strengthen the graft as would be expected, at 
the expense of a further loss of compliance. Chain-disrupting the crystalline 
phase however produced grafts which had both enhanced compliance and 
circumferential strength. Both of these could be as a result of optimisation of the 
interaction between the amorphous and crystalline phases due to the branching 
hard segment providing a greater surface area for that interaction. In particular, 
hard segment disruption may cause a stronger graft via increased H-bonding 
and van der Vaals forces between the two phases.  
Polycarbonate exhibits greater in vivo biostability than either polyether or 
polyester40 and would be highly desirable as a long term biological implant. 
Nanotechnology has previously been used to toughen polycarbonate344, and 
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despite the high porosity of the graft walls and the thin walls necessary for 
optimal compliance, a polycarbonate-based polyurethane is strong enough to 
handle the expected range of blood pressure. Many patients requiring vascular 
bypass surgery will be hypertensive, so the upper limits for the expected range 
will be more than 140/90. However, 400mmHg will never be achieved clinically 
by this group of patients, although blood pressures of 400/320 have been noted 
in powerlifters during their sport!  
 
 
8.4 Viscoelasticity 
 
Fig 8.10 and 8.11 demonstrate viscoelastic loops which result from 
pulsatile flow through a single 2% POSS thin conduit. These recordings were 
taken after a steady state had been achieved during pulsatile flow. From a 
single loop, the elastic distension ratio (EDR) was calculated and these are 
shown in Fig 8.12.  
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Fig 8.10. A single viscoelastic loop measured during steady pulsatile flow 
through a 2% POSS thin conduit. 
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Viscoelastic cycles
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Fig 8.11. Fifteen consecutive viscoelastic cycles during steady state pulsatile 
flow through a 2% POSS thin conduit. The area within each loop was similar, 
with the demonstrated variation being caused by lateral conduit wall movement 
due to the pulsatile flow. 
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Fig 8.12. Elastic Distension Ratios for each graft type with standard deviation. 
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The overall EDRs were comparable with human arteries. Shau et al345 
found EDR for brachial, radial and dorsalis pedis arteries to be 6.34%, 6.15% 
and 5.6% respectively. As with the artery, the diameter at any point during 
systole was higher than the same pressure in the diastolic phase. The 
difference between the two (quantified by elastic distension ratio) indicates the 
energy imparted into the vessel wall. In the case of an artery, excessive loss of 
pulsatile energy into the wall results in a requirement for increased ventricular 
work and even cardiac failure346. For this reason, the pulmonary artery does not 
demonstrate significant viscous behaviour. It is also why excessive viscosity of 
smaller calibre grafts should be discouraged. 
The role of the viscous component is to smooth the coupling between a 
pulsatile mechanical output from the heart and a steady non-turbulent stream at 
the peripheries. A further advantageous consequence of storing energy in the 
wall is that the diameter change during the cardiac cycle is lowered. In addition 
as viscous behaviour is dependent on the rate of change of stress, the strain on 
the wall at times of high cardiac output is not greatly increased, due to the 
increase in heart rate. These limits safeguard against excessive stress and 
over-distension. 
 
 
8.5 Longitudinal strain 
 
Figs 8.13-8.18 show the lengthening that results from intraluminal 
pressure for each graft type. 
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Fig 8.13.  Longitudinal strain due to pressure within the grafts: 2% POSS thin 
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Fig 8.14.  Longitudinal strain due to pressure within the grafts: 2% POSS fat. 
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Fig 8.15. Longitudinal strain due to pressure within the grafts: 6% POSS thin 
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Fig 8.16. Longitudinal strain due to pressure within the grafts: 6% POSS fat. 
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Fig 8.17. Longitudinal strain due to pressure within the grafts: 2% POSS thin 
with increased hard segment. 
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Fig 8.18. Longitudinal strain due to pressure within the grafts: 2% POSS thin 
with hard segment chain disruption. 
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 The strains calculated are small within the physiological blood pressure 
range, provided an initial 10% longitudinal stretch at implantation. The thick 
walled tubes demonstrated less elongation than their thin walled counterparts. 
Both hard segment modifications resulted in lower elongation for a given 
pressure than the unmodified nanocomposites. The chain disrupted conduits 
showed especially low longitudinal strain, even at pressures over 400mmHg 
despite being the most compliant . This suggests anisotropy of the material, or 
different elastic properties depending on the orientation being tested232. 
Furthermore, the 6% POSS conduits showed greater longitudinal strain than 
their 2% counterparts. In view of the lower circumferential compliance of 6% 
tubes, this shows a further accentuation of anisotropy. It may be that increased 
POSS concentration may serve to align the hard segments circumferentially, 
reducing elasticity radially but not longitudinally. Anisotropy is a feature of all 
biological tissues including arteries347. It is of critical importance when 
considering vascular grafts as significant elongation would result in oscillation of 
the whole conduit during pulsatile flow. This puts additional stress on the 
anastomoses, hinders optimal incorporation into the surrounding tissues and 
adds to turbulence of flow. At the extreme, it can cause buckling of the graft. 
The fact that the CD thin conduits reveal such anisotropy infers that the two 
phases are aligned to promote circumferential stretch but to discourage axial 
lengthening when compared with the other polymers. It has been demonstrated 
that there is significant longitudinal movement during pulsatile flow through the 
human aorta, carotid, brachial and popliteal arteries in vivo348. This appears to 
be greater for the intima-media than the adventitia, causing a relative shear 
stress between wall layers. However, this is only partly due to circumferential 
stressors. The viscous nature of the arterial wall is also responsible for 
longitudinal shear which would be most pronounced at the intima since this is 
the blood/vessel interface at which the shear stress is being exerted. 
 
 
8.5 Conclusion 
 
Incorporation of POSS into a polycarbonate-based-polyurethane has 
produced a non-thrombogenic nanocomposite with greater biostability than 
previous poly(ether) and poly(ester) urethanes. Although cast sheets of this 
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material are extremely strong, in this form at low stress levels, their distensibility 
is negligible, making compliance mismatch inevitable when used clinically for 
small artery bypass. A highly porous structure increases compliance but 
reduces the strength of the resultant graft. Porous grafts were manufactured 
and their mechanical properties were tested. 
No increase in strength occurred at higher levels of POSS. However 
increasing the hard segment component increased burst pressure from 
200mmHg to 400mmHg. Increasing the proportion of POSS or hard segment in 
the nanocomposite caused a reduction in compliance. As with increasing the 
hard segment, the effect of increasing wall thickness was to increase strength at 
the expense of a loss of compliance. However, modification of the hard segment 
by chain disruption techniques have lead to a 5mm diameter conduit with a 
compliance of 5%/mmHgx10-2 - similar to the superficial femoral artery; a 
viscous component providing energy capacitance during pulsatile flow, thereby 
reducing stress at the vessel wall and smoothing the pulsatile output from the 
heart to a non-turbulent stream at the periphery. The burst pressures for such 
grafts is well in excess of the levels that would be expected clinically and they 
are not at risk of elongation and buckling when implanted into the vasculature 
provided a 10% longitudinal stretch. 
The favourable mechanical and biocompatibility studies make the chain 
disrupted graft ready for in vivo evaluation. However, modification of the 
extrusion process or additional external reinforcement such as microfibre 
electrospinning will be required to strengthen the grafts further before human 
trials can be considered. 
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Conduit Hard Segment characteristic Wall 
thickness 
Number 
tested 
2% thin 2% POSS 0.33mm 6 
2% fat 2% POSS 0.58mm 6 
6% thin 6% POSS 0.33mm 6 
6% fat 6% POSS 0.58mm 6 
IH thin 2% POSS  with increased 
hard segment 
0.33mm 6 
CD thin 2% POSS with chain 
disrupted hard segment 
0.33mm 6 
 
Table 8.2. Summary of all conduits tested. The basic polyurethane 
consisted of a polycarbonate soft segment with hard segment containing 2 or 
6% silsesquioxane. The hard segments were further modified by increasing 
their proportion overall (without adding more POSS) and by interrupting their 
three dimensional structure. 
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9 
The methodology of burst pressure measurement 
 
9.1 Introduction 
 
When polytetrafluoroethylene was introduced as a vascular bypass graft 
material in 1975 by Impra and Gore, its burst pressure was assessed to be in 
the region of 600mmHg51. However, after its clinical use commenced, a number 
of cases of aneurysmal dilatation were reported, leading to an examination and 
optimisation of the sintering process used during graft manufacture, as well as 
the emergence of externally reinforced PTFE prostheses.  
As discussed earlier despite the poor long-term patency of PTFE in small 
calibre (<6mm) bypass, no suitable alternative has been forthcoming. However, 
there is an ongoing large volume of research into synthetic materials for 
vascular implantation. We have seen how in terms of mechanical 
characteristics, the ideal prosthesis would demonstrate similar viscoelastic 
properties to native artery, whilst simultaneously being able to cope with 
physiological blood flow. This latter is both in terms of absolute pressure and 
also defatiguability in high cycle testing.  
Segmented polyurethanes are at the forefront of material research for 
potential vascular prostheses244, due to their combination of elasticity and 
strength. As detailed in chapter 5, this is a result of their dual phase 
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configuration with crystalline hard segments floating in an amorphous soft 
segment with virtual crosslinking with van der Waal interactions and hydrogen 
bonding between the two. Additionally, polyurethanes have a low inflammatory 
response in vivo unlike rubber and traditional silicone rubbers. However, at 
present there are no polyurethane prostheses in general clinical use as vascular 
prostheses due to their long term biodegradation, poor thrombogenicity profile 
and the difficulties in producing polyurethane with the combination of high 
compliance and strength40.  
Although polyurethanes are elastic, they have high elastic moduli – the 
distensibility at the low pressures found physiologically is low. In order to 
increase their distensibility, various methods have been used to impart porosity 
to the conduit walls. Porosity is also desired to promote graft healing after 
implantation by transmural fibrovascular infiltration and in vivo endothelialisation 
after implantation206, with an ideal pore size between 10 and 45μm81. However, 
a very high pore size causes over-exuberant fibrous infiltration and a loss of 
elasticity80. In most cases, the degree of porosity required to simulate arterial 
distensibility in vitro is high. Unfortunately, a highly porous graft is much weaker 
than its non-porous counterpart. Therefore careful assessment of burst strength 
is critical in the progress of a potential graft through to the phases of in vivo 
work and subsequent clinical trial.  
A multitude of different methods have been used to measure burst 
pressure in tubular conduits. These methods usually consist of subjecting the 
grafts to increasing intraluminal pressure until they burst. However, the rate of 
pressure increase, the mechanism used to provide this pressure and the 
interface between the graft and the pressurising fluid vary considerably. 
Porous PCUPOSS grafts have been subjected to burst pressure testing 
using water at varying rates of infusion. Their burst strengths have been 
measured with and without a highly compliant latex sleeve inside the graft to 
transmit pressure to the graft wall. The aim was to discover whether the 
differences in methodology caused any difference in the results obtained. 
 
 
9.2 Materials and Methods 
 
  2% POSS-incorporated grafts were manufactured by the extrusion-phase 
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inversion technique described in chapter 6. 
 
 
9.2.1 Burst pressure assessment 
 
  A high pressure syringe pump (Harvard Apparatus PHD 2000 
Programmable) containing freshly deionised water (pH 7.0) was connected via 
a transducer (Honeywell Component No. 22PCCFB6G) to 8 cm lengths of graft 
with or without a non-porous latex tube lining. This was vertically suspended 
with distal clamping and weighted to ensure 10% longitudinal stretch. The 
transducer was precalibrated by connecting it to a standard clinical 
sphygmomanometer and a voltmeter to record voltage readings at 0mmHg, 
100mmHg and 200mmHg from which offset and gain figures were calculated 
and entered into a personal computer with bespoke software for recording the 
pressure at a sample rate of 10Hz. The transducer was connected via a 10v 
power source to the personal computer. Water was expelled from the pump with 
the graft unclamped to allow the apparatus to be filled completely, whilst 
ensuring all air was eliminated from the apparatus. The clamp and weight was 
applied and the water infused at 0.2ml/min; 50ml/min and 100ml/min in those 
grafts with latex lining. For the graft without latex inner lining, an initial infusion 
rate of 0.2ml/min was commenced, and this was gradually increased to take 
account of the percolation of water through the wall at high pressure and ensure 
an increasing intraluminal pressure. Figure 9.1 summarizes the different 
methods. 
The infusion was continued until the graft material burst, and the burst 
pressure recorded.  
 
9.2.2 Data collection and statistical analysis 
6 grafts were subjected to each method and mean and standard deviations (SD) 
of burst pressure and flow rate were calculated. One way ANOVA parametric 
variance analysis with Tukey post test analysis was undertaken to compare the 
results of the different methods.  
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Initial infusion rate: 0.2 ml/min 
Final infusion rate: 4.0ml/min 
 
Infusion rate: 
0.2 ml/min 
50 ml/min 
100 ml/min 
  
 
Fig 9.1. Summary of the different burst pressure measuring techniques. 
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9.3 Results 
 
Fig. 9.2 shows the burst pressures for each method used. The statistical 
summery of comparison is tabulated in table 9.1. The use of a latex inner lining 
resulted in a significantly increased burst pressure. An infusion rate of 0.2ml/min 
produced a lower burst pressure than 100ml/min. There was no significant 
difference in burst pressure between 0.2ml/min and 50ml/min or 50 and 
100ml/min. 
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Fig. 9.2 Burst pressures obtained via the different measuring techniques. Data 
are mean±SD of six experiments. 
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P value 
  No latex lining vs Latex lining 0.2ml/min P < 0.001 
  No latex lining vs Latex lining 50ml/min P < 0.001 
  No latex lining vs Latex lining 100ml/min P < 0.001 
  Latex lining 0.2ml/min vs Latex lining 50ml/min P > 0.05 (N/S) 
  Latex lining 0.2ml/min vs Latex lining 100ml/min P < 0.05 
  Latex lining 50ml/min vs Latex lining 100ml/min P > 0.05 (N/S) 
 
Table 9.1. The significance of the differences in results between the four 
different methods. (N/S) = non-significant 
 
 
 
 
 
Fig 9.3. Subjecting a graft with an interconnected porous structure to 
intraluminal pressure of 300mmHg leads to „sweating‟ of water through the wall. 
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Fig. 9.4 The aneurysmal point is a more accurate term than burst pressure, 
defined as the point at which further infusion at the same rate does not result in 
any increase in pressure (in this case 347mmHg). 
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  Fig. 9.3 shows an example of the percolation of water through the 
conduit wall at high pressure when a latex lining was not used. Fig. 9.4 shows 
how a peak pressure is reached before a reduction of pressure occurs despite 
continuing infusion, due to aneurysmal dilatation of the graft.  
 
9.4 Discussion 
 
The conduits tested had an open porous structure. This interconnected 
network of pores is a prerequisite for transmural migration of cells to promote 
endothelialisation. However, when pressurised, the effect is to force water 
through the pores leading to sweating through the graft wall – see Fig. 9.3. 
There are several consequences that follow. Firstly, the rate of infusion needs to 
be increased to ensure the intraluminal pressure continues to increase. 
Secondly, the degree of sweating increases in line with increasing pressure, 
due to the stretching of the interporous walls. This causes the pores to increase 
in size, raising the overall permeability of the wall. At very high pressures, 
fracture of the interporous walls occurs causing coalescence of pores into larger 
cavities. Due to the interconnecting nature of the pores, the pressure is instantly 
equalised between adjacent pores. On coalescence of two pores, this same 
pressure is in effect exerting stress on a larger balloon. The wall tension 
increases in proportion to the increased radius as given by Laplace: 
 
T = ∆pr/2 
 
where T represents tension in the pore wall; ∆p is the change in pressure; r is 
pore radius. This increase in tension makes it likely that the new cavity will also 
burst and coalesce into a larger cavity. This mechanism eventually leads to the 
graft bursting. 
In practice, blood will interact with the graft wall differently to water. Its 
progress through the open pore network will be impaired due to the larger size 
of particles involved. This will result in a non-uniform distribution of pressure 
across the graft wall. Also, the blood will leave a thin layer of clot on the luminal 
surface, effectively closing the pore system. This is an argument for using a 
non-porous latex sleeve which tests the strength of the whole wall thickness. 
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However, porous grafts are now being developed which are designed to 
discourage thrombus formation50. In addition, thrombus cover may not be 
uniform, leading to patches which are vulnerable to pore coalescence. 
Graft failure due to the redistribution of tension across large cavities due 
to pore coalescence is analogous to the mechanism by which Dacron grafts 
weaken. Dacron prostheses consist of knitted or woven fibres. Initial strength is 
lost due to the fraying and eventual breakage of a single fibre. This may be 
initiated by yarn slippage within the canvas causing an area of increased 
localised stress349. This leads to greater strain on the remaining fibres, as the 
same stress is exerted on fewer fibres349. The initial fraying of a single fibre by 
biodegradation350 can occur despite the high crystallinity of Dacron, resulting in 
excellent biostability of the overall structure. Hence, high burst pressures 
demonstrated initially in the laboratory under static testing conditions, may be 
inaccurate, when compared to the implanted graft under high cycle pulsatile 
flow. 
The higher burst pressures obtained when a latex sleeve is used 
suggests that the circumferential stress is being exerted equally across the 
whole wall rather than being concentrated through pores. However, the pore 
structure may make a non-porous lining essential due to the rapid transmural 
leaking of water. This is especially true for highly porous structures and those 
materials that are less porous but have very high burst pressures, such as 
expanded PTFE. Some groups have tested burst pressures at much greater 
rates of pressure increase than here, by connecting the conduits being tested 
straight to high flow gas supplies. The high infusion rates may be necessary in 
the methodology due to porosity allowing the gas to escape through the graft 
wall as fast as it is infused. At such high rates, the time between the 
development of a flaw and the subsequent rupture is almost negligible. By 
contrast, we found that slow infusion gradually lead to a point when subsequent 
continued infusion at that rate resulted in a reduction in pressure. We 
recognised this as the moment at which aneurysmal change was developing 
andat that infusion rate, no further pressure increase would occur before the 
graft would burst – Fig. 9.4. However, we found that if the rate of infusion was 
dramatically increased at this „aneurysmal point‟ a further increase in pressure 
was possible.  
Similarly to our findings, McClurken et al.351 noted that a constant 
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infusion of water into a latex balloon which was lining a PTFE graft, such that 
the sample burst over 10-20 seconds led to a point where massive dilatation 
started to occur causing a drop in pressure, so that at the moment the graft 
actually burst, the pressure was much lower than at its peak. Our proposal is 
that a very high infusion rate could continue to increase pressure in the conduit 
despite the distension, thereby overestimating burst strength.   
A viscoelastic component to the vessel wall properties also results in 
different mechanical behaviour depending on the rate of distension352. Although 
previous studies have shown the grafts to have viscosity comparable with 
human artery, this experiment has not quantified the relative importance of 
viscosity. 
Graft strength is the most fundamental characteristic of bypass grafts in 
development and therefore its accurate measurement is of paramount 
importance. The philosophy of measurement required by regulatory agencies 
such as the Food and Drug Administration (FDA) is to test above and beyond 
the limits which would be expected physiologically. At the same time, the FDA 
advocates a “least burdensome approach” to testing, recognising the large 
number of tests required to show graft safety353. These two philosophies are 
demonstrated by the FDA‟s approval of methods utilising water or saline rather 
than blood for burst pressure testing. In addition, although the difference in 
results due to different methodology for our grafts did not place them at risk of 
bursting in the physiological range of blood pressures, the difference is still very 
important as burst pressure is a fair indicator of structure, including any flaws, 
which is intimately related to the long term fatigue strength. For this reason, 
although precise qualitative guidelines are not given, the FDA is unlikely to 
approve synthetic grafts with burst pressures just above the physiological 
range. 
 In the reported literature, there is considerable variation in the methods 
used to measure burst strength which may lead to a discrepancy between 
results and subsequent graft performance after implantation. Table 9.2 shows 
the methods described for reporting burst pressures for vascular grafts and 
anastomoses in papers catalogued on Medline over the last ten years. The 
importance of the method used has often been unrecognised, on occasion 
leading to the omission of significant methodology which may affect the final 
result. 
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Graft/Anastomosis Method of 
burst 
pressure 
testing 
Infusion rate 
(ml/min) 
Burst 
pressure 
(mmHg) 
Biodegradable 
polyester scaffold354 
Phosphate 
buffered 
saline (PBS) 
via syringe 
pump; no 
lining 
0.67 >120 
Seeded carotid 
acellular matrix355 
Media 
perfusion 
solution via 
peristaltic 
pump at 
15rpm 
Not applicable 1402 (mean) 
Chitosan-blended 
polymer membrane-
covered stent356 
Saline via 
syringe pump 
4ml/min >500 (reached 
limit of 
apparatus) 
Glue adhesive 
anastomosis357 
Saline via 
hypodermic 
syringe 
Variable 
(manual) 
440(mean) 
Crosslinked acellular 
porcine carotid269 
Distilled 
water via air 
pressure 
Not given 2200 
(approximate) 
Heparinized acellular 
porcine carotid358 
Water via 
syringe pump 
0.8ml/min 3440 
Fibronectin tubes359 Growth 
media via 
syringe 
10mmHg/2min 187 (mean) 
Haemostased ends 
of explanted porcine 
arteries (ultrasound, 
diathermy and 
clips)360 
Saline via 
hypodermic 
syringe 
Variable 
(manual) 
Range 128-
854 
Solder/laser treated 
rat femoral artery 
aneurysm361 
Saline via  
syringe 
Variable 
(manual) 
>502 
Heparinized acellular 
porcine carotid362 
PBS via 
syringe pump 
45mmHg/min Minimum 1912 
Cryopreserved 
deendothelialised 
allograft vein with 
subsequent 
endothelialisation131 
„Fluid‟ filled 
syringe pump 
Not given 2300 
(approximate) 
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Haemostased ends 
of internal thoracic 
artery branches using 
harmonic scalpel363 
Air via 
hypodermic 
syringe 
Variable 
(manual) 
Range 210-
350 
Explanted canine 
carotid364 
High 
pressure 
nitrogen gas 
supply 
Not given Range 2600-
5400 
Porcine splenic artery 
anastomoses using 
protein-based 
solder365 
Syringe 
driver; fluid 
used not 
indicated 
Not given <1200 
polyethylene glycol 
derived adhesive on 
collagen, carotid and 
PTFE defects366 
Water via 
syringe driver 
5ml/min <840 
Seeded 
bioabsorbable 
polymer scaffolds146 
PBS - 
system not 
described 
Not given Range 50-326 
Hybrid polymer/tissue 
engineered grafts367 
PBS via 
syringe pump 
3mmHg/sec >240 
Microporous 
polyurethane132 
Air 
pressurized 
device 
300mmHg/sec Approximate 
range 1710-
2200 
Rat femoral artery 
anastomosis – 
sutures, sleeve, 
laser368  
Saline via 
syringe pump 
2ml/min Range 140 - 
>1500 
Protein solder and 
collagen patch repair 
of porcine arteries369 
PBS via 
syringe pump 
Not given Range 100-
600 
(approximate) 
Diathermy 
haemostasis of 
animal arteries and 
veins370 
Not 
described 
100mmHg/sec 
(artery); 
10mmHg/sec 
(vein) 
Range 195-
771 
 
Table 9.2. Methods used and results obtained for burst pressure testing of 
tubular conduits over the last ten years. A Medline search was undertaken for 
the key-term “burst pressure”. 
 
 - 255 - 
9.5 Conclusion 
 
 Using a latex sleeve increases the burst pressure obtained. This is due to 
the pores being negated by the non-porous sleeve. However, the mechanism by 
which graft failure occurs in-vivo may not be via pore coalescence, due to initial 
clot formation followed by a confluent neointimal layer. In addition, with highly 
porous grafts, it may be very difficult to maintain an increasing intraluminal 
pressure due to transmural leakage, leaving no option but to use a non-porous 
lining. 
 A high infusion rate overestimates burst pressure. The discrepancy may be 
even greater when using the very high infusion rates associated with gas 
cylinder pressure, but we cannot confirm this as our maximum  infusion rate 
was 100ml/min. 
 When burst pressure is measured, the precise method including infusion 
fluid, infusion rate and the use of lining materials needs to be carefully 
considered and described when reporting the results. Although the use of blood 
as the infusion fluid may be more physiologically realistic, this reduces the high 
burden of proof requested by standards agencies and changes a purely 
mechanical test into a functional one. 
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10 
In vivo durability testing 
 
10.1 Introduction 
 
In vivo studies of the developing graft can only be pursued once rigorous 
in vitro examination is complete and the results are satisfactory. The particular 
properties that require attention include cytocompatibility of the synthetic 
material, biostability of the graft, blood compatibility and mechanical integrity. 
Each of these factors can be solely responsible for catastrophic failure of the 
graft and there is no point in continuing to animal work if in vitro results in each 
area are not favourable. 
 However there are other critical factors which are not easily explored in 
vitro, relying on animal models to test them. This group of properties include 
durability and fatigue-resistance, which are particularly pertinent due to the 
constantly changing repetitive stresses of haemodynamic flow in a biological 
environment. A crude simulation of pulsatile flow at 37°C can be made, 
including accelerated inflation testing to attempt to demonstrate mechanical 
integrity over many years in a far shorter time-period (accelerated life testing), 
but this itself leads to a number of problems. Firstly, it is impossible to create the 
true biological environment, so mechanical stresses and biodegradative 
stresses cannot be applied simultaneously in a quantifiable realistic manner. 
Secondly, although it is an attractive proposition, accelerated inflation changes 
the behaviour of the graft, as it‟s viscoelastic nature by definition means that the 
level of distension(strain) due to inflation pressure(stress) is dependent on the 
rate at which the stress is applied and released (inflation cycle rate). In order to 
correct for this, accelerated cycle tests may be carried out at higher 
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temperatures than 37°C. This can then independently affect the biostability of 
the grafts. It is for this reason that investigators have moved to animal models 
without formal consideration of fatigue testing.  
In reference to material fatigue it is worthwhile to consider the case of 
Dacron development for several reasons. This material has now been implanted 
in humans for long periods of time. Also, it is used as an aortic graft, where the 
shear stresses are greatest, making failure due to fatigue a real risk. Dacron 
fibres were found in vitro to have an extremely strong crystalline nature Within 
ten years after introduction into clinical practice of the double-veloured crimped 
textile prosthesis which we are familiar with, structural failures were being 
identified within the knitted structure, in the form of defects due to dropped 
stitches, in particular in the dipped valleys formed by crimping371. These defects 
were due to problems inherent in the manufacturing process for Dacron grafts, 
but fatigue was implicit in the resultant graft aneurysms, as failure due to 
structural weakness alone would have been uncovered soon after implantation. 
These problems were neither uncovered in vitro nor suspected in vivo, as the 
time required for graft failure to develop was six to ten years. The mechanism of 
failure is presumably the increased concentration of stresses in the fibres 
around the defect, as well as the room available for further yarn slippage, 
enlarging the defect and thereby risking false aneurysm. Further slippage also 
weakens the structure generally, giving rise to aneurysmal dilatation of Dacron 
itself. Subsequently further improvements were made to the textile manufacture.   
 
10.2  Biodegradation studies of the graft 
 
10.2.1  Biodegradation of PCU: in vitro assessment 
 
 Simulation of the biological environment has proven to be difficult. The 
ideal in vitro test would expose the material to the various degradative 
mechanisms present in the biological environment in isolation as well as in 
combination. It would also quantify what time period of biological exposure 
corresponds with the test protocol. This latter is practically impossible, not least 
because the level of degradative stress in vivo is dependent on physiological 
conditions such as level of inflammatory response to the graft material. An 
alternative philosophy is to present a biodegradative regime that outstrips that 
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which would be reasonably expected in vivo. This latter direction was taken by 
my preceeding investigators. This method precludes the application of 
combined biodegradative and haemodynamic stresses – the two are likely to 
act synergistically to accelerate biodegradation. Wiggins‟ group372 have shown 
in vitro that oxidative solutions cause faster degradation when multidirectional 
dynamic mechanical stresses are applied to polyetherurethane samples.   
 The works of Zhao373 have also shown that successful biodegradation is 
reliant on the synergy between pre-stressing of the graft material and 
biologically derived degraders including oxidative, peroxidative and hydrolytic 
agents. In particular, natural proteins such as human plasma α2-macroglobulin 
and caeruloplasmin are involved in creation and propagation of surface cracks 
(environmental stress cracking) via oxidative mechanisms. Macrophages are 
involved in auto-oxidation and monocytes stimulate free radical generation. 
Ubiquitous enzymes (phospholipase A2) and macrophage-derived enzymes 
(cholesterol esterase) are also involved in hydrolytic degradation. 
Labow‟s review374 of macrophage activity in response to polyurethane grafts 
highlights several important points. Firstly, it is the presence of polyurethane 
itself which stimulates the differentiation of monocytes into macrophages. The 
monocyte‟s primary oxygen free radical secreting role and peroxidative function 
is swapped for the lysosomal secretion of the macrophage along with its 
phagocytic efficiency. As differentiation into macrophages is a result of subacute 
or chronic inflammation as would be expected with an implanted graft, this 
questions the role of free radicals in biodegradation. Along with cholesterol 
esterase, other minor esterases are secreted which also cause ester hydrolysis. 
Although the upregulation of cholesterol esterase is a well documented  
response to polyurethanes, the biomolecular trigger for this upregulation, which 
occurs at the ribonucleic acid level, is not known. The oxidising mechanism of 
macrophages is also due to lysosomal secretions, offering the intriguing 
possibility that macrophage secretions are tailored to the nature of the foreign 
body – poly(ether)urethane stimulates oxidising agents and poly(ester)urethane 
causes hydrolytic action. In addition, polyether-based polymers are slightly 
susceptible to hydrolysis at the urethane group, as opposed to the ester groups 
themselves for poly(ester)urethanes. Labow also highlights the synergy 
between the different degrading agents, pointing out the increased degradation 
of polyurethane when applying sustained strain to the material and pretreating it 
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with α2-macroglobulin before oxidising. 
These synergistic biodegradative and mechanical mechanisms point to the 
major deficiency of Salacinski et al.‟s142 use of physiological degradation 
solutions to assess biostability of poly(carbonate-urea)urethane (PCU), on 
which the current nanocomposite is based. The test material was exposed to 
plasma fractions (incorporating proteins which act as surface crack 
propagators), free radical generators, oxidising agents and hydrolytic enzymes 
individually, but not in combination. After 70days of exposure, they found no 
evidence of surface cracking of PCU whereas poly(ether)urethane (PEU) 
showed multiple cracks on SEM. This correlated with changes in molecular 
weight of PEU on exposure to the various plasma fractions. Oxidising solutions, 
and in particular peroxidation actually resulted in an increase in molecular 
weight for PCU. This same phenomenon was observed in vivo and in vitro with 
the Biospan® (aliphatic polycarbonate soft segment) prosthesis. Christenson 
and colleagues375 have shown via attenuated total reflectance-Fourier transform 
infrared spectroscopy (ATM-FTIR) that the oxidative degradation is associated 
with soft segment disruption as well as increased crosslinking. The increased 
molecular weight may be a result of this increased crosslinking. In vivo, the 
mechanism for this may be free radical damage to both soft and hard segments 
– see Fig. 10.1 and 10.2. 
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Fig 10.1. The mechanism of free radical stimulated oxidative crosslinking of 
adjacent polycarbonate soft segments.   
 
 
 - 261 - 
CH
2 O
HO
O
O
C CH
2
CH
2 O O
O
C CH
CH
2 O O
O
C CH
CH
2 O O
O
C CH
(polycarbonate chain)
Crosslink formed between
soft segment and hard segment
NHC
O
O CH2 NH C
O
O
HO
(MDI-based hard segment)
NHC
O
O CH NH C
O
O
NHC
O
O CH NH C
O
O
NHC
O
O CH NH C
O
O
 
Fig 10.2. Free radical mediated crosslinking between polycarbonate soft 
segment and the hard segment. 
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Peroxidising solutions also caused a reduction in elastic modulus of the 
PCU142, suggesting degradation which adversely affects mechanical properties, 
which was confirmed by showing an associated reduction of ultimate tensile 
strength. This is also in keeping with increased crosslinking, causing a reduction 
of chain flexibility. 
In fact, repeated macrophage derived free radical damage is thought to be a 
principle trigger for breakdown of soft segments375 which occurs via a 
combination of oxidative and hydrolytic mechanisms – Fig 10.3. 
 
CH
2 O
HO
O
O
C CH
2
CH
2 O O
O
C CH
(polycarbonate chain)
CH
2 O O
O
C CH
HO
CH
2 O O
O
C CH
OH
CH
2 O O
O
C CH
OH
OH
H O,
2
H+
CH
2 O O
O
C
O
C
CH
2 OH + CO2 + HO
O
C CH2
carboxylic acid
H O, H
2
+
CH
2 OH + CO2 + O CH CH2
aldehyde
 
Fig 10.3. After initial (oxidative) free radical damage, polycarbonate soft 
segment degradation is caused by a combination of oxidative and hydrolytic 
means.  
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 These phenomena are more pronounced in polyether-based PU due to the 
higher susceptibility of the ether groups to deprotonation, making the initial free 
radical assault more likely. These results appear to show some oxidative 
degradation of PCU. A more drastic effect on mechanical integrity was found 
when PEU was exposed to oxidising solutions with complete fragmentation of 
the graft material in one such solution. The unexpected loss of mechanical 
integrity in PCU on peroxidation was explained by suggesting that the 
peroxidative environment was in fact promoting hydrolytic degradation as well – 
supported by the degradation mechanisms discussed above. Therefore, the 
initial aim of separating out the different degradative mechanisms in vitro was 
not completely fulfilled. However, this apparent undesirable result did not 
preclude PCU from being tested in vivo, as it was pointed out that significant 
peroxidative conditions are not usually encountered physiologically.  
In vitro hydrolysis alone caused no degradation of PCU, with minor 
compliance changes with PEU. However, it is known that an acid environment 
favours hydrolytic breakdown. Furthermore, such an environment could be 
reasonably expected after graft implantation due to lysosomal secretion and 
attempts at phagocytosis and cell membrane lysis, especially if associated with 
infection. The protocol used would be more stringent by hydrolytic degradation 
in an acidic environment. 
The degradative solutions used in vitro needed in vivo validation in order to 
quantify how the in vitro results translate in terms of implantation time. It was 
demonstrated that PCU was more resistant to degradation than commercially 
available PEU, but this did not indicate whether there would be long term 
degradation of PCU after implantation. Therefore, Seifalian et al.‟s long term 
animal model82 to assess degradation of PCU which followed was of paramount 
importance. 
 
 
10.2.2 Biodegradation of PCU: in vivo assessment 
 
PCU was implanted in an aorto-iliac canine model82. The high flow 
haemodynamic parameters ensured a rigorous mechanical test simultaneous to 
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the in vivo exposure. 18 month and 36 month biodegradation was assessed. 
There were no macroscopic signs of dilatation or weakness after 36 months. 
Mechanical properties were preserved over that time with no significant 
difference from pre-implantation levels in either circumferential strength or 
compliance. Pitting, etching and environmental stress cracks were not observed 
on SEM. ATM-FTIR was used to observe the 1740cm-1 peaks, representing the 
C=O, and hence soft segment degradation (Fig 10.3)  and showed no difference 
across the anastomosis. It would seem that in this model at least, there was 
good biostability and durability over the long term, equating with a preservation 
of the favourable pre-implantation mechanical properties. However, the same 
material was subsequently implanted in an ovine carotid interposition model by 
Aldenhoff et al.47 for 10 weeks, and in each instance, there was dilatation of the 
conduits with wall breakdown and curvature within that short time. This study 
contributed to the shift of emphasis away from considering Chronoflex® as a 
permanent vascular implant.   
 
  
10.2.3 Biodegradation of PCUPOSS: an in vitro assessment 
 
In order to progress with polymer biostability and hence make a reasonable 
case for animal model work, the in vitro biodegradation profile for PCUPOSS 
needed to be shown to be better than for PCU. Kannan repeated the 
biodegradative solutions experiment on PCUPOSS376. He found that plasma 
proteins, free radicals, hydrolytic, oxidative and peroxidative environments had 
no effect on the hard or soft segments. However, the hydrolytic and peroxidative 
solutions did reduce the number of Si-O bonds in the sample, as evidenced by 
fourier transform infrared spectroscopy (FTIR). This was interpreted to mean 
that the peroxidation caused degradation within the POSS moiety, but the 
POSS function of improved interaction between soft and hard segment via 
cross-linking and hydrogen-bonding was preserved despite the siloxane bond 
degradation. As with PCU before, there was no evidence of any surface 
cracking on SEM, although some slight shearing of the crystalline peaks and 
pitting of the surface was noted with exposure to plasma fractions, as well as 
significant shearing of the surface with peroxidative solutions. Further evidence 
of the preservation of the soft segment structure was provided in the form of 
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maintenance of elasticity and burst strength as well as no significant change in 
glass transition temperature (Tg) as measured by Differential Scanning 
Calorimetry (DSC). This latter test did however show a reduction in melting 
point (Tm) for one peroxidative solution. Kannan‟s interpretation was that the 
vulnerable soft segment was not affected by the degradative solutions due to it‟s 
shielding by the hard segment, with POSS an adjunct to this shield. However, 
the POSS was being degraded by the peroxidative solutions, without any 
impact on mechanical properties. It is this last point which indicates that 
PCUPOSS could resist biodegradation better than PCU. 
 
 
 
10.3 Which is the most suitable animal model? 
 
It is widely recognised that a rapid confluent endothelial layer protects a 
synthetic graft from thrombosis and early occlusion. For this to occur, 
transmural capillary ingrowth is required as a supporting medium328 or even a 
direct source of endothelial cells377. However, such autonomous 
endothelialisation has never been achieved in clinical practice. This means that 
the results of animal studies where endothelialisation has occurred can not be 
applied to human trials. In particular, good patency of grafts which have 
endothelialised after being implanted in animals may not be reflected in 
humans. The literature is replete with animal models demonstrating 
endothelialising grafts, but few have translated to successful trials with ePTFE 
being the only commercially successful small calibre graft since its introduction 
in 197320. As a result, emphasis has turned towards facilitating endothelial 
seeding of grafts before implantation as well as tissue engineering of bypass 
grafts and endothelial progenitor cell adherence from circulating blood. 
Endothelialisation of both PTFE and Dacron® have been shown to improve 
patency in humans378;379. 
The behaviour of the implanted nanocomposite grafts without preceding 
in vitro endothelialisation is of interest. In order to validate any animal study, a 
careful consideration of which species will best model human vascular 
behaviour.  
Much of the assessment of graft behaviour in vivo has been undertaken 
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on small animals – rabbit and rodent. In both cases, PTFE graft healing 
behaviour is similar to humans with a fibrinous lumen lining with minimal 
endothelialisation within 30days206;380. However, the aorta of both is only 1.2-
1.5mm in diameter206;381 and so more appropriate for microvessel studies than 
our graft. 
A host of large animals have been popular for arterial bypass graft 
implantation studies including pig, sheep, goat, dog and baboon211. Larger 
animal models are generally considered more representative of human 
physiology with primates thought to be the most accurate reflection. This 
however, is not necessarily the case when considering the vascular system.  
Clowes addressed the endothelialisation potential of baboon vasculature, 
showing that there was rapid confluent endothelial coverage of PTFE of 
intermediate porosity (60μm internodal distance), as a result of transmural 
capillary infiltration377. This is in stark contrast with humans where the same 
PTFE does not allow capillary infiltration to cross the whole width of the graft 
wall, resulting in failure to endothelialise382.  
Anatomical and growth considerations need to be taken into account 
when considering suitability of animals. Pigs are often discounted from long 
term studies of implanted grafts because of their phenomenal growth rate 
through most of their lifespan. Subspecies which have reduced growth rates are 
very expensive383. However, porcine investigations in the short term have 
shown the development of a neointima which includes cells that superficially 
appear like endothelial cells, but closer investigation reveals that they do not 
stain positive for von Willebrand factor; nor do they have the characteristic 
intercellular junctions of endothelium384.  
Sheep and goat models have femoral and carotid vessels which are of 
an appropriate calibre for our study. The sheep carotid is particularly convenient 
for access, subsequent doppler access and presents a long unbranched length. 
The sheep is particularly popular in cardiac valve models, where valve and 
cardiac haemodynamics are adjudged to be similar to humans‟; however, the 
downside is that this model has a high intravascular calcification rate compared 
with humans. Poole-Warren et al. showed that, as with humans, the principle 
mechanism of endothelial lining of PTFE grafts in sheep was the limited in-
growth from the anastomoses with the artery385. James and colleagues showed 
that an endothelial lining was critical for short term patency of PTFE conduits in 
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the ovine model386. In fact, all six of the unseeded PTFE carotid interposition 
grafts implanted were occluded within 13 weeks. No systemic anticoagulation 
was used at the time of the implantations or post-operatively. The ovine model 
is therefore a very exacting one, equalling or even more stringent than the 
clinical scenario. 
 Canine models have enjoyed prominence due to similar healing 
properties as humans. However, unlike humans they endothelialise very readily 
and graft implantation studies are of little value. Dixit et al. compared dog and 
human endothelial cell behaviour, finding human endothelial migration at the 
anastomotic junction to be greater than canine counterparts. However, the 
emerging picture was complex and questions remained about the model used 
to illustrate the EC behaviour. Firstly, this group found similar migration rates for 
ECs on polystyrene and Photofix, a decellularized bovine (collagen) 
pericardium. This would suggest that the in vitro Photofix conditions were not 
close to the biological state. Next the human and canine EC types were 
morphologically and biochemically different. Human umbilical vein endothelial 
cells (HUVECs) are significantly larger and rounder than Canine endothelial 
cells (CECs) with the higher migration rate and distance of the former being 
haphazard with poor confluence and high senescence during the experiment. 
CECs on the other hand proliferate faster than their human counterparts. The 
critical issue of strength of adherence of the ECs was not addressed, and CEC 
attachment may be far more robust than HUVECs, which would correspond with 
the gaps noted in HUVEC migration patterns. The HUVECs showed greater 
secretion of prostacyclin (a powerful anti-aggregatory prostaglandin and hence 
their chosen proxy for EC function), but this fell off quickly compared to the 
sustained release over time in canine cells212. In summary, there are 
considerable differences between the two and Dixit discusses that one 
explanation of the success of canine endothelialisation may be high levels of 
spontaneous endothelialisation from circulating cells, which would fit with the 
findings of this limited study.  
It is apparent that an animal model that endothelialises the graft surface 
spontaneously is a poor representation of the clinical state. For this reason, 
canine  and baboon models need to be discounted. Furthermore, the biostability 
of PCU in the canine model demonstrated by our group82 relative to the ovine 
model47 questions its validity in a durability study. Porcine models are unsuitable 
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for long term implantation due to their rapidly increasing size. Small animals 
have vascular healing properties akin to humans, but larger vessel diameters 
are necessary. This leaves the ovine model, which is suitable in terms of healing 
properties, surgical access, vascular anatomy and a long adult phase with no 
increase in size. Perhaps most importantly it has already been shown by 
Aldenhoff47 to be a hostile biodegrading environment for a conduit closely 
related to PCUPOSS, in the context of favourable in-vitro biomimetic 
degradation testing as well as a falsely reassuring canine model. The downside 
of using this model for durability studies is that it is associated with high levels 
of early occlusion of prosthetic grafts, potentially bringing a premature end to 
the study period. The converse argument is that it is ideal for testing permanent 
vascular prostheses as the high early occlusion rate is due to the lack of 
endothelialisation of vascular prostheses during healing; a characteristic the 
sheep shares with humans. Ultimately, as the aim of the model is to show 
whether PCUPOSS is better able to cope with the biological environment than 
its predecessor (PCU), it makes sense to use the stringent model which is 
already known to degrade the latter.  
 
 
10.4 Method 
 
10.4.1 Animal model protocol  
 
All animals were cared for as per the guidelines provided in the Care of 
Laboratory Animals Handbook. 8 sheep (mean weight 56kg) were sedated by 
intramuscular administration of 0.2mg/kg xylazine and 10mg/kg ketamine, 
before anaesthetising with halothane gas. A duplex doppler was used to identify 
the right internal carotid artery of each animal and the blood flow rate within the 
artery as well as the arterial diameter was recorded. Differentiation was made 
from the external carotid artery by the presence of branches of the latter. The 
hair overlying the carotid artery was shaved bilaterally and each carotid was 
exposed in turn. 5000iu multiparin (heparin sodium) was administered and 
allowed to circulate for 5 minutes before clamps were applied. With control of 
either end of the internal carotid, proximal and distal soft clamps were placed. A 
5.5cm segment of unbranched common carotid was excised, at least 0.5cm 
 - 269 - 
distal to the carotid bifurcation. 5cm length of 4mm diameter prosthesis was 
anastomosed in its place in an end-to-end fashion using a continuous 6/0 
prolene suture, starting with the proximal anastomosis. Before the distal 
anastomosis was fashioned, blood was flushed through the graft by transiently 
releasing the proximal clamp, and once the proximal clamp was reapplied, the 
graft was flushed out with heparinised saline. The distal clamp was also 
transiently released to allow back-flow to flush out the distal vessel before the 
distal anastomosis was formed in the same way. This procedure was repeated 
immediately before the final suture was placed to complete the distal 
anastomosis. Any suture-hole bleeding was curtailed by applying gauze swabs 
to the anastomotic areas. The blood flow within the graft was assessed by 
duplex immediately after resumption of flow and 30 minutes later. The wound 
was closed in layers using absorbable sutures and dressed with a transparent 
bio-occlusive dressing. The animals were recovered and kept in free grazing 
conditions. Individual water troughs were provided for each animal, filled with 
150mg aspirin dissolved in 100mls of water at dawn daily, which was only 
refilled with water once the initial water had been consumed. The animals were 
sacrificed on the same day after a minimum of 17 months (520 days). 
 
10.4.2 Scanning Electron Microscopy 
 
This was performed on the explanted grafts to look for evidence of 
surface pitting, fissuring, cracking, balding and weakness propagation, 
compared to pre-implantation controls.  
 
10.4.3 Histological and Immunohistological Analysis 
 
Grafts were embedded in wax and Haematoxylin and Eosin (H and E) as 
well as trichrome staining was performed along with immunostaining using anti-
von Willebrand factor antibody and CD31 antibody (Alrich). Sequential thin 
slices were cut and mounted on slides for light microscopy. 
 
10.4.4 Mechanical testing 
 
Two grafts were used for post-implantation mechanical testing. 
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Compliance was measured for mean pressures between 20 and 100mmHg 
using a pulse pressure of 40mmHg in the flow circuit previously described. The 
graft was then placed in the burst pressure apparatus, using a latex lining 
sleeve and an infusion rate of 0.2ml/min until it failed. The fibrous capsule was 
removed from the second graft and the burst pressure measured in the same 
way. The results were compared with compliance and burst pressures for 
identical control grafts which had not been implanted.  
 
 
10.4.5 Chemical Analysis - Fourier Transform Infra-Red spectroscopy (FTIR) 
 
This is a powerful technique used to examine the covalent chemical 
bonds present in a sample. It works on the principle that different chemical 
bonds have characteristic patterns of vibration. When electromagnetic radiation 
is focussed on the vibrating bond, any wave of the same frequency as the 
vibration will be absorbed by the sample and not passed through to the 
detector. Most of this wave frequency falls in the infrared spectrum. Fourier 
transform maximises the absorption data extraction by beaming multiple 
infrared frequencies simultaneously at the sample, and varying these 
frequencies. The absorbance is computationally calculated. 
 
 
10.4.6 Thermal Analysis 
 
10.4.6.1 Thermal Gravimetric Analysis 
  
 This test is used to demonstrate the degradation temperature of a 
polymer by exposing the polymer sample to an increasing temperature ramp 
whilst simultaneously monitoring the sample weight. Therefore it is a measure of 
thermal degradation. An inert gas environment is used to ensure chemical 
degradation such as oxidation does not occur. 
TGA measurements were performed using a TGA Q500 (TA instruments, 
USA). Samples (about 10mg) were heated to 600 ºC at a heating rate of 10 ºC 
under a nitrogen purge to determine the temperature at which the residual 
weight of the sample became 95% of the original weight. 
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10.4.6.2 Differential Scanning Calorimetry (DSC) 
 
This test investigated the amount of energy required to increase the 
temperature of the graft sample (ie. heat capacity). At phase transition points it 
is the energy required to complete the transition, even without any further 
increase in temperature. Water exists in both solid and liquid forms at 0°C as 
represented by the stable ice/water mixture. Heat energy is required to enable 
the transition of ice to liquid even though the temperature of the water has not 
increased.  
Unique to polymers with an amorphous component is the glass transition 
point (Tg). This represents the temperature boundary between the glassy phase 
and the rubbery phase of the polymer. The glassy phase is a hard but brittle 
polymer, whereas the rubbery phase is soft and elastic. In the case of 
PCUPOSS (and all polyurethanes) the glass transition point relates to the 
amorphous soft segment. The contribution of the hard segment to glass 
transition is due to its soft-segment shielding role. Unlike the main phase 
transitions between solid and liquid (melting) and liquid and gas (vaporisation), 
Tg does not involve absorption or release of energy by the polymer. It simply 
reflects a change in heat capacity of the polymer. 
DSC measurements were performed on a Mettler Toledo 822e (UK) 
DSC. Heating scans were acquired from -50 to 250 ºC at a rate of 5 ºC/min. 
 
 
10.4.6.3 Dynamic Mechanical Analysis (DMA) 
 
Whereas DSC is limited to demonstrating Tg of the overall polymer, DMA 
can give more detail pertaining to soft segment and hard segment behaviour as 
well as a more accurate Tg. This information is obtained by monitoring the 
material behaviour under a small oscillating (sinusoidal) force during an 
increasing temperature ramp. By measuring the resultant strain, the elastic 
(storage) modulus can be demonstrated. By monitoring the phase delay in 
converting the oscillating stress to resultant strain which is given by the phase 
angle δ, the loss of energy to the environment can be demonstrated (loss 
modulus), which is related to the viscoelastic property of the polymer and is 
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comparable to the loss of energy demonstrated in the viscoelastic hysteresis 
loop during pulsatile flow. This loss of energy is quantified by „tan δ‟ which is the 
ratio of storage modulus to loss modulus.     
Dynamic Mechanical Analysis was performed using a TA-Q800 DMA (USA). 
DMA measurements were conducted at a heating rate of 3ºC/min and the 
frequency of 1 Hz in the tensile mode.  
 
 
10.5 Results 
 
10.5.1  Numbers of grafts 
 
8 grafts were implanted as internal carotid grafts in eight animals. 2 animals 
died before the end of the study period. One death was at 29 days due to a 
chest infection. The other death was at 91 days with the cause undetermined 
from post-mortem. On explantation of the remaining 6 grafts, 4 were visibly fully 
patent, one appeared partially occluded and one was occluded. These results, 
along with the duplex flow rates and vessel calibres measured are shown in 
Table 10.1. 
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No. Weight 
(kg) 
Common 
Carotid 
Diameter
(mm) 
Flow in 
artery 
(ml/min) X 
Flow in graft 
on 
implantation 
(ml/min) 
Flow 30 min 
after 
implantation 
(ml/min) Y 
Y/X Implantation 
(days) 
Outcome 
1 46.7 3.8 360 288 342 0.95 91 Died, fully patent 
2 46.1 3.6 420 315 370 0.88 545 Fully patent 
3 50.5 3.7 452 407 475 1.05 630 Fully patent 
4 47.2 3.9 380 247 304 0.80 605 Fully patent 
5 44.6 3.7 510 393 403 0.79 29 Died, fully patent 
6 48.5 4.1 335 285 328 0.98 523 Fully patent 
7 45.1 4.0 350 210 290 0.83 662 Occluded (thrombus) 
8 43.0 3.6 390 321 321 0.82 549 Partially occluded 
 
Table 10.1. Graft summary for each sheep, including duplex results pre and 
post-implantation. 
   
 
10.5.2  Gross appearance of grafts 
 
A loose external fibrous capsule surrounded each graft – Fig 10.4 and 10.5. 
This was not adherent to the graft surface and was removed easily by cleaving 
it longitudinally. A thin uniform neointima was visible over the lumen surface of 
each patent vessel – Fig 10.6 and 10.7. No thrombus was evident. The 
neointima was not thickened at the anastomoses. 
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Fig 10.4. Uniform smooth lining on the lumen seen on longitudinal cleavage of 
the graft. The prolene suture (blue) at the anastomotic line is visible. 
 
 
 
 
Fig 10.5. Close up of the smooth, uniform lumen lining of the explanted graft. 
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Fig 10.6. The fibrous capsule surrounding the explanted graft. 
 
 
 
 
Fig 10.7. Cross section of the explanted graft, showing the florid fibrous 
capsule. The section has been cut near the anastomotic line, showing the 
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native artery and suture line. 
 
 
10.5.3  Scanning Electron Microscopy 
 
Ultrastructural analysis confirmed that there was no physical breakdown of the 
graft material (Fig 10.8). Lumen analysis showed a regular longitudinal lattice of  
ridges(Fig 10.9) which on closer observation showed interspersed endothelial 
cell-like structures in varying states of flattening (Fig 10.10). 
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Fig 10.8. Outer Surface SEM of the explanted graft showing no evidence of 
pitting, fissuring, cracking or balding. Scale bar is 125μm 
 
Fig 10.9. Inner lumen SEM showing ultrascopic ridges covered with a lattice 
structure. Scale bar is 125μm 
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Fig 10.10. Higher magnification SEM of the ultrascopic ridges of the lumen 
lining of the explanted graft showing cell-like structures on the surface with 
varying degrees of flattening. Scale bar is 10μm. 
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10.5.4  Histology 
 
There was a dense cellular layer immediately adjacent to the graft lumen, with 
endothelial-like cells within this layer – see Fig 10.11. A loose fibrin-like layer 
was present on the luminal side of the cellular layer. There were occasional 
cells within the fibrinous layer. These had the appearance of myofibroblasts. 
Erythrocytes could be seen within the loose neointima as well. There were 
periodical aggregations of erythrocytes bound within connective tissue borders 
within the graft material itself. These had the histological appearance of 
immature capillaries growing through the wall of the graft. 
 
  
 
 
 
Fig 10.11. H&E staining of the graft wall, showing the lumen (superior).  
 
 
10.5.5  EC characterisation 
CD31 antibody immunostaining suggested two areas of increased uptake, 
namely the surface of the fibrinocellular lining of the graft as well as lining 
occasional small tubular cellular structures noted within the pores of the graft 
(Fig 10.12). However, the stain was taken up by the graft non-specifically, and it 
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could not be definitively shown that the staining was identifying endothelial 
structures. 
 
 
  
Fig 10.12. CD31 antibody staining showing uptake throughout the slide 
including the graft wall. There is a concentration of uptake at the blood contact 
surface on the periphery of the fibrinocellular layer which developed within the 
graft lumen. There is a second increased uptake in cellular tubular organisations 
within the pores. 
 
Anti-vWF immunostaining showed a clear increased uptake in the graft lumen 
without the associated uptake elsewhere. This was even evident in areas when 
the fibrin layer was thin or non-existent (Fig 10.13). This immunostain also 
highlighted the small tubular structures within occasional pores of the graft (Fig 
10.14). 
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Fig 10.13. The immediate graft wall luminal surface where the fibrinous layer is 
not present showing increased uptake of the anti-vWF immunostain. 
 
 
 Fig 10.14. Small tubular cellular structures within the graft pores which 
immunostain heavily with anti-vWF.  
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10.5.6  FTIR Analysis 
 
Fig 10.15 shows the spectroscopy result for the pre-implantation and post-
implantation grafts. There is no significant difference in either peak location or 
size for the two. The main peak of Si-O (1240cm-1) is not attenuated as Kannan 
found with in-vitro hydrolytic and peroxidative degradative solutions389. 
Replicating his findings from the in-vitro study, the polycarbonate soft segment 
(-NHCO- bonds at 1740 cm-1) was completely preserved.    
 
 
 
 
 
 
 
 
 
 
 
 
Fig 10.15. FTIR analysis of the pre and post-implantation grafts showing 
preservation of the Si-O peak at 1240 cm-1 and the -NHCO- bonds at 1740 cm-1. 
 
 
10.5.7  Compliance of graft pre and post implantation 
 
Fig 10.16 shows the compliance of the explanted graft with and without the 
fibrous capsule attached. For comparison, the compliance measurements of the 
original conduits are included. It shows that the fibrous capsule resulted in a 
dramatic loss of compliance. However, removal of the capsule returned the 
compliance to the level of the pre-implant graft, suggesting that the biological 
environment did not cause a loss of compliance due to structural degradation.  
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Fig 10.16. The compliance of the post-implantation graft compared with the pre-
implantation graft. The results are shown for the graft alone and with the fibrous 
capsule attached. 
 
 
10.5.8  Burst strength pre and post implantation 
 
The graft strength is shown in table 10.2. 
 
 (n=6) Pre-implantation 
 
Post-implantation Capsule removed 
Burst pressure (mmHg) 358 (+/-15) 874 363 
 
Table 10.2. Burst pressure for the graft pre and post-implantation. The post-
implantation burst pressure was obtained with and without the fibrous capsule. 
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10.5.9  Thermal GravimetricAnalysis 
 
 This showed two distinct temperatures at which the sample degraded as 
a function of increasing temperature; approximately 275 and 425°C for both pre 
and post-implantation grafts – Fig 10.17. These two represent the thermal 
degradation of the soft and hard segments respectively. It is evident that there 
was no change in soft segment thermal degradation after the prolonged period 
of implantation. 
 
Fig 10.17. TGA results for the pre-implantation and post-implantation grafts, 
showing the two distinct points of increasing weight loss as the temperature is 
increased – approximately 275 and 425°C. This is the same for both samples.  
 
 
10.5.10 Differential Scanning Calorimetry 
 
The DSC results are shown in Fig 10.18. As per Kannan‟s investigations389, the 
Tg for both samples were not significantly different (-37°C). This low Tg means 
that the grafts are well within the rubbery form at biological temperatures. The 
test was terminated before a clear melting point (Tm) was reached. 
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Fig 10.18. DSC thermograms for pre and post-implantation grafts. There was no 
significant difference in Tg. The test was terminated at 250°C which was before 
the melting point (Tm) was reached. 
 
 
10.5.11 Dynamic Mechanical Analysis 
 
Fig 10.19 to 10.21 show the DMA results for pre and post-implantation grafts. 
These demonstrate a difference of just 4°C in Tg between the two, which is not 
a significant difference. The Tg is clearly identifiable, suggesting a high degree 
of cross-linking between the soft and hard segments. The storage and loss 
modulus in the glassy region is higher in the implanted conduit, indicating an 
increase in crystallinity compared with the original graft. However, in the 
biological temperature range, and throughout the rubbery phase there is no 
significant difference. The tan δ value which represents the ratio of storage 
modulus to loss modulus is identical for the two grafts. 
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Fig 10.19. DMA result showing the storage modulus from the glassy phase, 
through the Tg into the rubbery plateau for the pre and post-implantation grafts. 
The increase in storage modulus after implantation is significant in the glassy 
phase. 
 
 
Fig 10.20. DMA result showing the loss modulus from the glassy phase, through 
the Tg into the rubbery plateau for the pre and post-implantation grafts. The 
increase in loss modulus after implantation is significant in the glassy phase. 
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Fig 10.21. Tan δ against temperature for pre and post-implantation grafts, 
showing the maximum peak value, corresponding with Tg. 
 
 
10.6 Discussion 
 
The aim of this animal model was to investigate the biostability, mechanical 
durability and fatigue-resistance of the graft. It is the same model that has 
previously shown rapid biodegradation of PCU47 (within 10weeks). In vitro 
studies have suggested that PCUPOSS would last considerably longer than 
PCU in the ovine model. However, one concern which existed before the study 
was that the grafts would occlude in this model before a reasonable period of 
haemodynamic flow through the prostheses. For a critical vascular prosthesis 
exposed to continuous haemodynamic stress, industry standards require fatigue 
testing to a minimum of 20 million cycles. In this case, the graft was subjected 
to a far greater cycle number. A very conservative estimate of average heart 
rate for the sheep is 60 beats per minute. For this heart rate, the number of 
cycles for the 6 grafts which completed the test period range from 45 million to 
54 million. This includes the assumption that the one occluded graft occluded 
on the day of the penultimate duplex showing it to still be patent. 
Unlike Aldenhoff‟s work with PCU in the same model47, these grafts were 
recovered with no visible signs of weakness or degradation. Ultrastructural 
analysis by SEM confirmed the graft integrity. Compliance analysis of the graft 
once the capsule was removed, demonstrated the same range of compliance of 
the pre-implantation graft. However, the fibrous capsule covering each graft 
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reduced compliance markedly. In fact, the compliance fell to only twice that of 
PTFE.  
The capsule also resulted in a large increase in the burst strength of the graft, 
which enhances the long term safety profile further. Investigation at the 
molecular level by  bond analysis using FTIR did not show degradation of the 
vulnerable soft segment; this latter being responsible for the preserved 
compliance properties of the graft. This correlated with the preceding in-vitro 
testing376. 
This is the first report of endothelialisation of a synthetic vascular bypass graft in 
an ovine model. Sheep vascular implants with medium term patency have 
shown no evidence of endothelialisation. The Thoralon® graft, which is a triple 
lamina poly(ether)urethane was used as an ovine coronary implant and 
remained patent for up to 426 days387. A thin neointima was observed 
histologically, similar to that found on PTFE grafts explanted from humans. 
However, this graft had no transmural endothelialising potential due to a non-
porous middle coaxial lamina. Hybrid materials with a biological component 
have been shown to endothelialise through the graft wall, with Grabenwoger 
demonstrating endothelial cell presence in the pores created by laser, as well as 
on the graft surface 3 months after implantation388.   
 
10.7 Conclusion 
 
This is the longest reported in vivo study for any vascular prosthesis in the ovine 
model. Synthetic grafts have been particularly disappointing in sheep, and these 
have never endothelialised, making this a stringent model. Incorporation of a 
POSS nanomolecule into an established polyurethane has conferred biostability 
to it as demonstrated in this long term stringent durability model incorporating 
both haemodynamic flow and a biological environment. The fatigue test is well 
beyond that required for international standard certification for a critical vascular 
prosthesis. There is evidence of patchy endothelial cell coverage but as this 
was not a primary outcome measure in this study, this will need to be evaluated 
with further animal work. The traditional thinking that ovine models only 
endothelialise grafts from the anastomotic edge is disputed by this report. It may 
be that other grafts have not been tested in ovine models for long enough to 
cause significant endothelialisation. 
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 The original graft design included matching of arterial compliance to 
minimise stenosis and midterm/longterm failure, principally by neointimal 
hyperplasia (NIH). However, four out of six grafts which were tested till 
completion of the study showed no evidence of anastomotic narrowing from NIH 
despite a fibrous capsule which dramatically reduced compliance. This may be 
partly due to the geometric difference between the end-to-end interpositional 
model used here compared with the traditional end-to-side anastomosis in 
clinical use. 
 The field of nanotechnology reopens opportunities to consider synthetic 
materials to meet the multiple demands of a successful small caliber vascular 
bypass graft. 
 Automated techniques for reproducible industrial manufacture of the graft 
are currently being developed in order to pursue clinical trials of this prosthesis. 
Also, to improve patency further, biofunctionalisation389 of the nanocomposite to 
encourage speedy endothelialisation is being pursued390. 
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11 
Conclusion 
 
At the start of my research I was handed a viscous polymer solution 
which had shown promising properties in vitro for consideration as a small 
calibre vascular bypass prosthesis. The department had considerable 
experience already with the polymer forming its basis – PCU; unfortunately 
PCU showed worrying bio-stability in vivo within a short time. To combat this 
problem, the polymer had been modified by covalent attachment of a nano-
engineered molecule – POSS, which was composed of dimeric rings of siloxane 
bonds. My aim was to reproducibly manufacture a small calibre graft which was 
mechanically robust enough for in vivo studies, in order to then assess the long 
term biostability and the effect of the biological environment on the mechanical 
properties. 
 
 
11.1 Introduction. 
 
As way of introduction, the need for a small calibre synthetic graft was 
established. The commonplace unavailability of suitable autologous vessels 
was described, along with the poor unassisted patency of the currently used 
prostheses. It is clear that the whole avenue of infra-inguinal bypass down to 
small vessels is severely compromised by the lack of a suitable synthetic 
prosthesis. By revisiting the history of vascular surgery, it was described how 
the development of graft materials has been in sporadic bursts, with a long 
initial paucity of research once vascular bypass was shown to be feasible. 
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Advances in materials technology and war were associated with the significant 
advances made. Nevertheless, no better material has been found to date than 
PTFE, first introduced in 1959 and in common use in the seventies. This is 
despite a large volume of research into the large number of new materials 
developed in the modern era. Polyurethane polymer technology looked most 
promising due to the ability to achieve precise mechanical characteristics by 
changing chemical composition, but long-term bio-stability of the soft segment 
was suspect. Polycarbonate-based macroglycol was more stable than polyester 
and polyether due to overall improved interactions between hard and soft 
segments within the polyurethane. Further improvement in the shielding effect 
by the hard segment on the soft segment was postulated by the incorporation of 
POSS into the hard segment. The intention of this study was to produce and 
mechanically test a small calibre compliant vascular bypass graft using this 
nanocomposite polymer. 
 
11.2 Mechanical properties 
 
In order to design a new graft, an appreciation of the mechanical 
properties required to ensure graft success along with the forces involved in 
haemodynamic flow needs careful consideration. Most of the literature 
concerning this is found in biomechanical and engineering journals and 
relatively inaccessible to the surgeon. It gave valuable insight into ideal graft 
design and the complex physics could be distilled into easily understood 
principles. Extrapolation from these concepts needs to be tempered by the 
realisation that blood is non-Newtonian and arteries are non-rigid pipes with 
unpredictable branching patterns. 
It was derived from Poisseuille‟s formula that small calibre vesels 
endured very high vascular resistance. The implication for a potential small 
calibre graft would be high outflow resistance, promoting relative stasis and the 
thrombotic state. Furthermore, at the proximal anastomosis, the calibre 
reduction of the graft would result in high wall shear stress. 
High WSS is associated with endothelial injury, which in turn is 
associated with NIH. Low WSS also contributes to NIH. There is conflicting 
evidence as to whether peri-anastomotic compliance mismatch between native 
vessel and graft causes NIH, but it is evident that this mismatch in combination 
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with anastomotic geometry is responsible for areas of abnormal WSS. With 
small calibre graft design, it is reasonable to aim for compliance matching, as 
the consequences of intimal hyperplasia are amplified by graft size. 
The flow in small distal vessels is not fully pulsatile due to the influence 
of vessel viscosity. By dissipation and storage of the pulsatile energy, the effect 
on flow is to become a more continuous stream, which in turn reduces WSS. A 
viscoelastic graft would be preferable to a purely elastic one for this reason. The 
presence of viscosity is inherent within the concept of compliance, which can be 
considered to be distensibility of the vessel at a given mean haemodynamic 
pressure. In an artery, distensibility is high at low mean pressures and vice 
versa, due to the organisation of elastin and collagen fibres. 
Porosity is one way in which graft compliance has been manipulated. It 
may also reduce thrombogenicity by improved blood:graft interface as well as 
transmural endothelialisation. However high porosity is associated with fibrous 
ingrowth which reduces compliance in vivo dramatically. High porosity can also 
result in a reduction in graft burst pressure. 
The burst pressure of native vessels far exceeds haemodynamic 
conditions. The same is true for commercially available prosthetic grafts. 
However, anastomotic suture lines fail at lower pressures when considering 
compliant grafts, and additionally, the viscoelastic properties of compliant 
materials may mean such high burst strengths are not required. 
 
11.3 Thrombogenicity 
 
 Although thrombogenicity studies had already been conducted on the 
nanocomposite polymer by a preceding investigator, it became clear that graft 
construction could not be separated into mechanical and blood compatibility 
properties with considerable overlap between the two. Fundamentally, a 
thrombogenic graft could not allow long term in vivo mechanical testing. The 
role of compliance matching on the development of intimal hyperplasia is 
dependent on graft thrombogenicity. Changing graft characteristics such as 
porosity have simultaneous effects on platelet adhesion and thrombogenicity. 
Turbulence and excessive WSS causes platelet activation and subsequent 
thrombosis. 
 The arterial blood:surface interface is the vascular endothelial cell which 
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inhibits platelet aggregation through membrane anticoagulants and cytokine 
release via multiple intracellular signalling pathways. These same mechanisms 
are attenuated to promote thrombosis to limit the consequences of vascular 
injury. They are also copied by graft developers to improve surface 
characteristics. In particular, heparin-bonding is being widely investigated, 
including clinically; this is particularly feasible with polyurethane which allows 
the possibility of covalently bonded heparin or heparin-like moieties. Heparin 
bonding also reduces intimal hyperplasia. More recently, the role of nitric oxide 
elution for platelet inhibition is being developed. 
 Rather than mimic the endothelial cell function, many groups have used 
strategies to encourage endothelialisation of the graft wall. The high flow 
through small calibre grafts is unlikely to allow significant luminal endothelial cell 
adherence, and pre-implantation seeding techniques have been examined 
using compliant grafts and different pulsatile conditions. Transmural 
angiogenesis and endothelialisation is dependent on the pore size of a graft. 
 Electronegative and to a lesser extent, hydrophilic graft surfaces are 
associated with platelet repulsion. Materials with excellent mechanical 
properties have had to be discounted due to hydrophobicity (silicon) and 
surface modification with hydrophilic domains such as heparin and polyethylene 
glycol could be used to convert a hydrophobic surface into an amphiphilic one, 
provided secure permanent bonding. 
 In summary, although it has been shown that the nanocomposite has low 
thrombogenicity, construction of a graft from this polymer needs to take account 
of the structural components affecting platelet adherence and activation along 
with the possibility of incorporating strategies to reduce thrombogenicity further. 
Long term mechanical testing in vivo will not be possible without considering 
thrombogenicity simultaneously. 
 
11.4 Tissue-engineering 
  
 There were several recurring themes which led me to look at tissue-
engineered blood vessels. The ideal vascular graft requires multiple 
characteristics which are difficult to achieve in synthetic prostheses. Several of 
these criteria appear to be in direct opposition; for example, strength and 
compliance. Furthermore, the required properties can change depending on the 
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prevailing haemodynamic conditions, both acutely and in the long term. 
Synthetic materials have been investigated for over half a century without being 
able to satisfy these multiple criteria. As native arteries have all of the required 
properties, it may be easier to artificially reconstruct the artery than develop a 
synthetic graft which fulfils all the demands. 
 Generally speaking, a tissue-engineered blood vessel is the combination 
of viable confluent sheets of cells arranged around a tubular scaffold. Synthetic 
grafts can act as the scaffold, although if they do not subsequently biodegrade, 
a hybrid graft rather than a fully tissue-engineered graft results. This former will 
continue to have many of the perceived disadvantages of a synthetic graft. The 
advantage of using a synthetic scaffold is that it gives initial mechanical stability, 
and time for the regenerating tissues to take up haemodynamic stress. 
Alternative strategies include using collagen sheets as a strong scaffold, or a 
fibrinous scaffold which stimulates fibroblasts to lay connective tissue down. 
Smooth muscle cells afford contractility and endothelial cells prevent thrombotic 
occlusion. 
 Achieving the appropriate connective tissue matrix and cellular structure 
along with robust mechanical properties is a huge challenge. Even after 
endothelial cell seeding mechanical strength required before consideration for 
implantation requires a month at the very least, excluding it as an option for 
critical limb ischaemia. As yet, tissue engineering is not a more viable option 
than a synthetic prosthesis. 
 Yet at the same time materials science continues to progress rapidly. 
Nanotechnology is an emerging field which is revolutionising materials science. 
Although traditional materials technology may not have yielded a graft which 
fulfils the multiple demands for a successful small calibre vascular graft, nano-
engineered molecule attachments may be able to improve the properties of 
traditional materials.  
 
 
11.5 Materials 
 
Traditional composite technology is a well established method of 
improving material properties. Polyurethanes can be considered 
„microcomposites‟ with microphase separation between macroglycol soft 
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segments imparting elasticity and crystalline hard segments imparting strength. 
However, polyurethanes have not shown the convincing long term biostability 
required for a permanent vascular implant. As yet the size-related properties of 
nanocomposites are not fully predictable. POSS is based on the siloxane bond 
which is biologically inert, making it suitable for implantation. However, long 
chains of siloxane have low solubility which makes them weak when used as 
the soft segment in polyurethanes. The original intention was to improve the 
biodegradation profile of polyurethanes, and in particular, PCU, by incorporating 
small cyclical siloxane structures in small quantities in the hard segment. The 
PCU-POSS polymer used has previously been shown to have low 
thrombogenicity as well as demonstrating resistance to degradation when 
exposed to biodegradative environments in vitro. This former property brings the 
realistic prospect of a small calibre graft that need not rely on endothelialisation 
in the short, medium or long term. It rebuts the argument that tissue-engineering 
is the only way to construct such a graft.  
 The nanocomposite was synthesized in house with a view to 
manufacturing it into small calibre bypass grafts. 
   
 
11.6 Graft manufacture 
 
 From the previous observations, a compliant porous graft of variable 
small calibre which could be reproducibly manufactured was sought. A 
combination of extrusion to ensure a uniform wall and phase inversion to 
remove solvent from the polymer in a precise manner, thereby coagulating the 
polymer was used.  
A purpose-built bench-top vertical extruder was made. Steel mandrels 
were driven through a polymer chamber into coagulant solution. Steel mandrel 
diameter determined graft calibre. The outlet aperture determined wall 
thickness. The precise alignment of the mandrel in relation to the exit aperture 
determined the uniformity of the wall thickness. Due to the vertical extrusion 
process, correction for gravity was unnecessary. Very precise wall uniformity 
was achieved across the whole graft circumference. 
In order for the mandrel to coat itself with polymer within the polymer 
chamber and drive through into the coagulant without the polymer drifting down 
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relative to the mandrel, polymer viscosity of 3PaS was required. The maximum 
usable length of 86mm was achieved by injecting 3.5ml of polymer in the 
polymer chamber. Storage of the polymer resulted in an increase in viscosity 
due to the evaporation of the DMAC solvent over time. Using different batches 
of raw materials had a profound effect on the viscosity. The industrial quality 
control for the raw materials were accepted, leaving the probability that the 
chemistry was changing during storage, for example by oxidation, hydration or 
spontaneous dimerization of the MDI. Therefore, to reduce variability, all of the 
grafts tested were made from a single batch of polymer made freshly from 
newly ordered raw materials. 
The thin and thick-walled grafts produced using these parameters were 
of uniform thickness and reproducible as assessed by bespoke image analysis. 
Combining the extrusion-phase inversion technique with salt leaching 
resulted in grafts which mirrored the high compliances of arteries at very low 
pressures (15%/mmHg x 10-2). However, the very high porosity was at the 
expense of strength. In addition, striving for such high compliance was 
unnecessary, for the compliance of arteries at physiological pressures was 
much lower (5%/mmHg x 10-2).  
It was discovered that a highly porous structure resulted even without 
salt-leaching. Using coagulant at 50oC produced grafts with pores which 
collapsed after drying the graft. This was prevented by using coagulant at 0oC. 
This difference was explained by higher porosity in grafts extruded at high 
temperature. The porosity was not homogenous. The outer surface was non-
porous with microscopic ridges; inside this there were small pores; bigger pores 
near the lumen, and a lumen with few small pores. 
Slowing the exchange of solvent for coagulant by reducing the DMAC 
gradient resulted in an increase in the size of the biggest pores near the lumen, 
without affecting the other layers. Adding ethanol to the coagulant led to an 
increase in pore size and pore uniformity at the lumen itself. 
The overall effect of the four layer pore design was to ensure the grafts 
did not need pre-clotting, and would show elastic strain via compression of the 
vessel wall rather than radial expansion. However, the non-porous outer skin 
could be associated with fibrous capsule formation, and resultant compliance 
loss. In addition, low porosity at the lumen is associated with poor spontaneous 
endothelialisation in animal models. However, unlike in animal models, synthetic 
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grafts have not been shown to spontaneously endothelialise in humans. 
The next step in developing these grafts was to mechanically 
characterise them. 
 
 
11.7 Mechanical characterisation 
 
 Tensile testing demonstrated the behaviour of the graft material under 
tensile stress, comparing it with PTFE and using the results to assess 
reproducibility of mechanical properties of the grafts produced. The testing 
process was hindered by the small dimensions of the samples and the graft/grip 
interface; the latter was addressed with bespoke grips. 
 On considering the testing protocol, it was clear that no single 
international standard was ideal. ISO 37 for highly elastic materials eliminated 
the oscillatory movements associated with slow load arm movement, but there 
was high levels of graft slippage. ISO 7198, which is specific to vascular 
implants, but not ideal for highly compliant materials resulted in high rates of 
premature test abortion due to oscillatory tensile movements. A further cause of 
test failure was test commencement with the sample in tension. This was 
inevitable with hoop specimen testing, leading to their substitution for small 
dogbone specimens, using a bespoke small cutter. 
The preliminary tensile testing of the nanocomposite cast sheet showed 
it to be both extremely strong and elastic. The ultimate strength was in the 
region of 60MPa, compared with 11MPa for commercially available small calibre 
expanded PTFE graft. POSS incorporation into PCU resulted in a threefold 
increase in ultimate strength, provided ideal stoichiometry was realised. This 
ideal chemistry was ensured by meticulous measuring and mixing of the 
reactants as well as rejecting any dimerised MDI. PTFE showed low elasticity. 
Although the cast sheets were extremely elastic, with failure occurring at 900 to 
1000% strain, at low level (physiological) stresses the elasticity was low. For 
comparison, PCU alone could be subjected to 600-800% strain before failure. 
As expected, the porous grafts were much weaker than the cast sheets, 
failing at 0.6-1.1 MPa. However, at low level stress, they were highly elastic. 
The J-shaped curve which protects against aneurysmal dilatation was not 
evident. The ultimate strength circumferentially was lower than longitudinally. 
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The stress-relaxation phenomenon was used to demonstrate the viscous 
component of graft mechanical behaviour under conditions of stress. This visco-
elastic behaviour highlighted the importance of assessing graft behaviour 
exposed to haemodynamic forces rather than stress in single directions, as the 
results of the latter depend on the rate of stress application. Furthermore, the 
clinical applicability of the stress/strain results needed to be determined. For 
these reasons, functional mechanical characterisation was undertaken. 
 
 
11.8 Functional mechanical characterisation  
 
To achieve the aim of matching human arterial compliance, a clear 
understanding of normal lower limb artery compliance was required. The 
compliances previously quoted for artery (including using the same pulsatile 
flow apparatus used here) were higher than the target compliance for two 
principle reasons. because they were ex-vivo segments without the restrictive 
effect of surrounding tissues and neurochemical modulation; the mean pressure 
used to measure compliance was lower than physiological norms. In vivo 
measurement using wall tracking ultrasound demonstrated compliance of 
3.5%/mmHg x 10-2 at the common femoral artery. 
However its compliance within the range of stresses expected in pulsatile 
haemodynamic flow was low. Porosity was introduced to improve the 
compliance at low stress levels. Initial attempts using a salt leaching technique 
in combination with coagulation-phase extrusion resulted in an extremely 
compliant graft which was too weak to withstand haemodynamic forces. 
However, on reflection the compliance being sought was higher than that for 
native artery. The reason for this error was twofold. Firstly the maximum 
compliance of the lower limb vessels was being considered rather than the 
normal compliance. So at very low pulse pressures which are not 
physiologically sustainable, arteries show very high compliance due to the 
predominence of the role of elastin fibres at low pressures. The second reason 
for an overestimation of the required compliance is due to the testing of recently 
explanted arteries rather than in situ investigation. The latter has contribution 
from inotropes along with the restrictive influence of soft tissue surrounding the 
vessel. Using wall-tracking ultrasound to measure compliance in native human 
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common femoral artery, 3.5 % / mmHg x 10-2 was the result, which tallied with 
other studies of in-vivo human lower limb arterial compliance. The compliance 
reduced further distally in smaller arteries. 
The salt-leaching technique, when combined with extrusion-phase 
inversion produced grafts which mirrored the very high compliances of ex-vivo 
arterial samples tested at low mean pressures (>15% / mmHg x 10-2). However, 
this level of compliance was unnecessary and these grafts burst within the flow 
circuit at a systolic pressure of only 140mmHg.  
The thick-walled nanocomposite grafts manufactured using deionised 
water at 0oC as coagulant showed a compliance of 5% / mmHg x 10-2. This 
compliance was the same for all mean pressures between 25 and 100mmHg, 
unlike arterial compliance. The thin-walled grafts were more compliant than the 
thick-walled; this compliance increased with increasing mean pressure which is 
undesirable due the propensity for aneurysmal dilatation in the long term. This 
pattern of compliance fitted with the previous tensile testing showing a convex 
curve as opposed to the desired J-shape. The burst pressures for thin and thick 
grafts were 220 and 365mmHg respectively. 
Modulation of the interaction between hard segment and soft segment 
was used to try to optimise strain-crystallisation whilst maintaining high burst 
pressure , thereby improving the compliance properties throughout the range of 
mean pressures. Increasing the proportion of POSS from 2% to 6% reduced 
compliance, with no effect on burst pressure. This illustrates that the properties 
imparted by interactions at the nanoscale level are not improved by increasing 
the amount of the nano-molecule. Increasing the hard segment proportion 
similarly reduced compliance. Branching disruption of the hard segment to 
reduce overall crystallinity did improve the burst pressure to 450 and 560mmHg 
for thin and thick-walled grafts respectively. It also increased compliance, with 
the thin-walled grafts demonstrating the desired high compliance at low mean 
pressure and low compliance at high mean pressure. 
All of the nanocomposite polymers used demonstated pulsatile energy 
transfer into the graft wall equivalent to that for human arteries; this is important 
for energy capacitance in the graft wall as well as converting the pulsatile pump 
energy of the heart into a steady stream of flow at the end organ. Inflation 
caused elongation (10%) of all nanocomposite grafts due to compliance in the 
longitudinal direction, meaning subsequent in vivo implantation would require a 
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10% stretch. 
The functional mechanical testing showed that compliant grafts which 
would in the immediate term be robust enough for in vivo haemodynamic 
testing. Whether this would translate to longer term stability in the biological 
environment was addressed in the final experimental chapter. Although the 
chain-disrupted polymer was found to have the best mechanical properties, only 
the 2% POSS nanocomposite had been fully chemically characterised so far, 
including toxicity studies. For this reason, the former was not chosen for animal 
studies. 
 
 
11.9 Burst pressure measurement 
 
 This small study was inspired by the large number of available standards 
available for testing materials and specifically critical biomedical implant 
materials such as cardiovascular devices. The precise standard used was not 
always important for FDA or CE approval, as long as the exact standard used 
was stated. The standards did not always prescribe sample preparation. For 
example a commercial mechanical testing firm prepared dogbone specimens by 
cutting the samples using scissors, which introduces considerable error, 
weakness and edge variation compared with a punch-cutter. For some 
mechanical investigations there were no established testing conditions, 
although the tests themselves were required for regulatory body approval 
before clinical use. Burst pressure testing was one such investigation. 
 Inflation tests of porous grafts was complicated by the leaking of the 
inflation fluid through the graft wall itself. As graft inflation increases, the pores 
stretch worsening the problem. Use of a latex lining eliminates this problem, and 
is essential for porous compliant materials. However, the burst pressure 
achieved is significantly higher if inflation of the latex lining is undertaken at very 
high inflation rate. Furthermore, in compliant materials the burst pressure may 
be lower than the true failure pressure, which is the aneurysmal point for the 
graft. This is the point at which further inflation does not result in further 
pressure increase due to aneurysmal ballooning of the graft. 
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11.10 In vivo model 
 
It was important to show that the graft was strong enough in the dynamic 
state over a longer term to ensure it would not fatigue easily. In addition, the 
biostability over PCU suggested in in-vitro testing needed to be confirmed in-
vivo. The most stringent test of defatigability would be an ovine model, firstly 
because of the clear failure of PCU in this model previously, and secondly, 
because of the poor record of patency of other established and prototype 
synthetic grafts in this model. However, ovine vascular haemodynamics, blood 
clotting profile and graft healing is  similar to the human, making it an apt model. 
In particular, in common with humans, the ovine model does not easily 
endothelialise synthetic grafts. An implantation period which was well in excess 
of the cycle-testing required from the international standard agencies for a 
critical vascular prosthesis was achieved with patent grafts. This period was the 
longest reported implantation of small calibre synthetic grafts in this model. 
Visual, microscopic, ultrascopic structural analysis, mechanical property 
analysis and physioco-chemical analysis all confirmed that the implantation in 
the biological environment, exposed to haemodynamic flow did not cause 
significant biodegradation. This contrasts markedly with the clear visible 
degradation of PCU within a few weeks in the ovine model, showing that the 
incorporation of the POSS nanomolecule afforded impressive resistance to 
biodegradation. 
 The patency may have been initially aided by graft compliance but over 
time a fibrous capsule reduced this property very markedly. This supports the 
theory that compliance matching is essential to prevent NIH in thrombogenic 
graft materials, but less important in conduits with a favourable thrombogenicity 
profile. The low level NIH that was seen may be as a result of the loss of 
compliance due to the fibrous capsules. 
 It was altogether a surprise to find some patchy endothelial-like cells 
which immunostained positive for CD31 and vWF. It may be that unlike humans 
the ovine model does endothelialise vascular grafts but very slowly, and 
previous synthetic conduits have occluded before such a time frame has 
passed. The ovine model was primarily performed to assess biodegradation, 
and the graft samples were required on explantation for thermal, mechanical 
and chemical testing. As a result the further investigation of the healing of the 
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graft including the percentage extent of endothelialisation, the functional 
capacity of these cells and the timing of laying down of these cells could not be 
investigated. This is the next step. 
 
 
 11.1 Further Work 
 
 As my research progressed, many other exciting avenues opened up, 
which I would have liked to have pursued, if time and facilities were available. 
On the mechanical side, the next step would have been to use the detailed 
biaxial tensile data in a finite element analysis logarithm to see if predictions of 
graft behaviour could be made from such models. 
 The final graft used for implantation was necessarily made from the 2% 
POSS nanocomposite. This was because the cytocompatibility and 
thrombogenicity studies were performed by my preceding investigators on this 
particular material. However, during the course of this mechanical investigation, 
it became clear that the chain-disrupted variant had superior mechanical 
properties to PCUPOSS. However, this could not be used in animal models 
without repeating the painstaking work referred to. There just wasn't time. 
However, this is an exciting avenue to pursue, and may result in an improved 
next generation nanocomposite graft, by way of its improved mechanical 
properties. 
 One graft did occlude, and another showed evidence of stenosis. 
Possible reasons for this has not been investigated. The fibrous capsule 
reducing compliance may be partly responsible and a control to implant a 
vascular graft in the ovine neck without anastomosing it into the vascular tree 
would start to answer the question of whether it was due to pure inflammatory 
reaction against the graft material or whether it was due to the constant rubbing 
of the external wall against the subcutaneous tissues as a result of the pulsation 
of the compliant graft. Another way to address this question would be to implant 
the graft as before with another larger graft surrounding it so that the pulsation 
would be 'hidden' within the outer envelope. 
 The PhD students following me are developing the graft further 
mechanically by using the extrusion-phase inversion principle to produce long 
lengths of graft in association with industrial partners. This will be essential for 
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the step up to clinical implantation. They are also introducing biofunctionality by 
adding groups for nitric oxide release and heparin-like moieties. These will add 
to the patency performance of the graft further. 
 Simultaneously the nanocomposite is being developed for many other 
biological implant applications such as microvascular grafts, breast implant 
capsules, biodegradable scaffolds for bone formation and small bowel. 
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